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Numerous studies investigating low-dose computed tomography (LDCT) as a
screening tool for lung cancer have either recently been completed or are ongoing.
However, the optimum strategy for detecting nodules in a CT screening programme
is still unknown. To date screening trials have varied substantially in their reading
strategies. Each of these strategies may lead to different rates of true and false
positive detection. The ideal strategy would maximise detection of lung cancers
while minimising unnecessary costly and potentially harmful investigations. The
type of strategy chosen also has significant implications for the number of
radiologists required for a screening programme, and their workload.
The investigations contained in this thesis are aimed at identifying an optimal
and pragmatic reading strategy for LDCT screening.
First, the potential role of radiographers as readers for LDCT screening was
investigated. Following training and an assessment of continuous feedback learning,
the performance of radiographers reading LDCT screening examinations was
prospectively compared against radiologists; the performance of these radiographers
was comparable to that of radiologists in the published literature, but inferior to that
of radiologists reading the same scans. However, using radiographers as concurrent
readers helped to improve radiologists' sensitivities in nodule detection, with an
increase in false positive detections that is still below that reported for computer-
aided detection (CAD) systems.
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When evaluated as first readers against a clinically-approved CAD system,
radiographers showed that they could achieve sensitivities comparable to or
exceeding that of CAD, with a lower number of average false positive detections for
the majority.
The impact of double- and triple-reading strategies using different methods of
arbitration for discordant findings was compared. Using more than one reader did not
invariably improve pulmonary nodule detection accuracy for experienced thoracic
radiologists, and resulted in increased false positive detections when double-reading
with independent arbitration or triple-reading were used.
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CHAPTER 1: INTRODUCTION
"On one point, however, there is nearly complete consensus ofopinion, and that is
that primary malignant neoplasms of the lungs are among the rarest forms of
disease
-Isaac Adler, Professor Emeritus at the New York Polyclinic,
"Primary malignant growths of the lungs and bronchi: a pathological and clinical
study", Longmans, Green and Co., New York, 1912.
1.1 Lung cancer
1.1.1 Prevalence and incidence of lung cancer
Tumours of the lung were rare at the beginning of the 20lh century. The
renowned physician Sir William Osier devoted only two pages to "New Growths in
the Lung" in the second edition of his "Principles and Practice of Medicine" in 1895,
stating that "primary growths are rare" [l]. In the first comprehensive monograph on
the topic, published in 1912, Isaac Adler, Professor Emeritus at the New York
Polyclinic, found only 374 verifiable cases of lung cancer in the published literature
worldwide [2], However, the incidence of lung cancer in the Western world
accelerated through the mid-20th century, almost exclusively due to an increase in
smoking prevalence during the first half of that century, itself driven by the
expansion of commercial cigarette production [3], Lung cancer is now the most
common cancer worldwide, with an estimated 1.61 million new cases, accounting for
approximately 12.7% of all new cancer cases globally in 2008, and remains the most
common cause of death from cancer for both men and women internationally [4],
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In the UK, lung cancer is the second most common cancer, but remains the
commonest cause of cancer death. In 2010, there were 34,859 deaths from lung
cancer in the UK, accounting for 24% of all male cancer deaths and 21% of all
female cancer deaths [5], Survival in the UK is poorer than many countries in Europe
[6], with only 8.2% of men and 9.3% of women alive at five years in England [7].
The late presentation of lung cancer in the UK [8, 9] is an important reason for this
poor survival: according to the National Lung Cancer Audit Report 2005, 43% of
patients with non-small cell lung cancer in England and Wales presented with stage
IIIB or greater, and would have been unsuitable for surgical resection [10].
The peak incidence and mortality trends closely reflect the trends in
maximum exposure to cigarette smoke over time. In the UK, smoking was at its most
prevalent in the generation of men born around 1910-1911, and in women born
around 1925-1930 [11], Consequently, the overall incidence of lung cancer in males
aged 60-69 rose to a peak in the late 1970s, with a peak of 440 cases per 100,000
men in 1977, while a delayed peak of 880 cases per 100,000 men older than 80 years
of age was seen in 1985. Since then, however, the incidence of lung cancer in men in
the UK has been declining, mirroring global trends: between 2009 and 2011, the
European age-standardised rates for males aged 60-69 and older than 80 were 193
and 574 per 100,000 men, respectively [12],
Although the incidence of lung cancer in women is still lower than in men,
there has been a worrying rise in the incidence amongst women across all age groups
since the 1970s. In England, for example, the age-standardised incidence rate of lung
cancer in women has increased by 9.3% in 10 years, from 34.3 per 100,000
population in 1999 to 37.5 per 100,000 population in 2009 [13], Overall, lung cancer
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rates increased by 62% between 1975 and 2011 among women aged 60-69 [12],
Much of the rise is again attributable to smoking prevalence in women amongst
different birth cohorts. There is also evidence suggesting that lung cancer incidence
in women who are lifelong never-smokers is higher than in men [14, 15], However, a
recent analysis concluded that while never-smoking women aged 50-54 and 55-59
years had a statistically significantly higher incidence of lung cancer than never-
smoking men, the overall age-standardised incidence rates of lung cancer in never-
smoking women of European descent are similar to, and not higher, than those in
never-smoking men [16],
1.1.2 Risk factors for lung cancer
Risk factors for lung cancer include smoking, occupational or industrial
exposure to carcinogens (including asbestos exposure), family history, and previous
history of malignancy, especially treatment for previous Hodgkin's lymphoma.
Smoking is by far the greatest risk factor for the development of lung cancer.
Cigarette smoke is known to contain over 60 carcinogens, such as polycyclic
aromatic hydrocarbons, 7V-nitrosamines, aromatic amines, aldehydes, volatile organic
hydrocarbons, and metals [17]. The now irrefutable causative link between smoking
and lung cancer was suspected as early as the 1920s [3], but it was in 1950 that five
case-control studies firmly established an association between lung cancer and
smoking [18-22], In a recent analysis, Parkin concluded that in 2010, 85% of lung
cancers in men and 80% in women in the UK were attributable to smoking [23],
When environmental exposure to cigarette smoke is included, these proportions
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increased to 87% and 84% for men and women, respectively. However, the
contribution of tobacco exposure to global lung cancer incidence, especially in
women, is thought to be decreasing; for example, up to 53% of lung cancer in
women worldwide is now not attributable to tobacco use [24], Unfortunately, such
analyses of temporal changes in the proportional contribution of tobacco smoke
exposure to lung cancer incidence have been hindered by the limited reliability of
smoking information from population-based registries.
Intensity and duration of smoking are positively correlated with lung cancer
risk and mortality. In one study, the cumulative risk of death from lung cancer by
age 75 among current smokers was about 16%, increasing to 24% for those smoking
at least 25 cigarettes per day [25], Current smokers are 14.7 times more likely to die
of lung cancer than lifelong non-smokers, and 3.6 times compared to former smokers
[26].
Intensity and duration can be combined into a single measure of smoking
activity by calculating pack-years (the number of cigarette packs smoked per day,
multiplied by the number of years of smoking). However, smoking at a lower
intensity for longer is more harmful than smoking at a higher intensity for a shorter
period [27], and using pack-years as a measure of smoking activity can therefore
mask the more important effect of duration.
1.1.3 Pathological classification of lung cancer
Histologically, lung cancer can broadly be divided into non-small cell and
small cell cancer. Non-small cell lung cancer (NSCLC) is by far the most common
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type worldwide, accounting for 85.3% of histologically confirmed lung cancer cases
in the USA between 2004-2008 [28], The most common subtypes of NSCLC are
squamous cell carcinoma and adenocarcinoma, accounting for approximately 32%
and 26% of all cancers in England and Wales in the period between 2006-2008,
respectively [29], However, there has been a change in the relative prevalence of
these histological subtypes over the past three decades in particular. The prevalence
of adenocarcinoma has been rising, such that it is now the most common subtype of
lung cancer in the USA [28], and its incidence is rising in the UK and Europe [30],
This change has been predominantly attributed to smoking low-tar (i.e. filter) and
low-nicotine cigarettes, resulting in smokers smoking more per day and inhaling
more deeply, with a consequent increase in the proportions of carcinogenic N-
nitrosamines within the inhaled smoke [31], The tendency to inhale more deeply on
such cigarettes also exposes the peripheral lung to higher doses of the carcinogens
within cigarette smoke, with the effect that adenocarcinomas occur primarily in the
periphery of the lung [31],
The first standardised classification of lung cancer by histological subtype
was published by the World Health Organization (WHO) in 1967 [32], There have
been three further editions since then, with the most recent histological classification
published in 2004 [33], The classification has considerably evolved through the four
iterations. The third edition, released in 1999, recognised pre-invasive lesions such as
atypical adenomatous hyperplasia (AAH) and tumours of mixed histological subtype
(Figure 1.1) [34], A revised classification of adenocarcinoma was recently
recommended by a joint committee consisting of members from the International
Association for the Study of Lung Cancer (IASLC), American Thoracic Society
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(ATS) and European Respiratory Society (ERS) in 2011 [35]. Chief among its
recommendations was the introduction of new terms to replace the previously used
terms "bronchioloalveolar carcinoma" (BAC) and "mixed type adenocarcinoma", as
these latter categories had encompassed groups of tumours within the
adenocarcinoma spectrum that were quite diverse in radiological and histological
appearance, and in their natural history (see also section 1.5.3.3).
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Figure 1.1. Adenocarcinoma formerly termed mixed subtype. Hematoxylin and eosin
stain at X20 magnification demonstrates an invasive component comprising solid
nests and acinar glands infiltrating fibrous stroma. The tumour also has non-invasive
lepidic components. The term "mixed subtype" adenocarcinoma has now been
discarded. (From reference [34].)
1.1.4 Clinical presentation of lung cancer
Cough is the most common presenting symptom of lung cancer, but occurs
variably in 8-75% of patients [36], Other symptoms include dyspnoea, chest pain,
and haemoptysis. Elowever, patients may commonly present with signs and
symptoms that are not related to the primary tumour. Such symptoms may be
constitutional (such as anorexia and weight loss), or secondary to paraneoplastic
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manifestations or metastatic disease. Up to 43% of patients present late, with
unresectable disease [10, 37], On the other hand, 6-13% of patients may be
asymptomatic at diagnosis [38-40],
The clinical presentation can also be related to the histological subtype [41],
For instance, small cell carcinoma is an aggressive tumour with early metastasis,
while peripheral adenocarcinomas may grow silently and not present until they are
either discovered incidentally on chest radiograph or computed tomography (CT), or
if they present with local invasion, nodal and/or metastatic disease.
1.1.5 Investigations, staging and prognosis
Investigations in lung cancer are aimed at securing the diagnosis, obtaining
staging information, and determining therapeutic options. Staging and diagnosis are
performed using radiological imaging techniques or bronchoscope techniques.
The chest radiograph remains the initial investigation of choice [29], The
chest radiograph may depict: (a) the primary tumour itself, as a solitary pulmonary
lesion; (b) lobar or segmental collapse or consolidation, as a consequence of
bronchial obstruction and inflammation; or (c) abnormalities related to the presence
of local invasion, nodal disease or metastatic disease - for example rib erosion, hilar
lymphadenopathy, or multiple pulmonary nodules. However, chest radiography is
also unreliable in its detection of lung cancer, because it may not be able to detect
small lesions (under 2cm), peripheral lesions may be obscured by bone, and central
lesions arising in the trachea, main and lobar bronchi can be hard to detect due to the
superimposition of mediastinal structures (Figure l.2a) [42],
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The advent of CT has helped to overcome many of the difficulties
encountered in diagnosing lung cancer with the chest radiograph. With its markedly
improved contrast and spatial resolution and its ability to resolve superimposed
structures, thoracic CT avoids most of the obscuring effects that hamper chest
radiography (Figure 1.2b) [43], CT provides improved detection of lesions which are
just a few millimetres in diameter [44], as well as staging information [36],
However, "central" lesions, especially lesions adjacent to the hilum or mediastinum,
may still be easily missed on CT as compared to peripheral lesions [45], without the
benefit of additional reconstruction techniques such as maximum intensity
projections (see section 1.6.2.1).
Figure 1.2. Left lower lobe cancer missed on chest radiograph. (A) Posteroanterior
chest radiograph demonstrates a nodule in the left retrocardiac region that is only
faintly perceptible (arrow). (B) CT section through the left lower lobe demonstrates
the nodule clearly.
Fibreoptic bronchoscopy is an invaluable diagnostic tool for visualising and
sampling central bronchial tumours. Rigid bronchoscopes have been in use since
1897 [46], but were gradually replaced as a primary means of airway visualisation
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with the introduction of the flexible bronchoscope in 1967 [47], Bronchoscopy
enables direct sampling of an endobronchial lesion or indirect sampling by obtaining
bronchial washings or brushings. Furthermore, bronchoscopy allows the
simultaneous sampling of suspicious lymph nodes, using transbronchial needle
aspiration (TBNA) if they are accessible. TBNA may be performed either unguided
("blind") [48] or more recently with ultrasound guidance, using endobronchial
ultrasound (EBUS) [49],
2-[lsF]-Fluoro2-deoxy-D-glucose (FDG) positron emission tomography
(PET) is an imaging tool which identifies malignant neoplasms by taking advantage
of their increased glucose uptake and utilisation, which is proportional to their
metabolic activity [50, 51], The relative uptake of FDG can be calculated from a
static FDG-PET image by the standardised uptake value (SUV). The SUV of a given
tissue is given by:
tracer activity in tissue
(injected radiotracer dose/ patient weight)
where tissue tracer activity is in microcuries per gram, injected radiotracer dose is in
millicuries, and patient weight is in kilograms [51]. FDG-PET integrated with CT
(PET-CT) is now recommended for the non-invasive evaluation of lymph node
involvement and identification of extranodal metastatic disease, if the patient is
suitable for potentially curative treatment [29, 52], Due to its ability to depict intra-
and extrathoracic metastases, FDG-PET may help prevent unnecessary thoracotomy
in up to 20% of patients previously considered operable [53],
CT-guided percutaneous biopsy can be undertaken to obtain histological
tissue from peripheral lesions, provided the lesion is anatomically amenable to
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percutaneous biopsy, and the patient has satisfactory lung function. Obtaining
sufficient tissue for molecular and genetic typing is becoming increasingly important,
with the growing number of molecular targeted therapies available for
adenocarcinoma; thus, core biopsy is preferred over fine needle aspiration.
Alternatively, diagnosis by video-assisted thoracoscope surgery (VATS) biopsy, or
open lung biopsy, may be performed [54],
As with any malignancy, the staging system used for lung cancer allows the
grouping of tumours by their biological behaviour so that the prognostication and
tumours of similar tumours can be standardised and compared. The Tumour, Node,
Metastasis (TNM) staging system, first proposed by Denoix [55], incorporates
different types of staging with different combinations of T, N and M descriptors
forming stage groupings with similar prognoses. It was adapted for use in lung
cancer staging by Dr Clifton Mountain in 1973 [56], with T descriptors broadly
classifiable into size-based and non-size based descriptors. Since then, the TNM
staging of lung cancer has undergone six iterations, with the latest (the 7th edition)
providing the most changes to the system. In this latest edition, new size sub¬
divisions have been created, the status of intrapulmonary metastatic nodules have
been modified, and the concept of intra- and extrathoracic non-nodal metastatic
disease has been introduced, with pleural and pericardial dissemination now
representing M, rather than T descriptors (Table 1.1) [57], These changes have
resulted in new stage groupings (Table 1.2) that have addressed the heterogeneity in
prognosis seen in previous staging editions [58], Also, unlike previous editions, the
7th edition TNM descriptors apply to both NSCLC and small cell carcinoma [59]; a
33
different system had previously been used for small cell carcinoma (limited versus
extensive stage).
Most importantly, the latest edition of the TNM staging reinforces the
importance of the size of tumour as an indicator of prognosis. Patients with tumours
staged pathologically as Tla (< 2cm) have a 77% 5-year survival rate, compared to
those that are T3 on the basis of size (> 7cm), who have a 35% 5-year survival [60],
Patients with pathological stage IA disease (Tla or Tib, NO MO) have a 73% 5-year





Tx Primary tumour cannot be assessed, OR primary tumour detected by
sputum/ bronchial washings but not visualized on any imaging
TO No evidence of primary tumour
Tis Carcinoma in situ
T1 Tumour < 3cm in greatest dimension, surrounded by lung or visceral
pleura, without invasion more proximal than the lobar bronchus1
T1a Tumour < 2cm in greatest dimension
T1b Tumour > 2cm but < 3cm in greatest dimension
T2 Tumour > 3cm but < 7cm OR tumour with any of the following features2:
involves main bronchus, > 2cm distal to the carina; invades visceral
pleura; associated with atelectasis/obstructive pneumonitis that extends
to the hilar region without involving entire lung
T2a Tumour > 3cm but < 5cm in greatest dimension
T2b Tumour > 5cm but < 7cm in greatest dimension
T3 Tumour > 7cm OR tumour that directly invades any of the
following: chest wall (including superior sulcus tumours), diaphragm,
phrenic nerve, mediastinal pleura, parietal pericardium; OR tumour in the
main bronchus < 2cm distal to the carina but without involvement of the
carina; OR associated atelectasis or obstructive pneumonitis of the entire
lung OR separate tumour nodule(s) in the same lobe
T4 Tumour of any size that invades any of the following: mediastinum, heart,
great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral
body, carina; OR separate tumour nodule(s) in a different ipsilateral lobe
Node
Nx Regional lymph nodes cannot be assessed
N1 No regional lymph node metastasis
Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes
and intrapulmonary nodes, including involvement by direct extension
N2 Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)
N3 Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or







Distant metastasis cannot be assessed
No distant metastasis
Distant metastasis
Separate tumour nodule(s) in a contralateral lobe; OR tumour with
pleural nodules or malignant pleural (or pericardial) effusion
Distant metastasis
Table 1.1. The 7th edition of the TNM staging of lung cancer [57].
includes any superficial spreading tumour (of any size) with its invasive component limited
to the bronchial wall, but which may extend proximally to the main bronchus.
2T2 tumours with these features are classified T2a if < 5cm, or if size cannot be determined,
and T2b if > 5cm but < 7cm.
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NO
7tn Edition N descriptor
N1 N2 N3
T1a IA IIA IIIA MIB
T1b IA IIA MIA MIB
7th edition
T2a IB IIA MIA MIB
T descriptor T2b IIA MB IMA MIB
T3 MB IMA IMA MIB
T4 MIA IIIA 1MB MIB
7tn edition M1a IV IV IV IV
M descriptor
Mib IV IV IV IV
Table 1.2. Stage groupings based on the tumour (T), node (N) and metastasis (M)
descriptors of the 7th edition of the TNM staging of lung cancer [57].
1.1.6 Therapeutic strategies
Therapeutic advances relevant to small tumours and early lung cancer that
may incidentally be discovered on screening asymptomatic high-risk individuals are
discussed, as a detailed discussion of all therapeutic strategies for lung cancer is
beyond the scope of this thesis.
Surgery with curative intent remains the standard of care for all patients with
resectable lung cancer who are surgical candidates [29, 61], In general, these are
patients who have Stage I or II NSCLC. Surgery may also be contemplated for early
stage (stage I or II) small cell lung carcinoma [62], but unfortunately such early
presentation is rare.
Size of tumour in NSCLC is an independent prognostic factor for survival in
patients undergoing surgical resection [63-68], For example, in a retrospective
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analysis of 6644 patients in the Japanese Lung Cancer Registry, Asamura et al. found
that patients with pathologically staged node-negative, metastasis-negative tumours <
2cm had a 5-year survival of 83.7%, as opposed to tumours 2.1-3cm in size (76.0%)
[63], Indeed, the improved prognosis of tumours smaller than 2cm was a significant
impetus for the new size subdivisions in the latest TNM staging edition [60],
The surgical method of choice remains lobectomy for patients who are able to
tolerate it. However, lung-sparing operations, broadly termed sublobar resections, are
now an option for patients with suboptimal fitness. Sublobar resections include
wedge resections and segmentectomy, and can be perfonned via open thoracotomy
or VATS. Wedge resections can be used with smaller peripheral tumours and NO
disease, but do not allow the intra-operative sampling of N1 nodes [69], Interest in
sublobar resection has been prompted by the more favourable prognosis of tumours
smaller than 2cm. For instance, a recent analysis by Carr et al. has suggested that
patients with (7th edition TNM) stage IA who underwent segmentectomy had similar
recurrence rates, mortality, and 5-year cancer-specific survival to those at a similar
stage who underwent lobectomy, despite the fact that the segmentectomy cohort was
older and had a significantly lower mean forced expiratory volume in 1 second [65].
There is an increasing array of non-surgical interventions available for
patients who are either unfit for or have declined surgery. The emergence of
stereotactic body radiation therapy (SBRT) has made radiotherapy with curative
intent a viable option for such patients. SBRT is a technique in which high doses of
radiation using numerous small, highly focussed, and accurate radiation beams are
delivered in only 1 to 5 treatments over 1 to 2 weeks [70], An evaluation of 59
patients by the Radiation Therapy Oncology Group, 44 of whom had T1 tumours
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(i.e. up to 3cm) based on the 6 TNM edition, had revealed that SBRT could deliver
3-year disease-free and overall survival rates of 48.3% and 55.8% respectively [71],
A recent comparison of SBRT and wedge resection for stage 1 NSCLC showed that
although wedge resection resulted in improved survival at 30 months, both
modalities showed comparable cause-specific survival, and SBRT reduced the risk of
local recurrence [72],
Platinum-based chemotherapy, as an adjuvant to surgical resection for
patients with stage II NSCLC where there is N1 node involvement, is of proven
thbenefit [73], The role of adjuvant chemotherapy in patients with TNM 6 edition
stage IB disease has remained controversial. An increase in disease-free survival may
be seen in patients with tumours 4cm or greater, but no statistically significant
survival difference at 74 months has been observed in patients receiving
chemotherapy, as compared to those who have not [74], Furthermore, patients who
were classified as stage IB in the 6th edition of TNM staging have now been upstaged
to later stages (stages IIA or IIB) in the 7th edition; the application of chemotherapy
regimens based on the prior editions to patients who are stage IB according to the
new edition is thus unproven, and, outside of clinical trials, such chemotherapy is no
longer recommended [73],
Percutaneous ablative therapy with radiofrequency ablation (RFA),
microwave ablation (MWA) and percutaneous cryoablation therapy (PCT) for small
lung tumours have also been considered as options for patients unsuitable for
surgery. RFA (Figure 1.3) and MWA are heat-based methods that achieve cell death
through thermocoagulation, while PCT causes cell death by ice crystal formation in
the target tissue. In general, technical success of ablation is more likely with tumours
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that are 3cm or smaller in diameter. An analysis of 64 patients with clinical stage I
NSCLC showed that while 3-year cancer-specific survival for a cohort of surgically
unfit patients was best with sublobar resection (90.6%), a comparable survival
benefit was still seen with RFA (87.5%) and PCT (90.2%) [75], However, long-term
data from larger populations regarding these modalities is not yet available. Given
the larger and favourable evidence base for SBRT at present, percutaneous ablative
therapies are not currently recommended as first choice non-surgical interventions,
but may still be considered in patients who are not candidates for SBRT or sublobar
resection [76],
Figure 1.3. Radiofrequency ablation (RFA). (A) Radiofrequency ablation probe,
through which radio waves are emitted. (B) CT section demonstrating the probe within
a right lower lobe tumour during an RFA procedure. Images courtesy of Dr Sisa
Grubnic, St George's Hospital, London.
1.1.7 Physiological considerations
Physiological evaluation is crucial to determining safety to undergo both
diagnostic procedures and therapy. The forced expiratory volume in one second
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(FEV1) and the diffusing capacity of the lung with carbon monoxide (DLco) are both
important predictors of postoperative morbidity and death [77, 78], However, FEV1
and DLco correlate poorly with each other [79], and a reduced DLco can predict
morbidity in patients undergoing lobectomy and pneumonectomy, even in the
absence of obstructive lung disease [80], For these reasons, current guidelines
recommend that both the predicted postoperative FEV1 and DLco should be
calculated in patients being considered for lung cancer resection [81, 82],
1.2 Principles and practice of population-based screening for
cancer
1.2.1 General principles
In 1951, the United States Commission on Chronic Illness defined screening
as "the presumptive identification of unrecognised disease or defects by means of
tests, examinations, or other procedures that can be applied rapidly" [83], This
definition recognises two components to screening:
1) A modality that can be used to identify an abnormality (or biomarker) that
may signify pathology; and
2) The speed (and by implication, ease) with which that modality can be
applied.
Screening is thus aimed at either the asymptomatic individual to detect a
preclinical phase of the target condition, or the symptomatic individual in whom the
condition has not yet been recognised. Screening can instigate diagnosis, but is
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distinct from diagnosis [84], because the abnormality detected is not in itself
diagnostic of the target condition.
In a seminal publication in 1968, Wilson and Jungner set forth 10 key
principles that could be considered "guides to planning case-finding" {sic), that were
applicable to screening at any level (Table 1.3) [85], In addition, Wilson and Jungner
elaborated some practical aspects of screening programmes, including data
collection, handling and storage. In essence, these principles define criteria for the
disease, test, treatment, case-finding and cost-effectiveness in an ethical framework,
such that the Hippocratic principle ofprimum non nocere (first, do no harm), and the
prima facie principle ofjustice - in this case, distributive justice as applied to limited
resources that should be used fairly [86] - are adhered to.
Modern modifications to Wilson and Junger's criteria have been proposed
[87, 88], Andermann et al. summarised some of the modifications that have been
suggested (Table 1.4). In the main, the updated criteria suggest that a target
population be explicitly defined, and the aims, evaluation, and quality assurance
methods of a screening programme be defined at the outset. Wilson and Jungner
discussed mass screening (unselected screening of the whole population) as opposed
to selective screening of high-risk groups, but did not make defining a target
population a guiding principle.
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1. The condition to be screened should be an important health problem
2. An acceptable treatment should exist.
3. Facilities for diagnosis and treatment should be available.
4. There should be a recognisable latent or early symptomatic stage.
5. A suitable test or examination should exist.
6. The test should be acceptable to the population.
7. The natural history of the condition, including the evolution from latent to declared
disease, should be adequately understood.
8. There should be agreement on whom to treat.
9. The costs of case-finding (including diagnosis and treatment of patients
diagnosed) should be economically balanced in relation to possible expenditure
on medical care as a whole.
10. Case-finding should be a continuing process and not a once-off endeavour.
Table 1.3. Key principles of screening for disease, as described by Wilson and Junger
[85].
1. The screening programme should respond to a recognized need.
2. The objectives of screening should be defined at the outset.
3. There should be a defined target population.
4. There should be scientific evidence of screening programme effectiveness.
5. The programme should integrate education, testing, clinical services and
programme management.
6. There should be quality assurance, with mechanisms to minimize potential risks of
screening.
7. The programme should ensure informed choice, confidentiality and respect for
autonomy.
8. The programme should promote equity and access to screening for the entire
target population.
9. Programme evaluation should be planned from the outset.
10. The overall benefits of screening should outweigh the harm.
Table 1.4. Modified principles of screening for disease, as summarised by Andermann
et al [87].
42
In the UK, the principles described by Wilson and Jungner, and the
subsequent modern modifications, have formed the basis for 22 contemporary
criteria for the appraisal of a screening programme itself, as described by the UK
National Screening Committee (Table 1.5) [89],
The Condition
1. The condition should be an important health problem
2. The epidemiology and natural history of the condition should be adequately
understood and there should be a detectable risk factor, disease marker, latent
period or early symptomatic stage.
3. All the cost-effective primary prevention interventions should have been
implemented as far as practicable.
4. If the carriers of a mutation are identified as a result of screening the natural
history of people with this status should be understood, including the
psychological implications.
The Test
5. There should be a simple, safe, precise and validated screening test.
6. The distribution of test values in the target population should be known and a
suitable cut-off level defined and agreed.
7. The test should be acceptable to the population.
8. There should be an agreed policy on the further diagnostic investigation of
individuals with a positive test result and on the choices available to those
individuals.
9. If the test is for mutations the criteria used to select the subset of mutations to be
covered by screening, if all possible mutations are not being tested, should be
clearly set out.
The Treatment
10. There should be an effective treatment or intervention for patients identified
through early detection, with evidence of early treatment leading to better
outcomes than late treatment.
11. There should be agreed evidence based policies covering which individuals
should be offered treatment and the appropriate treatment to be offered.
12. Clinical management of the condition and patient outcomes should be optimised
in all health care providers prior to participation in a screening programme.
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The Screening Programme
13. There should be evidence from high quality Randomised Controlled Trials that the
screening programme is effective in reducing mortality or morbidity. The
information that is provided about the test and its outcome must be of value and
readily understood by the individual being screened.
14. There should be evidence that the complete screening programme (test,
diagnostic procedures, treatment/ intervention) is clinically, socially and ethically
acceptable to health professionals and the public.
15. The benefit from the screening programme should outweigh the physical and
psychological harm.
16. The opportunity cost of the screening programme should be economically
balanced in relation to expenditure on medical care as a whole (ie. value for
money). Assessment against these criteria should have regard to evidence from
cost benefit and/or cost effectiveness analyses and have regard to the effective
use of available resource.
17. All other options for managing the condition should have been considered (eg.
improving treatment, providing other services), to ensure that no more cost
effective intervention could be introduced or current interventions increased within
the resources available.
18. There should be a plan for managing and monitoring the screening programme
and an agreed set of quality assurance standards.
19. Adequate staffing and facilities for testing, diagnosis, treatment and programme
management should be available prior to the commencement of the screening
programme.
20. Evidence-based information, explaining the consequences of testing, investigation
and treatment, should be made available to potential participants to assist them in
making an informed choice.
21. Public pressure for widening the eligibility criteria for reducing the screening
interval, and for increasing the sensitivity of the testing process, should be
anticipated. Decisions about these parameters should be scientifically justifiable to
the public.
22. If screening is for a mutation the programme should be acceptable to people
identified as carriers and to other family members.
Table 1.5. Contemporary criteria used by the UK National Screening Committee for the
appraisal of a screening programme [89].
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1.2.2 Assessment of screening effectiveness
1.2.2.1 Outcome-related measures
Outcome-related measures of screening include survival, disease-specific
mortality, all-cause mortality, absolute risk reduction and relative risk reduction.
Survival rates, usually expressed as the percentage of subjects alive at 1 or 5
years, are a convenient outcome measure, especially for studies assessing therapeutic
benefits or prognosis. However, survival is subject to the multiple biases of lead-
time, length and overdiagnosis (see section 1.2.3.1) and is hence potentially
inaccurate when assessing screening [90],
Disease-specific mortality evaluates death that is directly attributable to the
condition being screened, while all-cause mortality is a measure of deaths in a
particular cohort as a whole. Intuitively, it would seem disease-specific mortality is
the best measure of the effectiveness of screening. However, disease-specific
mortality crucially relies on the accurate classification of the cause of death, without
bias towards the particular condition under study. This has led to the idea that all-
cause mortality could be a better measure of outcome, as it circumvents the problem
of inaccurate recording of cause of death. For a given condition to be able to
demonstrate a significant reduction in all-cause mortality, however, the prevalence of
that condition in the population would have to be high, and for this reason screening
rarely demonstrates such an effect [91], and all-cause mortality could be considered
too stringent an outcome measure [92], The debate regarding which measure is more
accurate still continues, as reflected in two opposing articles in a recent issue of the
British Medical Journal [92, 93],
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Fatality rate (or case-fatality rate) is defined as the number of cancer deaths
divided by the total number of cancers detected, and expressed as a percentage.
Fatality rates thus provide a comparison of cancer deaths against those with the
disease, as opposed to mortality, where the comparison is against the entire screened
population.
Mortality rates and fatality rates can sometimes yield apparently conflicting
data about the efficacy of screening, if the cumulative incidence of cancer differs
among populations in a randomised trial [90], Additionally, it is important to focus
the measurement of efficacy on the time period during which a benefit from
screening is likely to be evident. For example, the Malmo breast screening trial found
no significant difference in cumulative mortality rates between the screened and
unscreened populations [94], However, using data from this trial, Henschke et al.
argued that cumulative mortality is an insensitive measure that masks true benefit,
and that annual fatality rate, which reflects the timing of death relative to the start of
screening, is more sensitive [95], Annual fatality rate in screened and non-screened
cohorts would be equal during the early years of screening introduction, as the
majority of cancers detected in the early rounds of screening would be cancers that in
any case were about to manifest clinically. However, as screening continued, less
aggressive cancers would be detected early, and so the annual fatality rate in the
screened group would fall. Once screening ceased, the annual fatality rate in the
screened group would again rise, until it equalled that of the non-screened cohort.
Absolute risk reduction is the difference in risk of developing lung cancer
between the screened and non-screened cohorts [96], Relative risk reduction is the
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percentage reduction in risk between the screened and non-screened cohorts, given
by:
(risk in screened cohort) - (risk in unscreened cohort) x 100
(risk in unscreened cohort)
1.2.2.2 Detection-related measures
Detection-related performance measures include cancer detection rate
(including early stage detection rate), sensitivity, specificity, positive predictive
value, false positive rate, and false negative rate.
Cancer detection rate is the number of cancers detected as a proportion of the
total number screened. Another meaningful metric of cancer detection is the
proportion of early stage cancers (for example, Stage 1 lung cancers).
Sensitivity is the ability of the screening test to detect a positive case. The
higher the sensitivity, the lower the proportion of false negative cases, and hence the
lower the false negative rate (i.e. the probability of a false negative). Put another
way, the false negative rate can be expressed by (1 - sensitivity).
Conversely, specificity is the ability of the screening test to detect a negative
case. The higher the specificity, the lower the proportion of false positive cases, and
hence the lower the false positive rate (i.e. the probability of a false positive). Put
another way, the false positive rate can be expressed by (1 - specificity) [97],
Sensitivity and specificity are characteristics of the screening test itself, and
are unaffected by the prevalence of the particular condition in the population [97],
However, they do rely on there being a gold standard for diagnosis. The ideal
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screening test would have a high sensitivity (for a low false negative rate) and
specificity (for a low false positive rate).
Finally, the positive predictive value of a test reflects the number of cases
with a positive test that have the disease, as a proportion of the total number of
positive tests. Unlike sensitivity and specificity, the positive predictive value is
proportional to disease prevalence.
The measurement of the detection-related performance measures above is
further detailed in section 2.8.1.
1.2.2.3 Cost-effectiveness
Cost-effectiveness describes the situation where the most benefit is
gained from the least cost. In order to prove its cost-effectiveness, a medical
intervention such as a screening programme must be able to justify its cost by
providing an increased benefit in comparison to alternative strategies [98], The cost
of the intervention can thus be thought of in terms of an opportunity cost - that is, the
benefit that could be obtained by the next best use of the resources that have instead
been allocated to that intervention [99],
In its simplest form, the average cost-effectiveness ratio is calculated by
dividing the cost of a given intervention by a measure of its effectiveness. However,
such a ratio does not take into account the cost of alternative strategies. In
comparison, the incremental cost effectiveness ratio (ICER) does take alternative
strategies into account, and is given by:
(cost of intervention) - (cost of alternative)
(effectiveness of intervention) - (effectiveness of alternative)
[100],
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The justification for an intervention also depends on the "utility" of the
intervention - that is, the preference that individuals have for a given outcome [101],
In turn, these "preferences" are the levels of satisfaction, desirability or distress
associated with a particular health outcome [102], If increased life expectancy is the
sole outcome, cost-effectiveness can be determined on the basis of whether or not
increased life expectancy has been delivered by the intervention. However, many
medical interventions (including screening) may affect measures other than life
expectancy alone, such as pain or disability; as such, cost-effectiveness analyses
increasingly incorporate measures of both life expectancy and preferences. A popular
measure in this regard is quality-adjusted life years (QALYs). A QALY is an overall
measure of health outcome that weighs life expectancy against an estimate of a
person's health-related quality of life. QALYs attempt to address the trade-offs
between mortality, morbidity, and the preferences of patients and society by
combining these factors into a single measure [102]. In the UK, the National Institute
for Health and Care Excellence generally views an intervention with an ICER of less
than £20,000 per QALY gained as cost-effective [103],
Favourable cost-effectiveness has been found in breast screening [104, 105],
while mixed results have been reported for lung cancer screening [106-109], For
example, Wisnivesky et al. reported that screening could be expected to increase
survival by 0.1 year at an incremental cost of approximately 230 US dollars, using
data from the Early Lung Cancer Action Project (ELCAP) [106], In contrast,
Mahadevia et al. found that the ICERs for current, quitting and former smokers were
116,300, 558,600, and 2,322,700 US dollars per QALY gained (approximately £73
261, £351,890 and £1,463,186) respectively. They concluded that barriers such as
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cost of CT and participant anxiety over indeterminate nodules did not make
screening with low-dose CT cost-effective at present [108],
1.2.3 Potential problems in screening
Like all medical interventions, screening has the potential for both benefit
and harm. Unlike other medical interventions, however, it is performed on an
individual in whom disease is not yet recognised. Thus, the difficulties that may be
encountered in screening must be borne in mind when interpreting screening trial
results and assessing its effectiveness.
1.2.3.1 Types of screening bias
Lead-time bias - Lead-time bias exists when the timing of detection/
diagnosis has not been accounted for when comparing survival rates. Lead-time bias
is inherent in measurement of survival because screen-detected cases are by
definition ones that are in a preclinical phase, in contrast to symptomatic cases. As
such, if survival is measured from the time of detection, the survival of a screen-
detected case will invariably be longer than that of a symptomatic case, simply by
virtue of it being detected earlier, even if both screened and non-screened cases die
from the disease at the same point in time (Figure 1.4) [91],
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Figure 1.4. Depiction of lead-time bias. (From reference [91].)
Length bias - Whereas lead-time bias is a function of timing of detection,
length bias could occur if screen-detected tumours are biologically less aggressive.
These tumours would have intrinsically better survival rates than symptomatic cases.
Overdiagnosis bias - Overdiagnosis refers to the diagnosis of a cancer that
would otherwise not cause death [110], either because the individual is more likely to
die from other causes, or the tumour behaves less aggressively. Overdiagnosis can
lead to higher incidence and higher survival in a screened cohort, but still have no
effect on mortality, since the screen-detected cancers are not contributing to
mortality [90],
1.2.3.2 Adherence and contamination
In any screening programme, the rate of adherence needs to be quantified -
that is, the proportion of respondents who complied with the screening regimen and
were followed up. A low rate of adherence can affect the power to detect a
significant mortality effect. Similarly, in the context of a randomised control trial
comparing screening with no screening, contamination refers to the proportion of
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subjects in the non-screening arm who undergo the screening intervention (which
they may do independent of the trial) [111]. High contamination also affects the
power of a screening study because reduced mortality may be seen in both the
screened and non-screened cohorts if the screening intervention is effective.
1.2.3.3 Adverse effects
The potential harms of screening can occur due to both false positive and
false negative results. A false positive result can lead to two adverse consequences:
morbidity arising from investigation of the detected abnormality, and also undue
anxiety. Both of these consequences have been quantified in mammographic
screening, and are not insignificant (see section 1.2.4). In the context of
overdiagnosis, undue harm to the screened individual may also be caused by true
positive results triggering the treatment of a lesion that is relatively indolent.
In contrast, a false negative result may provide false reassurance, and act as
license for an individual to continue engaging in risk-taking behaviour [92], Such an
individual may also suffer morbidity in later years when disease manifests clinically,
as they may feel that the screening process has failed them [112].
Another potential adverse effect of screening from both an individual and a
health resource allocation perspective is opportunity costs. For the screened
individual, these include lost wages or expenses incurred by participating in
screening [91], while at the population level these would include the diversion of
resources away from other healthcare priorities.
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1.2.4 Cancer screening in practice
Screening for cancer has had varying degrees of success. The National Health
Service currently runs three programmes to screen for breast, cervical and colon
cancer [113]. Here the example of mammographic screening is considered, to
illustrate the potential problems and adverse effects discussed earlier.
The first large scale assessment of screening for breast cancer was undertaken
in the Health Insurance Plan (HIP) randomised control trial in New York, initiated in
1963. This trial randomised 62,000 women aged 40-64 years old to receive either a
combination of annual double-view mammography and clinical breast examination,
or usual care (no screening). It demonstrated a 25% reduction in breast cancer-
specific mortality in the screened cohort after 18 years of follow-up [114],
Subsequently, four trials from Sweden (The Two Counties, Malmo, Stockholm and
Gothenburg trials) [115-118], which compared mammography alone to no screening,
as well as trials in Edinburgh [119] and Canada [120], provided compelling evidence
of reduction in breast cancer-specific mortality. However, 49 years after the initiation
of the HIP trial, questions are still asked with respect to the length of follow-up,
biases in randomisation, and the benefit of screening in the 40-49 age group [121],
On the basis of the accumulating evidence of benefit at the time, the National
Health Service Breast Screening Programme (NHS BSP) was initiated in 1988 [122],
Similar national programmes have been initiated in other countries, such as Sweden
[123] and the Netherlands [124], The NHS BSP initially invited women aged 50-64
for single view mammography, but it has since been continuously modifying its
practice. Currently, two-view mammography is being offered to women aged 50-70,
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with plans to extend routine three-yearly invitations to those aged 47-49 and 71-73
by 2016 [125],
However, conflicting evidence regarding the mortality benefit from breast
screening continues to cast doubt over its effectiveness. For instance, Nystrom et al.
quoted a 24% reduction in mortality in an overview of five Swedish trials [126], In a
recent review of breast screening trials for the Cochrane database, Gotzsche and
Nielsen found problems with misclassification of death that led to inaccurate
estimates of cancer-specific mortality, and inadequate randomization in four of the
eight trials evaluated. They concluded that while mammographic screening is likely
to reduce mortality, the effect is probably closer to a 15% relative risk reduction in
cancer-specific mortality rather than the higher levels previously described, and
could also result in an absolute increase in overdiagnosis of 0.5% [127], This view of
increased overdiagnosis has been disputed by evidence from the Swedish two-county
trial and the NHS BSP [128], However, an independent UK review recently
concluded that 43 deaths from breast cancer would be prevented and 129 cases of
breast cancer would be overdiagnosed for every 10,000 UK women aged 50 years
invited to screening for the next 20 years, i.e. one breast cancer death prevented for
about every three overdiagnosed cases [129],
The psychological impact of breast screening has been evaluated in detail. In a
systematic review of 54 papers from 13 countries, Brett et al. concluded that women who
were recalled for further investigations suffered significant short-term, and possibly
long-term anxiety. The increased risk of anxiety was associated with multiple factors,
including pain during mammograms and previous false positive rates [130],
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From the above discussion, it can be seen that the breast screening experience
holds important lessons for other screening modalities that are still building an evidence
base, including low-dose CT (LDCT) screening for lung cancer.
1.3 History and practice of lung cancer screening
1.3.1 Screening principles as applied to lung cancer
Lung cancer meets the majority of the principles for screening set forth by
Wilson and Jungner (Table 1.2) [85], Considering each principle in turn:
1) It is an important health problem with a significant human and financial
cost (section 1.1.1).
2) and 3) There are acceptable surgical and non-surgical treatments, with
facilities for diagnosis and treatment available (section 1.1.6). However,
access to some diagnostic tests and treatments may be concentrated in large
centres and vary regionally.
4) and 8) Stage I cancers can be recognised in a preclinical phase, and have
improved survival (section 1.1.5). There are also international guidelines as to
who should be offered treatment [29, 61],
5) and 6) LDCT is a possible test with a low amount of radiation (section
1.4). However, it is unclear if LDCT is acceptable to the population as a
whole.
7) The understanding of the natural history of the various histological
subtypes of lung cancer continues to improve. However, new advances in
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molecular and genetic subtyping are forcing reappraisal and reclassification
of some forms of lung cancer, for example adenocarcinoma [35], New
staging information has helped to redefine stage groups for lung cancer which
more accurately reflect prognosis [58],
9) and 10) The feasibility and cost-effectiveness of "case-finding", i.e.
recruitment to a lung screening programme, are aspects being evaluated in
multiple LDCT lung screening trials at present. Cost-effectiveness has been
evaluated in observational studies of lung cancer screening [106-109], but not
explored fully in randomised control trials.
1.3.2 Lung cancer screening with chest radiography
There have been several trials initiated between the 1950s and 1990s to
evaluate lung screening with chest radiography, all but one of which (The Tokyo
Metropolitan Government Study) involved exclusively men [90]. Two of the earliest
screening studies on chest radiography and sputum cytology screening for lung
cancer were performed in the UK, and also exclusively targeted men [131, 132].
Five large randomised trials of varying design have been conducted. Three of
these trials, the Memorial Sloan Kettering Lung Project (MSKLP), the Johns
Hopkins Lung Project (JHLP) and the Mayo Lung Project (MLP) together
constituted the Cooperative Early Lung Detection Program of the National Cancer
Institute (NCI) [133], targeting male heavy smokers aged 45 and over. The other two
trials were the Czech Study on Lung Cancer Screening and the Prostate, Lung,
Colorectal and Ovarian (PLCO) randomised trial.
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The MSKLP and the JHLP both randomised participants to a single screen
with an annual chest radiograph, or a dual screen consisting of an annual radiograph
and sputum cytology examination every 4 months, over 5 years. Both trials in effect
had two different interventions and so arguably they did not contain an effective
control group. No effect on any outcome parameter (stage distribution, resectability,
survival or mortality) was observed in either trial after 5 years [ 134, 135],
In the third component of the NCI study, the MLP, participants initially
underwent a prevalence screen with a single chest radiograph and sputum study;
those with no cancer were then randomised to a four-monthly chest radiograph and
sputum cytology study, or a control group where annual chest radiograph and sputum
cytological examination were recommended but not enforced (i.e. an "advice"
group). Again, the control group here may thus not have been sufficiently rigorous.
The MLP also suffered from a poor adherence rate. At initial follow-up, there were
no differences in mortality, but 5-year survival in the screened group was more than
double that of the control group. However, there was an excess of 46 lung cancer
cases (i.e. a 29% higher incidence) in the screened group [136], After 20.5 years of
median follow-up, the survival benefit in the screened arm not only persisted but was
greater (by about 3 times); again, lung cancer deaths were not statistically
significantly different in the two groups, but were in fact higher in the intervention
arm (4.4 per 1000 in the screened group and 3.3 per 1000 in the control arm) [137],
Furthermore, the persistence excess cancer rate in the screened group (17% after
more than 20 years follow-up) indicates that overdiagnosis (see section 1.2.3.1) may
have been a contributory factor [138],
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The PLCO trial is the largest randomised control trial (RCT) to date to assess
chest radiography screening. It was initiated in 1993 and has only recently completed
follow-up and analysis [139], The PLCO randomised 154,901 participants aged 55-
74 (men and women) to receive either an annual chest radiograph or no intervention
("usual care") over 4 years. This trial was population-based, and thus unlike the
previous chest radiography trials, did not target a high-risk group. The trial was
designed to detect a 10% or greater reduction in lung cancer-specific mortality with
at least 90% power. After 13 years, no mortality difference was observed between
the groups, with 1213 lung cancer deaths in the screened group, versus 1230 in the
control group. Unlike the MLP, no statistically significant difference in incidence
was found between the two groups (6% higher incidence in the screened group), but
the large majority of lung cancers in the screened group were detected outside of
screening.
Thus, the overall conclusion from the trials assessing screening with chest
radiography has been that there is no significant reduction in mortality, and
overdiagnosis is a significant concern.
1.3.3 Lung cancer screening with low-dose computed tomography
(LDCT)
1.3.3.1 Observational trials assessing screening with LDCT
The lack of benefit from screening with chest radiography not only led to
recommendations against screening, but arguably also extended caution to screening
with alternative strategies, including CT [ 140].
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LDCT had emerged as a potential screening tool by the end of the 1980s
[141], The first trial to assess LDCT was the Early Lung Cancer Action Project
(ELCAP) in the 1990s that enrolled 1000 volunteers with a 10 pack-year smoking
history to undergo two-view (posteroanterior and lateral) chest radiography and an
LDCT scan. Enrollees with between 1 and 6 nodules had each nodule evaluated for
size, location, calcification, shape and edge. Patients with more than 6 nodules were
considered to have diffuse nodular disease. Nodules measuring up to 20mm that had
smooth edges with benign patterns of calcification were classified as benign. For
non-calcified nodules, a follow-up algorithm based on diameter was devised [142],
Using this algorithm allowed the detection of 27 (2.7%) lung cancers with LDCT, as
opposed to 7 (0.7%) with chest radiography. Also, 23 of the 27 (85.2%) cancers on
LDCT as opposed to 4 of 7 (57 .1%) on chest radiography were stage I, with 26 of the
27 LDCT-detected cancers being resectable.
The success of ELCAP provided the springboard for the International
ELCAP (I-ELCAP) [143], as well as 10 other studies initiated between 1993 and
2000 [144-153], However, these were all single-arm observational cohort studies, as
opposed to RCTs, and therefore their ability to detect a true effect of LDCT on
mortality was limited [91]. Consequently, a multitude of recently concluded or
ongoing RCTs assessing LDCT either against usual care, or some other intervention
were initiated. A selection of these is now discussed.
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1.3.3.2 Randomised control trials assessing LDCT screening
Tables 1.6 and 1.7 summarise the nodule management algorithms of recent
randomised control trials assessing LDCT. In general, these trials have follow-up





NLST [154] NELSON [155] DLCST [156] UKLS [157]
<2 < 15 None LDCT at 12 None
months
3 15-50 LDCT at 12
months
4 LDCT at
5 50-500 3,6,12 or 24 LDCT at 3 Combination LDCT at 3
6 months, months; of VDT months;
7 depending on assessment of assessment assessment of
8 lesion size VDT; if VDT < and FDG- VDT;
9 and level of 400 days- refer PET for if VDT < 400
10 suspicion of to pulmonologist nodules 5- days- refer to
malignancy VDT=400-600 15mm pulmonologist;
days- LDCT at 9 if VDT > 400
months days- LDCT at
VDT > 600 9 months
days- LDCT at 9
months
15 >500 LDCT at Referral to Referral to
>20 3,6,12 or 24 pulmonologist multi-
months, for work-up disciplinary











Table 1.6. Management algorithms for solid nodules in the NLST, NELSON, DLCST
and UKLS trials.
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< 2 < 15 LDCT at LDCT at 3,6 None None
3 15-50 3,6 and 12 and 12
months; if months; if
4 unchange unchanged,
5 50-500 d, further further CT at LDCT at 3 Nodules 60-
CT at 24 24 months months; if > 250mm3- LDCT
months 1mm increase at 3 months; if
6 Oral in diameter, volume increased
7 antibiotics, FDG-PET or by > 25%,
LDCT in 6-8 invasive suspected
weeks; if no procedure malignancy
regression,
8 follow-up CT FDG-PET; if
9 or invasive PET-positive, Nodules >
procedure FNA 250mm3- FDG-
recommended. PET or lung
10 Oral antibiotics, LDCT in If PET-negative, biopsy
15 >500 6-8 weeks; if no repeat CT in 3
regression, FDG-PET months.
> 20 Discretionary oral
antibiotics, then LDCT or
standard contrast-







repeat CT in 4
weeks
performed
Table 1.7. Management algorithms for solid nodules in the DANTE, ITALUNG and
MILD trials.
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The National Lung Screening Trial (NLST) was a 33-centre prospective RCT
in the United States that randomised high-risk participants to LDCT or single-view
chest radiography. The NLST was allied to the PLCO trial, and this was part of the
reason why the NLST used radiography, and not usual care in the control group
[161]. Three rounds of annual screening were performed, and interim analyses were
conducted from April 2006 through to 2010, encompassing the last round of
screening in 2007. The study was designed to have 90% power to detect a 21%
reduction in mortality, independent of the number of rounds of screening [162], A
positive result in the NLST constituted a finding suspicious for lung cancer, defined
on LDCT as non-calcified nodule(s) (NCNs) >4mm in greatest transverse dimension,
or any other suspicious finding. The NLST protocol was not prescriptive, but some
recommendations for follow-up of positive screens based on contemporary standard
practice were provided [154],
The NLST used outreach methods such as direct mailings and advertisements
in the mass media, to enrol 53,454 enrolees between August 2002 and April 2004.
The NLST participants were younger, substantially better educated, and were less
likely to be current smokers, compared to the general population as assessed by the
Tobacco Use Supplement of the US Census Department Continuous Population
Survey for 2002-2004 [163], but were otherwise representative of the general
population. The interim analysis performed in October 2010 revealed 356 deaths
from lung cancer in the LDCT arm of the trial, compared to 443 in the chest
radiography arm, corresponding to cumulative lung cancer mortality rates of 247 and
309 deaths per 100,000 person-years, respectively. This 20.0% reduction in lung
cancer-specific mortality was statistically significant, exceeding that expected by
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chance. A lower but still statistically significant decrease in all-cause mortality of
6.7% was also observed in the LDCT cohort. The majority of patients were
diagnosed at an early stage, with 93% of stage 1 lung cancer patients detected by CT
undergoing surgery with curative intent [164],
However, the false positive rate of screens varied between 95% and 98% on
LDCT in the three screening rounds, compared to between 93% and 96% on
radiography. Also, the proportion of confirmed cancers increased in the final
screening round (5.2% versus 2.4% in the second round), although the proportion of
cases designated positive decreased (16.8% versus 27.9%). The reasons for this are
still unclear [164], Although the NLST does not directly compare LDCT with usual
care, a recent sub-analysis of NLST-matched participants in the PLCO trial has
revealed no significant difference in lung cancer mortality between CXR screening
and usual care [139]; this has been taken to indirectly imply no significant difference
between CT and usual care.
The NELSON (Nederlands-Leuvens Longkanker Screenings Onderzoek) trial
in the Netherlands and Belgium has been ongoing since 2003 [165], In contrast to the
NLST, NELSON randomised participants to screening with LDCT or 'usual care',
i.e. no screening at all. Rather than pre-defined eligibility criteria, NELSON used a
population-based questionnaire to determine what the optimum risk-based selection
criteria would need to be to achieve a balance between risk profile, sample size and
required rates of participation and retention [165], This approach to recruitment
seemed to provide better concordance of characteristics between the trial and general
populations [166], NELSON offered four rounds of screening: participants
underwent screening at baseline, one year, three years and finally 5.5 years later
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[167], Further, participants will be followed up over a longer period of 10 years in
total.
NELSON is the first study to incorporate volume doubling time (VDT)
calculations using semi-automated volumetry into a prescriptive nodule management
algorithm. Nodules are classified into four categories: categories I and II are
considered negative [benign or NCN less than category III, respectively], category III
indeterminate (a solid NCN, or solid component of a part-solid nodule with a volume
of 50-500mm ; a non-solid nodule or non-solid component of a part-solid nodule
with a mean diameter of > 8mm; or a solid pleural-based nodule 5-10mm in
minimum diameter i.e. perpendicular to the pleura), and category IV positive (a solid
NCN, or solid component of a part-solid nodule with a volume > 500mm \ or a solid
pleural-based nodule > 10mm in minimum diameter) [155], Participants with
indeterminate nodules are invited back for a subsequent low-dose CT at 3 months
(baseline screening) or 6-8 weeks (subsequent incidence screening). Cases where the
VDT is less than 400 days are then considered positive, and further diagnostic
strategies are then pursued. Finally, a VDT of > 600 days was considered negative.
The threshold of a VDT < 400 days was chosen as lung cancers with a VDT greater
than this may be overdiagnosed cases that do not contribute to mortality [168-170],
The rationale for a shorter initial interval of follow-up CT during incidence screening
was that any new malignant nodule that had appeared over the 1 year between
baseline and first incidence screen must have a short VDT, and therefore, would be
shown to be growing rapidly even after a brief period of follow-up. Combining
volumetric assessment with a standardised growth measurement in this way
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potentially limited the unnecessary investigation of indeterminate but ultimately
stable nodules.
NELSON also differs from the NSLT in that two independent readers initially
interpreted LDCT studies, unlike the single reader strategy used in the NLST. On
baseline screening, 8623 NCNs were detected in approximately half of all
participants, and 98% of these nodules were solid. According to the NELSON nodule
definitions, 196 participants had 260 nodules that were positive, in which 70 lung
cancers were finally detected. This detection rate of 0.9% was lower than that of
other published trials [142, 152, 171-173], but the proportions of Stage I disease in
the baseline, second and third screening rounds were similar to that of other trials
(64.9%, 70.7% and 62.3% respectively) [167], Results of the fourth screening round
and mortality data are still awaited. Recruitment characteristics and key results from
the NLST and NELSON trials are compared in Table 1.8.
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NLST [164] NELSON [169, 174]
Parameter assessed Mean diameter Volume and diameter
Screening round 1 2 3 1 2
No. recruited 53454 15822
No. screened by LDCT 26309 24715 24102 7557 7289
Positivity rate1(%) 27.3 27.9 16.8 20.8 7.8
No. of lung cancers in
LDCT arm
270 168 211 70 54
Lung cancer detection
rate (%)
1.0 0.7 0.9 0.9 0.5
Stage I cancer (%) 63.0 (across 3 screening rounds) 64.9 70.7
Invasive procedures
(%)2
% with no lung cancer
1.7 1.1 1.3







3.8 2.4 5.2 4.6 9.5
Table 1.8. Characteristics and key results of the NLST and NELSON trials.
1
Positivity rate is defined as the number of subjects with a positive finding, divided by the
total number of subjects screened in the LDCT arm, expressed as a percentage. Note that
the nodule management strategy of the NELSON study allowed studies to be called
indeterminate and subjected to follow-up scans, but for the purposes of standardization with
other trials, indeterminate scans have been considered as positive and included in the
calculation of the positivity rate.
2The ways in which invasive procedures have been defined and reported so far has varied
between trials. For example, the rates of invasive procedures for NLST shown here include
bronchoscopy, while those of NELSON do not.
Four smaller European randomised control trials that have recently published
results are comparing LDCT with usual care in some form. These are the Danish
Lung Cancer Screening Trial (DLCST), The Detection And Screening of early lung
cancer by Novel imaging Technology and molecular Essays (DANTE) study, the
Italian Lung (ITALUNG) trial, and the Multicentric Italian Lung Detection (MILD)
trial. The DLCST was initially allied to the NELSON study, with a similar nodule
management protocol [156]. The DANTE study is using an initial baseline screening
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chest radiograph to then randomise participants to LDCT screening or usual care. All
four trials have incorporated FDG-PET into their algorithms (Tables 1.4 and 1.5). In
addition, the DANTE and ITALUNG trial incorporated discretionary antibiotic use
and follow-up imaging into their nodule follow-up pathways. The MILD trial is
unique in two respects: it is only following a maximum of four NCNs, and it is
further randomising those in the screened cohort to repeat LDCT in 1 or 2 years
[160],
The DANTE and ITALUNG studies have reported lower percentages of stage
I cancers at baseline analysis compared to earlier observational studies [158, 159],
Furthermore, the DANTE, DLCST and MILD trials have revealed no significant
difference in mortality between screened and control cohorts, but the short median
follow-up duration (less than 5 years) means these results should be interpreted with
caution [160, 175, 176],
1.3.3.3 Potential questions to be answered by LDCT trials
The current European randomised screening trials are well-placed to answer
questions regarding differences in lung cancer detection and mortality rates in
different populations, the optimal nodule measurement and management strategy, the
duration and interval of screening, LDCT reading strategies, and cost-effectiveness.
1.3.3.4 The UK Lung Screening Trial
In comparison to some other European countries, the UK has been slow to
commence a national LDCT screening trial. An RCT comparing LDCT with usual
care has been planned since 2000, by the UK Cancer Coordinating Committee for
Research (UKCCR) [ 177], but faced various delays. However, a pilot study of the
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UK lung cancer screening trial (UKLS) is now underway, and aims to randomise
4000 participants to a single LDCT or usual care arm, with a shorter total follow-up
period of 18 months. The recruitment and nodule management strategies of the study
have been based on the NELSON trial, but with important differences. Individuals
aged 50-75 will initially be approached via a questionnaire, and a cohort with a
higher risk profile than that of NELSON will be selected based on a five-year lung
cancer predictive risk model devised by the Liverpool Lung Project [178], Unlike
NELSON, nodules measuring 15-50mm3 will be targeted for follow-up, in view of
the single screen design.
The participants will undergo only a single screening LDCT unless follow-up
is required based on the management algorithm. This 'single-screen design' is felt to
be the most cost-effective and rapid method of answering the primary question - does
LDCT reduce lung cancer mortality [157]? While it is not reflective of an actual
iinplementable screening programme in which repeated screening would occur, the
ideal interval for screening may be theoretically determined. The single-screen
design has also been used in other screening studies [179],
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1.4 Screening with low-dose computed tomography:
technical considerations
1.4.1 Computed tomography systems
The technique of computed tomography was pioneered by Sir Geoffrey
Hounsfield in 1973 [180], Modern CT scanners fundamentally have an x-ray source
emitting a fan beam and rotating on a gantry, through a ring composed of a detector
array. The patient is moved through the ring during the image acquisition, and the x-
rays penetrate the patient and are incident on the detector. The signals from the
detector are reconstructed by a computer, and the resulting image is a cross-sectional
display that corresponds to the degree of attenuation of the x-rays by the various
materials within the scanned volume. The attenuation of a given material is a
function of its density - the higher the density, the greater the attenuation. The
density of a material on CT is calculated by its relative difference from the
attenuation of water (arbitrarily assigned a value of 0), on a logarithmic scale, called
a CT number (or Hounsfield number), and expressed in Hounsfield Units (HU).
The newest generations of CT scanners have multiple rows of detectors, and
are called multidetector CT (MDCT) or multislice CT. The multiple rows allow
thinner collimation and overlapping coverage in the longitudinal (z) axis, and so can
perform volumetric scanning (continuous scanning of the whole volume). This has
enabled near isotropic resolution - that is, all three dimensions of the volumetric data
element (or voxel) are nearly equal [181]. Isotropy has facilitated accurate three-
dimensional image reconstructions without distortion along the z-axis.
69
The lungs already have an inherently high contrast resolution on CT because
the attenuation of the lung predominantly consists of two materials of markedly
different density (air and the vasculature). The increased z-axis coverage of MDCT,
coupled with greatly improved gantry rotation speeds, now allows the thorax to be
scanned within one breath-hold. Thus contemporary CT scanning of the lungs has
both high spatial and contrast resolution.
1.4.2 Radiation exposure
The dose delivered by a conventional chest CT can be greater than 100 times
that of a posteroanterior chest radiograph [182], As with any medical exposure to
ionising radiation, the dose to the patient from CT should always follow the ALARA
(as low as reasonably achievable) principle: the delivery of the minimum radiation
dose possible to achieve an image of diagnostic quality, so that the hazards of
ionising radiation are minimised.
CT dose depends on a number of acquisition parameters and patient factors.
The energy of the x-ray beam for any given CT acquisition depends upon the anode-
cathode voltage (in kilovolts, and may be stated as its peak value, kVp, or now more
usually as kV), the tube current (in milliamperes, mA), and the tube current-time
product (in milliampere-seconds, mAs), which is the product of tube current and the
exposure time per gantry rotation. Lowering the kV reduces the effective energy and
number of photons of the x-ray spectrum, while lowering the mAs reduces the
number of photons but does not change the effective energy of the spectrum [183], A
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reduced number of photons will result in a decreased dose, but will also affect image
quality due to an increase in image noise.
Scanner geometry can affect absorbed dose because of differences in the
distance between the focal spot of the radiation source and the scanner isocentre;
according to the inverse square law, radiation intensity is inversely proportional to
the square of the distance between the source and the point of measurement. MDCT
scanners have a shorter focal spot to isocentre distance compared to single-slice CT
scanners, and so may result in increased dose if all other factors are kept constant
[184],
Helical pitch is defined as the ratio of table feed per gantry rotation to the
nominal width of the x-ray beam. Thus, an increased pitch results in a decreased scan
time and reduced dose. Pitch, section collimation and table speed are all intertwined:
for a given collimation, a faster table speed will increase pitch. However, an
increased pitch can result in decreased spatial resolution, since it decreases the
duration of radiation exposure for a particular anatomical section scanned [185],
Similarly, a thicker collimation is more dose-efficient; this is because a thicker
collimation on MDCT can limit a phenomenon known as "overbeaming", whereby a
proportion of the x-ray beam falls beyond the edge of the detector rows and so does
not contribute to image quality [185], However, a thicker collimation can also limit
the thickness of the reconstructed image. In this way, trade-offs between dose and
image optimization must be carefully balanced.
Patient factors that affect radiation dose include body weight and shape. The
attenuation of a given x-ray beam increases with the thickness of the material in its
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path, and thus, with increasing body mass index, there is a decrease in the detected x-
ray intensity. To compensate, an increased tube current and kilovoltage may be
employed for a person with a higher body mass index, thereby increasing the
effective dose [186], However, as body shape varies, the intensity detected can vary
along the z-axis according to the thickness of the part of the body scanned [ 187],
Modern CT scanners have automated exposure control (AEC) functions that allow
modulation of the exposure to compensate for some of these patient factors [188],
Common descriptors of CT dose are the CT dose index over the volume
scanned (CTDIvoi), which takes the axial scan spacing and helical pitch into account,
and the dose-length product (DLP), which is the product of CTDIvoi and the length
covered. The DLP is measured in milligray-centimetres (mGy-cm). A conversion
factor for the chest can be used to estimate the effective dose, in millisieverts (mSv).
[189], There is variability in the effective dose delivered by a standard dose CT
thorax, primarily due to the variation in tube current-exposure time product. For
instance, a thoracic CT performed with a 4-slice MDCT at 120 kVp tube voltage,
4x 1 mm detector configuration, 0.5s rotation time, a pitch of 1.75, and effective mAs
of 100 can result in an effective dose of 6.8 mSv [190], The risk of radiation-induced
malignancy from such a standard-dose CT chest examination has been estimated at
approximately 1 in 4000 [191],
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1.4.3 Low-dose CT technique
The feasibility of low-dose CT (LDCT) in the thorax was reported by Naidich
et al. in 1990 [141], They compared CT images obtained at 120kV, 140 mA, 2
second scan time, and 10mm thick sections reconstructed with a standard algorithm,
to two different low-dose protocols: in the first protocol, they altered only the tube
current to 10 mA and acquired images at 5 different levels selected from the initial
standard dose CT. In the second protocol, they acquired a half-scan at 10 mA that
was performed with an acquisition time that was two-thirds that of a full scan.
Acceptable visualization was obtained at all chosen levels [141],
Subsequently, other investigators have proven that LDCT is acceptable for
viewing normal structures [192, 193] and for a variety of pathological conditions
[194, 195], including pulmonary nodule detection (see section 1.6.2.1). The dose
reduction using such protocols is significant: For example, Remy-Jardin et al.
estimated that using a low-dose protocol (120 kVp, 60-100 mAs depending on body
weight) provided a dose of 1,9mSv and 2.4mSv across a 30-cm section of the thorax
for male and female patients respectively, compared to 3.4 mSv and 4.4 mSv
respectively at standard dose [194], LDCT thus provides a viable imaging strategy at
reduced dose in those subjects requiring serial CT surveillance. It is worth noting that
some authors have taken the view that due to a lack of a precise definition, the term
"low-dose CT" should be abandoned in favour of accurate reporting of dose
parameters [196],
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1.4.4 Image reconstruction, post-processing and reading
Thoracic CT images are normally reconstructed using a high-frequency
reconstruction algorithm (also called a reconstruction kernel) that maximises the
inherent high contrast ratio within the lungs [197], A volumetric MDCT study can be
reconstructed at varying slice thickness - thinner slices provide more resolution but
have increased noise, whereas the converse is true for thicker slices. As for all CT
studies, the grayscale is optimized for the structures being analysed, by altering the
window settings of the image. For the lungs, a frequently used window setting is
with the centre level at -600 HU, with a width of 1500 HU [198],
Modern CT images are viewed on softcopy on a Picture Archiving and
Communications (PACS) workstation, which improves a radiologist's workflow,
given the large number of images generated by MDCT. A variety of reconstructions
can be performed using the raw data at the scanner console or from thin slices on
most PACS workstations. Multiplanar reconstructions (MPRs) can be performed in
any orthogonal and non-orthogonal plane [199], Maximum intensity projection
(MIP) reconstructions are obtained by summing the pixels with the highest CT
numbers within a given voxel. In this way, the conspicuity of high attenuation
structures is increased (Figure 1.5) (see also section 1.6.2.1). Conversely, minimum
intensity projection (minIP) improves visualisation of low attenuation structures, and
so for example, makes air within bronchi below the subsegmental level more readily
visible [200].
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Figure 1.5. Maximum intensity projection (MIP). (A) 1mm-collimation CT image
demonstrates a nodule in the right lower lobe adjacent to a vessel, but that is quite
easy to miss. (B) 5mm MIP reconstruction depicts the adjacent vessel more clearly
and increases nodule conspicuity.
1.4.5 CT measurement methods for lung nodules
The size of a lung nodule can be measured using diameter, area or volume,
though traditionally the diameter of a nodule has been the most widely used method
in clinical practice. This diameter can either be a uni-dimensional measurement of
the maximum diameter of the lesion, or using length and width to provide a mean
diameter, as recommended by the Fleischner Society [44], Bi-dimensional
measurements can also be performed to obtain a cross-sectional area; in turn, this
cross-sectional area can be multiplied by sectional increment to obtain a volume
measurement [201 ]. Different modifying equations to account for section-to-section
variability in nodule shape can be applied for spherical, elliptical or irregularly-
shaped nodules [202],
For three-dimensional segmentation of lung nodules, volume rendering is
first performed. Volume rendering is a 3D technique that applies a histogram-derived
tissue classification based on attenuation to the entire CT dataset. By mapping CT
attenuation values to opacity, brightness and colour, structures of different density
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can be selectively concealed or revealed [203], The exact technique and algorithm
differs between manufacturers, but in principle segmentation of a nodule can be
performed, to define the structure of interest and exclude structures such as vessels
and adjacent lung parenchyma (Figure 1.6). A measurement algorithm can be
initiated with a mouse click, to calculate the nodule volume [204], As this requires
high computational power, volumetric analysis is not routinely available on PACS
workstations, but is available on dedicated workstations provided by CT
manufacturers. The volumetric segmentation method used in the UKLS and in this
thesis is described in more detail in Chapter 2, section 2.7.2.
Figure 1.6. 3D segmentation and volume calculation of a small lung nodule using
LungCARE software (Siemens Medical Solutions, Erlangen, Germany). Segmentation
is initiated simply by clicking on a nodule on the CT image.
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1.4.6 Overview of computer-aided detection and diagnosis
Investigations into using computer-aided detection (CAD) in thoracic CT
began in earnest in the 1990s [205], Currently, CAD in thoracic CT is used to
describe a spectrum of activities encompassing detection, interpretation, decision¬
making, quantitative analysis and enhanced visualization [206], The term CADx is
sometimes also used to distinguish computer-aided diagnosis from other aspects of
CAD. However, for the purposes of this discussion they will be considered as
synonymous.
CAD has three basic components: an imaging processing step, a segmentation
step, and finally a feature extraction or classification step. Ko and Naidich provided
an illustration of how these components may be involved in nodule detection and
interpretation [207], The initial image processing is necessary to separate the thoracic
cage from the surrounding lung, using downsampling (a technique whereby pixel
width is changed to make the image matrix smaller) and subsequent application of a
threshold based on attenuation to remove air from the surrounding tissues within the
image. Subsequently, the pleura can be removed, and the lung parenchyma can then
be segmented so that the CAD algorithm can analyse candidate regions for the
presence of nodules and normal structures (Figure 1.7). Regions of interest (ROIs)
are drawn over potential target candidates and interrogated using a method known as
feature extraction or classification, which relies on a database of predetermined
features such as sphericity [207],
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Figure 1.7. Lung segmentation and detection in a CAD algorithm. The lung border has
been traced, with the black crosses indicating the most anterior, posterior, lateral, and
medial pixels of each lung. The pixels of both lungs are used to calculate the centre of
the thorax (white cross over trachea), and the pixels of the individual lungs are used
to calculate the respective right and left lung centres (white crosses in the respective
lungs). Candidate regions have then been detected by the computer, and colour-
coded white for nodules and black for vessels. (From reference [207].)
Multiple feature classification methods are available, and most use a set of
features such as size, shape and intensity, to form the inputs into the algorithm, and
generate a single output (malignant or benign). These methods include artificial
neural networks, support vector machines, linear discriminant analysis and traditional
and belief decision trees. The data used to generate the feature classification is
derived from expert panels forming a consensus of "truth" as to what constitutes a
nodule, except for neural networks, which can adapt and leam. However, approaches
using the distribution of interpretations (rather than the final consensus answer)
performed by a radiologist are also possible, provided multiple aspects of those
interpretations have been adequately captured [208], Thus, the reference standard
used by a particular CAD algorithm is heavily dependent on the robustness of its
"truth" dataset. The Lung Image Database Consortium (LIDC) has recently
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completed the compilation of a large database of corroborated lesions, where the
various features of lesions that have been defined as nodules and non-nodules by
multiple radiologists have been recorded in detail, to assist in the development of
more robust reference standards [209].
1.5 The pulmonary nodule
1.5.1 Relevant pulmonary anatomy
The normal right lung consists of three lobes: the upper, middle and lower
lobes. The normal left lung consists of two lobes, the upper and lower lobes. The
trachea divides into right and left bronchi, which in turn divide into the lobar bronchi
and then ramify into segmental bronchi. Each segmental bronchus is part of a
separate functionally independent unit of lung termed a bronchopulmonary segment.
There are usually 10 bronchopulmonary segments in the right lung and eight on the
left, as described by Jackson and Huber in 1946, and Boyden in 1955 (Table 1.9)
[210],
The segmental bronchi then repeatedly divide until the terminal bronchiole is
encountered, which is the most peripheral bronchiole without alveoli. At the end of
each terminal bronchiole is the acinus, consisting of respiratory bronchioles that lead
into alveolar ducts, which in turn lead into the alveoli.
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Table 1.9. Nomenclature of normal bronchopulmonary segmental anatomy. (Modified
from [210].)
The term pulmonary lobule (previously secondary pulmonary lobule) refers
to the smallest unit of lung that is bound by connective tissue septa, as described by
Miller (Figure 1.8) ([211].
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Figure 1.8. The normal pulmonary lobule. (From reference [212].)
Each pulmonary lobule is about 1-2.5cm in diameter and polyhedral in shape
[213], and contains between 3 and 24 acini depending on its size [214], At the centre
of each pulmonary lobule is a bronchiole and adjacent artery, while pulmonary
venous branches and lymphatics lie within the interlobular septa [213],
In the right lung, the lower lobe is divided from the upper and middle lobes by
the right oblique or major fissure. The upper lobe is divided from the middle lobe by
the horizontal or minor fissure, which extends anteriorly from the oblique fissure in
the axial plane. On the left the upper and lower lobes are also divided by the left
oblique fissure, orientated more vertically than the right. The oblique and minor
fissures may be incomplete in 12.5-90% [215, 216] of cases, respectively. Some
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form of accessory fissure dividing a segment from the remainder of the lobe may be
encountered in 22-32% [217, 218],
The connective tissue which supports the lung is termed the interstitium. The
interstitium as described by Weibel consists of the peribronchovascular interstitium
(a strong sheath surrounding the large bronchi and arteries emanating from the
hilum); the centrilobular interstitium (a peripheral continuation of the
peribronchovascular interstitium); the subpleural interstitium (from which the
interlobular septa that form the boundaries of the pulmonary lobule project); and the




Isaac Adler recognised the presentation of a lung cancer as a "single nodule,
usually quite small", but viewed it as a rare occurrence [220], The following year,
Wenkebach provided one of the first discourses on radiographic patterns of lung
pathology. He emphasised the sharp boundaries and homogeneous nature of tumours
of the lung on chest radiography as a distinguishing characteristic from "infiltrations"
such as pneumonia [221], It was not until the mid-2011' century, however, that
numerous reports begun to describe the difficulties in managing "the solitary
pulmonary mass", "nodule" or "coin lesions" [222-224], By the 1970s, radiographic
criteria for the definition of a solitary pulmonary nodule had been established. These
included an oval or round shape, a diameter of 4-6cm or less in diameter,
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homogeneous density, surrounded by lung, and with delineated margins [225], The
advent of conventional whole lung tomography [226] and subsequently thoracic CT
[227] increased the detectability of pulmonary nodules. Subsequent refinements in
CT technique with thick-section spiral CT [228] and MDCT, with its thinner sections
[229] have made the increased detection of pulmonary nodules inevitable.
1.5.2.2 Definition, types and location of pulmonary nodules
Nodules may be defined by their size, attenuation, location and/or radiologic
pattern. The Fleischner Society defines a pulmonary nodule as "a rounded opacity,
well or poorly defined, measuring up to 3cm in diameter" [230], A micronodule is an
opacity measuring less than 3mm in diameter. A solid nodule has homogeneous
soft-tissue attenuation, while a ground-glass nodule (also termed a non-solid nodule)
has a hazy attenuation - lower than soft tissue, but not obscuring the bronchial or
vascular structures within it. A part-solid nodule (also termed a semi-solid nodule)
contains both solid and ground-glass density [230, 231], The term subsolidnodule
encompasses both pure ground-glass nodules and part-solid nodules (Figure 1.9)
[232].
Figure 1.9. A part-solid nodule with a predominantly solid component.
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Centrilobular nodules are located a few millimetres away from the pleural
surface or interlobular septa as their name implies [233]. Perilymphatic nodules lie
within the peribronchovascular, subpleural or centrilobular interstitium, as well as
within the interlobular septa [212], The terms subpleural, perifissuraljuxtapleural
and juxtavascular have also been used to describe nodule location [234, 235] but do
not have standardised definitions.
The pattern of nodularity can be a helpful descriptor. Tree-in-bud nodularity
refers to branching centrilobular nodularity that is due to either endobronchial
impaction by inflammatory material or fluid, or a peribronchial abnormality such as
fibrosis. Multiple causes for tree-in-bud nodularity have been described, but most
relate to infection and bronchiolitis [236], Miliary nodularity refers to the random
distribution of micronodules throughout the lung, usually seen in disseminated
haematogenous spread of tuberculosis or metastases.
1.5.2.3 Causes of pulmonary nodules
Some of the causes of a solitary pulmonary nodule are listed in Table 1.10.
These can broadly be categorised into neoplastic and non-neoplastic causes. Non¬
neoplastic causes can further be divided into inflammatory, vascular, congenital and




Malignant Primary lung cancer
Metastatic disease1 (including colon, breast, prostate, testicular,










Non-infectious Sarcoidosis1, Wegener granulomatosis1, Idiopathic bronchocentric
granulomatosis, Rheumatoid arthritis1,Amyloidosis 1
Intrapulmonary lymph node
Vascular Infarct
Congenital Intraparenchymal bronchogenic cyst
Bronchopulmonary sequestration/
congenital pulmonary airway malformation
Table 1.10. Some causes of pulmonary nodules. Modified from Brandman et al. [238]
and Erasmus et al. [237].
1
These conditions commonly cause multiple nodules.
It is important to note that an opacity that is considered a nodule on chest
radiograph may not be a true nodule at all. Instead, it may be due to an external
object, due to composite shadows from the overlap of two structures, or
"psuedotumour" due to fluid in a fissure, for example. In the case of external objects
this can usually be resolved by ensuring the confounding objects are removed, while
different projections or repeat films at different inspirations can be obtained to
analyse composite shadows. CT can help resolve apparent persistent nodular
opacities on a chest radiograph that are in fact caused by fluid or composited bony
structures.
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The prevalence of solitary pulmonary nodules on LDCT of high-risk patients in
screening studies has been estimated at between 8 to 57%, but differences in the
definition of a nodule and in reporting methods (e.g. no clear separation of those with
multiple versus single nodules, reporting of percentage of patients with nodules,
rather than the number of nodules itself) is at least partly responsible for this wide
variation [239],
1.5.3 Differentiating benign and malignant nodules on CT
The initial radiological differentiation of benign from malignant nodules
relies on morphological evaluation of size, contour, internal characteristics and
location, in combination with clinical probability of malignancy. If a nodule remains
indeterminate after this evaluation, assessment of growth and sometimes functional
characteristics are necessary.
1.5.3.1 Size
In general, a small nodule is more likely to be benign, and indeed 80% of
benign nodules are less than 2cm in diameter. However, up to 42% of nodules
measuring less than 2cm may be malignant, as shown in a series of 634 solitary
pulmonary nodules assessed by CT [240], A systematic review of eight trials
(including ELCAP) has reinforced the notion that nodules measuring under 5mm are
almost always benign [239], The likelihood of malignancy increases as size
increases, with odds ratios for malignancy increasing from 0.74 for nodules
measuring 1.1-2.0cm, to 3.67 and 5.23 for nodules measuring 2.1-3.0cm and >
3.0cm, respectively [241],
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1.5.3.2 Shape and contour
A sharp well-defined margin may be seen in both benign and malignant
nodules, and is thus not a particularly helpful discriminator. In a series of 85
malignant and 11 benign nodules, Zwirewich et al. reported that a sharp margin was
seen with almost equal frequency (85% of malignant and 82% of benign nodules)
[242], However, a spiculated or irregular margin, especially with distortion of the
adjacent vessels (described as a "corona radiata" appearance) is known to correlate
well with malignancy. Kuriyama et al. showed that fine spiculations, pleural
retraction, and peripheral vessel convergence (analogous to the "corona radiata")
were strong indicators of malignancy in peripheral lung cancers [243], However,
these edge characteristics are not sufficiently sensitive or specific for benignity or
malignancy in isolation.
1.5.3.3 Internal characteristics
Internal characteristics include calcification, cavitation, attenuation (fat, solid
or ground-glass), bubble-like lucencies (sometimes referred to as "pseudocavitation")
and air bronchograms. Benign lesions are associated with rather dense and discrete
calcification in four characteristic patterns. Central, diffuse, solid or laminated
calcification may be seen in calcified granulomas, such as histoplasmosis or
tuberculosis, while "popcorn" calcification indicates chondroid calcification within a
hamartoma (Figure 1.10) [237], Hamartomas are benign neoplasms composed of
mesenchymal tissues such as fat and connective tissue, typically combined with
respiratory epithelium [244], Absence of such discrete calcification is not indicative
of malignancy, as benign lesions often have no calcification. On the other hand, foci
of calcification on CT may be seen in malignant lesions, either due to a focus of pre-
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existing granuloma that has been subsequently encompassed by tumour, or due to
dystrophic calcification. In a series of 353 patients undergoing CT for lung cancer,
20 (6%) showed some evidence of calcification [245],
Figure 1.10. Hamartoma demonstrating "popcorn" calcification on a coronal CT image
with bone window settings. (From reference [238].)
In addition to "popcorn" calcification, the presence of intralesional fat on
thin-section CT points towards a hamartoma. In one series of 47 histologically-
proven hamartomas, fat was seen on CT in 18 (38%), and fat and calcium in 10
nodules (21.3%), using a definition of -40 HU to -120 HU on CT. However, only
about half of hamartomas contain fat [246],
Both benign and malignant lesions may cavitate. The thickness of the cavity
wall can provide a clue to aetiology: cavitary nodules on chest radiograph with a wall
thickness less than 4mm were benign in 92% of cases, while those with a wall
thickness greater than 16 mm were malignant in 95% of cases in one series [247],
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However, cavities with an intermediate thickness of 5 to 15mm were malignant in
just over half of cases in that investigation, underscoring the lack of sensitivity and
specificity of this sign in the majority of cavitary nodules.
Ground-glass nodules may be seen in both inflammatory and neoplastic
conditions, with different radio-pathologic correlations. Multifocal centrilobular
ground-glass nodularity may be seen in respiratory bronchiolitis-interstitial lung
disease, for example [248], It is now recognised that the subtype of adenocarcinoma
formerly termed bronchioloalveolar carcinoma (BAC) has a range of heterogeneous
ground-glass CT appearances. These include ground-glass nodules (with or without
associated features such as bubble-like lucencies or psuedocavitation, and air
bronchograms), part-solid nodules with varying proportions of solid and ground-
glass attenuation, and multifocal consolidation [249], In a seminal paper, Noguchi
proposed six subtypes of "small" (2cm or less in greatest dimension)
adenocarcinoma of the lung, labelled A-F. Types A-C were termed replacement
adenocarcinomas, as they represented progressive forms of localised BAC with
increasing degrees of invasion, while types D-F were subtypes of invasive
adenocarcinoma that could arise de novo [250], There is limited evidence suggesting
that these subtypes correlate with different but overlapping radiological appearances
[251], The heterogeneity of cancers classified as BAC are partly behind its removal
in the recent reclassification of adenocarcinoma [35], Using the new terms, ground-
glass and part-solid nodules that are malignant represent an overlapping pathological
and radiological spectrum of adenocarcinoma-in-situ (AIS), minimally-invasive
adenocarcinoma (MIA), lepidic predominant adenocarcinoma (LPA) and invasive
adenocarcinoma (Figure 1.11) [252],
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Figure 1.11. Internal characteristics of two different subsolid nodules in the same
patient. (A) CT image demonstrates a pure ground-glass nodule, which was revealed
to be an adenocarcinoma-in-situ (AIS) on surgical resection. (B) A larger and more
dense nodule with some air bronchograms and pleural retraction was also resected
and corresponded to a lepidic predominant adenocarcinoma (LPA).
1.5.3.4 Location
As a general rule, malignant nodules are more likely to be found in the upper
lobes [253]; however, this feature is not specific for malignancy. Intrapulmonary
lymph nodes (IPLNs) are a group of nodules that can be recognised by their location,
as long as they meet other morphologic criteria. Some histopathology-corroborated
CT features of IPLNs have been described in studies with relatively small samples
[235, 254-256], Typically, an IPLN is up to 12mm in maximum diameter, is
polygonal or coffee-bean shaped, lies within 15mm of a pleural surface, has a smooth
surface, and often has at least one linear opacity connecting it to the pleural surface,
reflecting an interlobular septum [235, 255], IPLNs are relatively uncommon in the
upper lobes. In an analysis of LDCT scans from screening subjects, Ahn et al.
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postulated that the lack of malignancy in perifissural nodules seen in their cohort was
possibly due to the fact that they were IPLNs, as the majority of these nodules were
triangular or ovoid (44% and 42% respectively), and had a septal connection (73%)
[234],
1.5.3.5 Growth assessment
The demonstration of a growing nodule remains one of the most useful
discriminators of malignancy. Cancers may grow at different rates and in different
patterns. The two mathematical models most often used to describe cancer growth
are the exponential model and the Gompertzian model.
The exponential model presupposes that the cancer has a constant rate of
doubling, most conveniently calculated by the doubling time [257], The time taken
for one volume doubling, the volume doubling time (VDT) can be calculated using
the formula:
VDT = At x In 2
In (V2/V1)
where VI is the volume of a given nodule at time tl, V2 is the volume at time t2
when it is next measured, and At is the interval between tl and t2 [258],
However, the exponential model does not provide an adequate explanation for
the types of tumour growth seen in vivo. For example, doubling times are known to
exceed cell cycle times [259], The Gompertzian model allows for an exponential
growth phase in the early stage, which then saturates and reaches a plateau with
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increasing tumour size, possibly due to some form of negative feedback inhibiting
growth [260],
In experimental studies, lung cancers in vivo have been found to grow at quite
different rates, and in patterns that conform to neither model of growth alone. Lindell
et al. studied the growth patterns of 18 screening-diagnosed lung cancers of different
subtypes, using long- and short-axis diameter CT measurements to estimate volume
[261], They found that while the majority of lesions grew at a constant rate, there
were also cancers that grew very slowly - these were mostly seen in the BAC and
adenocarcinoma groups (Figure 1.12). Furthermore, 22% of lesions showed a
decrease in volume at some point on both visual estimates and calliper assessments.
A 1.700 ] _BAC(n = 7) .1,600" --- Adenocarcinoma (n = 7) »
1 5QQ . Squamous cell carcinoma (n = 2) j
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• Deceased, lung cancer (n=3)
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1,200* * Living, recurrence (n=1) ,
qpiMoam Time from first to last detection of tumor (days)
Figure 1.12. Growth curves of 18 non-small cell lung cancers (NSCLC) followed over
five years. Many adenocarcinomas demonstrate periods of quite slow growth,
followed by a rapid accelerated growth, as well as periods of decreases in size.
NSCLC-NOS= non-small cell lung cancer not otherwise specified. (From reference
(261].)
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Size and growth of a nodule can be measured using diameter or volume.
Volumetric analysis is intuitively more sensitive to changes in size as compared to
diameter measurement, since volumetry captures the lesion in its entirety, and not
just a cross-sectional area [258, 262], The improved sensitivity of volumetry for
growth is highlighted by the fact that for a completely spherical nodule to undergo
one volume doubling, there needs to be only a 26% increase in diameter. Volume
change is now the main parameter of assessment in the NELSON, DLCST, MILD
and UKLS trials [155-157, 160],
The VDT of malignant nodules is highly variable, in the range of 20 and 400
days [202, 258, 261, 263-265], with shorter VDTs noted for small cell lung cancers.
A recent analysis of 111 lung cancers detected after an initial negative baseline
screen (i.e. incident cancers) in the I-ELCAP trial found that such cancers had a
median VDT of 98 days [266]. A solid nodule that has demonstrated stability (i.e. no
growth) over 2 years has generally been considered to be benign [44], However,
ground-glass nodules that may represent in-situ or minimally invasive forms of
adenocarcinoma (formerly BAC) may have much longer doubling times that could
exceed two years (730 days) and so falsely be considered benign. Lor example,
Hasegawa et al. demonstrated that the mean VDT varied between 817 days in pure
ground-glass lesions, to 149 days in solid lesions, in a screening-derived cohort of
proven lung cancers [263], Slower growth in such lesions should not be mistaken for
benignity [267], Indeed, a recent analysis of 42 prevalent and 21 incident non-small
cell lung cancers from the Pittsburgh Lung Screening Study has demonstrated that
prevalent cancers were more likely to have a longer VDT (> 365 days) and contain a
higher proportion of cancers in the adenocarcinoma spectrum [268], On the other
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hand, nodules with VDT of greater than 400 days may represent overdiagnosed cases
[168],
1.5.3.6 Density change
Because growth may not be an accurate predictor of malignancy in ground-
glass or part-solid nodules, the assessment of change in density (with an increasing
solid component) may be more useful in these lesions [269, 270], Henschke et al.
reported that the frequency of malignancy in a high-risk population was higher in
part-solid nodules compared to pure ground-glass nodules (63% vs 18%) [271], De
Hoop et al. recently proposed that mass (i.e. the product of density, as measured by
CT attenuation number and volume) be used as a novel method to determine growth
in ground-glass nodules. They found that this parameter could predict growth earlier
than either density or size alone, and seemed to have a lower interobserver variability
than that of volume [272],
1.5.3.7 Functional characteristics
Functional evaluation can be performed with FDG-PET and PET-CT, or
dynamic contrast-enhanced CT. Magnetic resonance (MR) assessment is currently
only performed in experimental studies.
FDG-PET can demonstrate increased metabolic activity indicating malignancy
in non-calcified nodules > 10mm in diameter with a sensitivity of 96.8% and
specificity of 77.8% [273], Accordingly, the American College of Chest Physicians
(ACCP) recommends that nodules measuring at least 8 to 10mm with a low to
moderate pre-test probability for malignancy should be referred for FDG-PET for
further characterisation, but there is little value to be gained in FDG-PET work-up
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for smaller nodules [274], The role of integrated PET-CT in nodule characterisation
has yet to be extensively evaluated [275], but new insights may be gained from the
Italian screening studies [DANTE, MILD, ITALUNG and the Continuous
Observation of Smoking Subjects (COSMOS) studies] incorporating PET and PET-
CT into their algorithms for nodule management. For example, Veronesi et al. found
that the diagnostic sensitivity of PET-CT in such cases was 88%, but increased to
100% for solid non-calcified > 10mm, in an analysis of the COSMOS study [276], In
a later analysis they have suggested that decreasing the maximum standardised
uptake value (SUVmax) (see section 1.1.5) to 1.5 from 2.0 improves sensitivity
without compromising specificity in NCNs < 10mm, but this strategy will require
further validation [173],
Dynamic contrast-enhanced CT is a technique which uses measurable contrast
enhancement above a defined threshold as a surrogate for the increased vascularity
within malignant nodules. The threshold for classifying enhancement as malignant
can be varied between 15 HU and 30 HU with corresponding sensitivities and
specificities of 98% and 58%, and 99% and 54% respectively [275, 277], This
method has shown good correlation with angiogenesis, as measured by vascular
endothelial growth factor (VEGF) of nodules on subsequent immunohistochemical
staining of pathological samples [278], In the screening setting, it has only been used
thus far in the COSMOS study, where a subset of 54 subjects with intraparenchymal
but not perihilar nodules measuring > 8mm underwent dynamic contrast-enhanced
CT, resulting in 100% sensitivity but a low 59% specificity for lung cancer [173],
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1.5.4 Follow-up strategies for the indeterminate pulmonary nodule
Strategies to follow up the indeterminate pulmonary nodule are necessarily
conservative, since the vast majority of small nodules are benign. These strategies
must maximize the chances of lung cancer detection, minimize false positive rates,
avoid unnecessary anxiety to the patient, and avert undue harm as a result of repeated
radiation exposure or unnecessary invasive procedures, while also being cost-
effective. The Fleischner guidelines for small (< 8mm) non-calcified solid pulmonary
nodule management is the most well-known strategy (Table l. 11) that is applicable
to persons 35 years or older, and is based on the mean diameter (length and width) of





< 4 No follow-up CT at 12 months; if unchanged, no
further follow-up
4-6 CT at 12 months; if unchanged, no
further follow-up
CT at 6-12 months, then at 18-24
months if unchanged
6-8 CT at 6-12 months, then at 18-24
months if unchanged
CT at 3-6 months, then 9-12 months,
and 24 months if unchanged
> 8 CT at 3, 9 and 24 months if
unchanged, FDG-PET, dynamic
contrast-enhanced CT, and/or biopsy
CT at 3, 9 and 24 months if
unchanged, FDG-PET, dynamic
contrast-enhanced CT, and/or biopsy
Table 1.11. Fleischner Society recommendations for the management of small
pulmonary nodules. Adapted from MacMahon et al. 2005 [44].
However, the Fleischner guidelines do not distinguish between solitary or
multiple pulmonary nodules. The exact prevalence of individuals with multiple
pulmonary nodules in the population is unclear; in the high-risk populations involved
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in screening studies between 29-32% in those with at least one non-calcified nodule
had multiple nodules [142, 159].
Recently, the Fleischner society has also published guidelines for the
management of subsolid nodules [232], These guidelines advocate longer periods of
follow-up and greater intervals between follow-up CT scans, with distinct
recommendations made for the follow-up of solitary ground-glass nodules, solitary
part-solid nodules, and multiple subsolid nodules.
1.5.5 Geographical and ethnic variations
Indeterminate pulmonary nodules do not seem to have a higher prevalence in
any one geographic location [239], A study from Western Australia concluded that
the prevalence of small nodules was significantly lower (39%) than an equivalent
cohort from the Mayo Clinic Lung Screening Project (51%), but this study was
performed on only 49 asymptomatic smokers [279], It is expected that calcified
pulmonary nodules would be seen in areas with endemic granulomatous diseases
such as histoplasmosis or tuberculosis, and in populations with a high incidence of
pneumoconioses. However, recent data from the NLST has shown no variation in
false positive rates between screening centres within and outside the US
"histoplasmosis belt", suggesting that such geographical differences may not
substantially contribute to variation in nodule frequency [280],
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1.6 Reader performance in pulmonary nodule perception on
CT
1.6.1 Reference standards and reader variation in nodule perception
A nodule first needs to be perceived, i.e. correctly detected and interpreted,
before the strategies to designate it as benign or malignant as outlined in the
preceding section can be used. Kundel et al. state that perception has at least three
components: search, pattern recognition and decision-making [281], Applying these
components to CT nodule reading, a nodule must:
1 .First be detected (a function of search);
2.Then be identified as different in contrast to normal structures or opacities (a
function ofpattern recognition); and finally
3. Have a decision made on it, as to whether it constitutes a true "nodule" and
needs follow-up, in terms of the likelihood of malignancy and with or without
the help of a nodule management strategy (decision-making).
It is well known that radiologists fail to detect lung cancers on chest
radiographs that were visible as pulmonary nodules in retrospect, to varying degrees
[282, 283], Although some of the technical factors that would make missing such
nodules on chest radiograph (e.g. overlapping vascular structures or obscuring ribs)
are not a significant problem on thoracic CT due to its cross-sectional nature and
high spatial and contrast resolution, there are still a host of other factors that lead to
variation in performance for nodule perception (discussed in the next section). To be
able to quantify such differences in perception, a reference standard for the number
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of "true" nodules in any given scan is crucial. Ideally, the reference standard would
be the "gold" standard with actual histopathological corroboration of each nodule.
Indeed some authors have argued that clinical, follow-up and histopathological proof
should be the basis of "truth" for such interpretation: in one of the earliest
investigations of "truth" in 1978, Revesz et al. highlighted the problem posed by
using reference standards that approximate the "truth" [284], They investigated the
accuracy of three different chest radiographic techniques, based on radiologists'
interpretations as compared to five different reference standards: majority vote
(majority of expert panel agree), consensus opinion (all experts agree), expert
judgment (a further expert arbitrating), feedback review, and clinical/pathologic
proof. They found that each of the radiographic techniques could be proven to be
superior to the other depending on which definition of truth was used, the implication
being that any diagnostic test could be falsely thought to be accurate if measured
against a particular truth standard, i.e. the truth is subjective.
However, it would not only be impractical but also unethical to seek
histopathological corroboration for multiple nodules found on a CT scan, the vast
majority of which are likely to be benign [239], Instead, reference standards using a
majority or consensus of opinions are probably the most popular form of "truth". It
could be argued that if a test measures favourably against different surrogate
reference standards, it would serve as a more robust validation of that test in the
absence of a definitive truth.
Two studies from the Lung Image Database Consortium (LIDC) have elegantly
illustrated the above concept. Armato et al. asked four radiologists to analyse 25
thoracic CT studies for nodules > 3mm in diameter, and created 24 different expert
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"truth" sets based on combinations of pairs and triplets of these radiologists, against
which the sensitivity of each radiologist was measured [285], They showed that
sensitivity varied widely between 51-83.2%, depending on the definition of "truth".
Another study used a similar design of different combinations of four radiologists as
a reference standard for CAD performance assessment [286], Between the most
liberal (any 1 of 4 readers) and strictest (all 4 readers in consensus) definitions of
reader agreement as the reference standard, the number of "true" nodules > 3 mm
decreased 48% (from 174 to 90) and CAD sensitivity for nodules > 3 mm increased
from 70% to 79%, while a much larger decrease (84%) was seen in the number of
nodules < 3mm. These studies also highlight two further issues: first, the sensitivity
of a reader (whether human or CAD) increases as the truth panel used becomes more
restrictive, since the denominator of agreed nodules becomes smaller. Secondly, by
using the same dataset to both define the reference standard and test readers, a level
of uncertainty as to the validity of the reference standard may be introduced, i.e.
there may be "chance" agreement between test and reference standard reading [287],
This uncertainty may be reduced by using different datasets to establish the reference
standard and to test readers, or by resampling the expert panel with a different dataset
to ensure consistency at a different point in time.
Reader performance or CAD studies generally report the establishment of their
own reference standard [288-294], In light of the above discussion it is imperative to
view all reported sensitivity data in the context of the "truth" standard used. All CAD
systems should also ideally report the type of truth panels on which their algorithms
were based [295],
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1.6.2 Factors influencing reader performance
1.6.2.1 Influence of technical factors
Several investigators have already demonstrated the feasibility of low-dose
CT for the detection of pulmonary nodules, predominantly by lowering tube current-
time product [296-303], The feasibility of pulmonary nodule detection is probably a
consequence of the inherent high contrast within the lung, which enables it to tolerate
reductions in signal-to-noise ratio. A recent study showed a decrease in sensitivity
for only one reader out of three, when tube current-time product was lowered to
5mAs compared to 300mAs [304], Despite this, there can be decreased detection if
tube current-time products are decreased to lower than 20mAs, particularly for
nodules less than 5mm in experimental settings [299],
The measurement of diameter with electronic callipers is subject to
considerable intra- and inter-reader variability [305-307], Revel et al. showed that,
when measuring nodules 2cm or less in a non-screening cohort, the limits of intra-
and inter-observer variability were 1.32mm and 1.73mm respectively. This means
that a nodule could confidently be said to have grown only if its diameter had
increased beyond these limits [307], For example, because only a 26% increase in
diameter of a spherical nodule is required to represent a single volume doubling
[308], it could be falsely concluded that a nodule measuring 5mm at baseline and
then 6.3mm at 3 month follow-up has doubled in volume, when it is in fact stable
and the difference is due to measurement error. This has implications for the
confidence assigned to the interpretation of manual nodule measurements made by
readers.
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Volumetric analysis, especially semi-automated volumetry, also demonstrates a
degree of interobserver variability, but less so compared to that of diameter
measurements. Volume measurements can be expected to be more accurate than uni-
or bi-dimensional measurements alone, since a volumetric measurement evaluates
the entirety of a nodule [201, 258, 309], In a study of 322 synthetic nodules
implanted in porcine lungs, Bolte and colleagues demonstrated that volumetry could
estimate true lesion size to within a mean deviation of-9.2% for semi-automated and
-0.3% for manual-corrected volumetry [310], Volumetric software-derived
measurements also demonstrate good reproducibility [258, 31 1,312] and high inter¬
observer agreement [311,313,314], The measurement error between volumetric
measurements of the same nodule is up to about 27%, with the majority of
volumetric measurements demonstrating variability of less than 10% [311,313],
Many studies have evaluated different technical parameters that may be responsible
for variation in volume reproducibility. The conclusions of these studies can be
summarised as follows:
• There is less variability in volumetry as the size of measured nodules increases
[315-318];
• Volumetric segmentation is less accurate when nodules are non-spherical and
have irregular margins (Figure 1.13) [317, 319];
• Measurement reproducibility is increased with decreasing section thickness
[316, 320]; and
• Using different segmentation algorithms within the same software package can
increase inter-observer variability [321],
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Figure 1.13. 3D volumetric segmentation of a non-spherical nodule. Segmentation
performed on the same nodule yields different volumes due to its irregular shape.
The volumetric analysis of non-solid nodules or the ground-glass component of
subsolid nodules is still suboptimal, but improvements in segmentation algorithms
for this purpose are ongoing [322],
Nodule detection also varies with slice thickness; reduced slice thickness with
MDCT has led to an increased ability to detect small pulmonary nodules. Fischbach
et al. used two readers to evaluate 100 CT thoracic examinations that had been
reconstructed at 1,25mm and 5mm slice thickness [229], They found that although
nodules greater than 10mm in diameter were equally well depicted at both slice
thicknesses, there was a significant improvement in detection of nodules < 5mm.
Also, interobserver agreement was high for nodules detected at 1,25mm but only
moderate for those detected at 5mm.
The use of maximum intensity projections (MIP) can also contribute to
increased detection. This was first demonstrated by Gruden et al., in a study of 25
patients with pulmonary metastases (all 3-9mm in diameter), whose scans were
reviewed by 5 radiologists of varying experience [323], They showed that the use of
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10mm thick, 8mm interval MIP cine reconstructions significantly improved the
detection of central nodules that can potentially be obscured by vasculature for senior
radiologists, while the detection of peripheral nodules was improved for the junior
radiologists, hence mitigating the effect of reader experience in nodule detection.
Valencia et al. subsequently demonstrated that the use of 10mm thick axial and
coronal MIP images resulted in increased detection of nodules less than 5mm, as
compared to 1mm and 10mm axial images, whereas the detection of nodules greater
than 5mm was not statistically significantly different between all reconstruction
types [324], An investigation performed on LDCT screening images has suggested
that MIP review may also be the least time-consuming reading technique as
compared to axial 1mm review and to CAD as a second reader, while simultaneously
providing the highest sensitivity for detection of all nodules among the three methods
[325],
A technique of volume rendering that uses different densities to depict vessels
and nodules has been suggested as superior to MIP [326], However, such a volume
rendering technique has not been used widely, whereas a MIP function is now quite
easily integrated into 3D reconstruction packages within a PACS system such that a
radiologist can view MIPs as part of his or her reporting workflow.
CT reporting using cine review of softcopy images on a workstation
("scrolling") is now the norm. Thus, intuitively it can be expected that an increased
cine frame rate would result in a decreased sensitivity for pulmonary nodule
detection. Copley et al. investigated four different cine speeds (1,5, 10 and 15
frames per second) for a single craniocaudal evaluation of the lungs for pulmonary
nodules. They found that there was a trend towards reduced detection of pulmonary
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nodules with increasing cine speeds that was independent of observer experience
(expert radiologists or junior residents formed their reading panel); however, this
trend was not statistically significant and no MIPs were used during the reading
process [327],
The presence of co-existent pulmonary disease also affects perception of
nodules, but leads to errors of interpretation rather than detection. In a study of 32
missed lung cancers in a Japanese LDCT screening programme, 13 cancers that had
mean diameters of 15.9mm (range 6-26mm) were reported but misinterpreted as
findings other than lung cancer on 16 CT scans (i.e. 16 lesions wrongly interpreted).
14 out of these 16 lesions had features that mimicked benign disease, and were
associated with underlying tuberculosis, emphysema, fibrosis, silicosis and asbestosis
[328],
1.6.2.2 Influence ofpsychophysical factors
Psychophysics is the exploration of the relationship between physical image
quality and diagnostic performance [329], Much of the literature informing this field
has involved plain film radiography, and not CT. However, a brief overview of
psychophysical factors is useful in understanding factors affecting reader
performance.
The fundamental unit of visual processing is a fixation, during which the image
projected onto the retina is processed. Various models to explain how such visual
processing occurs have been devised, but none comprehensively explains visual
processing. As discussed earlier, Kundel et al. took the view that perception involves
search, pattern recognition, and decision-making. Intertwined with these perceptual
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components are object knowledge and background knowledge [281], Object
knowledge influences pattern recognition: the observer must be aware of the features
of the target lesion before a search for this can begin. Background knowledge refers
to understanding of the features of the normal structures, such as the expected
anatomy and course of bronchi and arteries, or the location of fissures. In this way,
any object that is not part of the "background" normal lung would be perceived as
abnonnal.
A similar model put forward by Lesgold et al. describes cognitive and
perceptual components of search [330], The perceptual component controls where
the eye moves, but depends on the knowledge base, which is informed by the
cognitive component. This is analogous to object and background knowledge,
because the cognitive component creates a prototype of "normal" such that
deviations from that prototype can be analysed to see if it fits a target.
Visual search can also be understood using the "global-focal" model, which
hypothesizes that the two processes of global analysis andfocalfeature analysis
interact during visual search [331], Global analysis uses sensory input from the
whole retina to give a general overview of a scene, while focalfeature analysis is
concentrated on the detailed interpretation of the sensory input in the central retinal
fields, along the axis of gaze [329], These two processes can occur during scanning
an image either during a single fixation, or a fixation cluster (a number of fixations at
a particular location of the image). Pattern analysis occurs during global analysis,
while integration of all features occurs to give a detailed analysis during focal feature
analysis.
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The "global-focal" model can be integrated into another decision-making
model of visual perception, the Gregory-Rock model (Figure 1.14). In this model,
global and focal feature analyses inform a rapid phase of "literal" or "bottom-up"
perception, while a slower phase of "preferred" or "top-down" perception is
informed by knowledge of the outside world, similar to the object knowledge
described above [329],
Global Analysis ~ ► Literal Perception Very Fast (msec)











Image Analysis slow (min)
Overt Decisions
Figure 1.14. A model of visual perception that integrates the "global-focal" and
Gregory-Rock models. (From reference [329].)
Satisfaction of search is an important source of errors of detection. Satisfaction
of search describes the phenomenon where in the absence of a specific target, a
general free-search (i.e. undirected) visual task is performed, with no defined
expectation as to the outcome of the task [332]. As such, the observer has no
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reference point from which he or she can decide to call a study normal, and may
selectively divert attention to different fixation clusters, thereby missing some
targets. If there are an unknown number of targets, the detection of one target will
make the detection of subsequent ones less likely [333], Of course, CAD readers do
not suffer from satisfaction of search.
1.6.2.3 Influence of the number of readers
Only a handful of studies have evaluated the influence of double- versus single-
reading on pulmonary nodule detection, and with the exception of one recent study,
these have looked at non-screening populations. Wormanns et al. evaluated the
performance of three readers in reading scans of nine patients with pulmonary
metastases [334], They simulated double-reading on both standard-dose (SDCT) and
low-dose (LDCT) by using all possible pair combinations of the three readers.
Sensitivity for nodule detection (the majority of which were less than 5mm)
increased from 63% to 74% on SDCT and 64% to 79% on LDCT for single and
double readers respectively. However, they concluded that 20% of nodules still
remained undetected.
A number of European randomized screening trials are using double-reading
with consensus to evaluate pulmonary nodules, but only the NELSON trial has
provided an analysis thus far. Wang et al. retrospectively looked at 74 lung cancers
that were detectable at baseline (prevalence) screening [ 174], At that stage of
screening the NELSON trial used two readers: a local radiologist and a second
unblinded central radiologist. In discordant cases consensus was attempted, and an
expert third radiologist's opinion was used in the event of non-consensus. They
108
compared the detection of nodules using this double-reading process to the findings
of the initial single reader, and found that although the detection rate of nodules
increased by 19%, the cancer detection or recall rates did not increase significantly,
with 2.7% additional subjects with lung cancer found. They concluded that there was
no benefit in using consensus double-reading, because the use of volumetry in the
NELSON nodule management algorithm is more objective. However, this conclusion
was probably premature, due to their small sample size (as the authors concede) and
also because in order for volumetry to be performed, all important nodules must
already have been detected. In other words, volumetry helps with interpretation, but
not with detection itself.
1.6.2.4 Influence of reader experience and education
The visual processes described in section 1.6.2.2 occur differently in an
untrained observer and an experienced radiologist. By studying eye positions,
Kundel and La Follette found that the scan paths of first year medical students were
localised to central parts, whereas trained radiologists used a circumferential pattern
of scanning while simultaneously moving their eyes to a target lesion faster [335], As
the majority of missed lung nodules on chest radiographs are fixated in the central
visual field, this difference in perception between expert and novice may have
implications for nodule detection rates [281],
However, the effect of the level of reader experience in nodule detection on CT
is still debatable. For instance, Marten et al. found that two experienced radiologists
outperformed two inexperienced radiologists in nodule detection [336], In contrast,
Awai et al. found no significant difference in nodule detection sensitivity between
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five board-certified radiologists and five radiology residents with only two years of
training [337], They argued that the residents would have accumulated sufficient
cross-sectional anatomical CT knowledge to perform a nodule detection task as well
as an experienced radiologist. In two other studies, the most inexperienced reader in
fact had the highest sensitivity on axial (1-1,25mm slice thickness) image review
[325,338].
Thus far, there are no studies evaluating the role of radiographers in pulmonary
nodule reading on LDCT. The lack of radiographer studies is not surprising, given
that radiographers do not undertake CT reporting. However, as LDCT lung cancer
screening is actually a very specific task, it is useful to look at the feasibility of
radiographers in LDCT screening, especially when considering the limited evidence
for improved detection with increased experience.
A precedent for radiographer reading exists in mammographic screening, where
several countries, including the UK and Netherlands, involve trained radiographers
in reading screening studies [339-341], These radiographers (or advanced
practitioners) undergo continuous self- and external-assessment. A study from the
Netherlands compared the effect of two periods of screening with different reading
methodologies. The first period involved double-reading by two radiologists who
read simultaneously to reach consensus. In the second period, independent double-
reading by radiographers (reading simultaneously) followed by an independent
double-reading by two radiologists (who were blinded to the radiographers'
opinions) was performed, and results were compared with the first period [341], In
the event that no consensus could be reached by the radiologists, a third radiologist
would provide arbitration. Cases were referred for workup if any single reader (either
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radiographer or radiologist) remained adamant that workup was necessary. The
radiographer reading resulted in a higher referral rate (1.43% vs 1.02%) and a non-
statistically significant higher cancer detection rate per 1000 women screened (5.25
vs 4.86), but decreased the positive predictive value due to the higher number of
false positives. Thus, an independent double-reading radiographer approach can
increase the sensitivity of a breast cancer detection programme, but at the expense of
diminished specificity.
1.6.2.5 Influence of methods of consensus and arbitration
Traditionally discrepancies in observer readings have been dealt with either by:
• combining radiologists' readings (which assumes all discordant readings are
due to differences in detection) [334, 342, 343];
• a process of consensus where readers discuss individual discrepancies [159],
The latter method deals with both discrepancies due to detection and
interpretation, and is commonly accepted both as a valid method of resolving
discrepancy, and of deriving the reference standard in radiological studies
[208, 344], However, consensus interpretation is itself subject to inherent
limitations such as "groupthink" [344];
• using an independent "expert" arbiter (where one [334], two [289, 290, 293,
294, 336, 337] or even three [345, 346] experts have been used);
• using "internal" arbitration where a reader is independently shown and asked to
form an opinion on nodules identified by other readers and not by
themselves; or
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• using a combination of these methods.
Thus far, few studies have evaluated the impact of different methods of consensus
and arbitration on observer performance.
1.6.3 Comparisons between radiologists and computer-aided detection
(CAD)
Multiple studies have been performed assessing the role of CAD in
combination with radiologists in pulmonary nodule detection (Table 1.12). While
the results of the individual studies vary, there are four important conclusions that
can be drawn from these studies:
l .CAD is not effective as a first reader (whereby a CAD reading is performed
and then presented to a radiologist for acceptance or rejection of CAD
findings, without the radiologist also independently reading the study);
2.CAD is effective as a second reader (whereby a CAD reading is performed
after an initial radiologist's independent reading, so that the radiologist can
then accept or reject any additional CAD findings);
3.The beneficial effect of CAD holds for both inexperienced and experienced
readers, but may be greater when used in combination with an experienced
reader; and
4.The sensitivity of CAD increases with increasing nodule diameter.
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Table 1.12. A selection of trials investigating the sensitivity of computer-aided
detection.
'Sensitivities in this study were 54%, 64%, 68% and 76% for nodules of 3, 4, 5 and 6mm,
respectively.
CAD can potentially be calibrated to a particular specificity and sensitivity,
depending on the desired goal (increased detection or minimization of false
positives). For example, in a study by Rubin et al., independent double-reading by
radiologists was simulated and compared to CAD as a second reader [289],
Simulated double-reading by two radiologists resulted in a mean of 2.8-3.0 false
positive detections per patient (depending on the reader pair), and improved
sensitivity to 63% on average, from 50% for a single reading. In comparison, the
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mean sensitivity for a radiologist-CAD first reader-second reader modelled
combination, assuming all true positive CAD detections were accepted by the
radiologist, would be 76%, 79%, 84% and 85% for maximum false positivity
thresholds of 3,5,10 and 15 false positive detections allowed, respectively. Thus,
even at the strict threshold of 3 false positive detections allowed for CAD, the
sensitivity of the reader-CAD combination was higher than that of a radiologist
alone.
There are also conflicting reports of the varying benefit of CAD according to
reader experience. Marten et al. investigated four radiologists, two experienced (8
and 6 years experience) and two inexperienced (residents with 6 months experience)
who read 18 MDCT scans containing a total of 96 nodules according to their
reference standard [336], Thereafter, a CAD evaluation was performed. CAD
significantly outperformed the inexperienced radiologists, but did not significantly
outperform the experienced radiologists. Combinations of the readers and CAD
revealed that an experienced radiologist-CAD combination significantly
outperformed a single reader and an experienced-inexperienced reader combination,
while an inexperienced reader-CAD combination did not outperform an experienced
reader or CAD. The authors concluded that an inexperienced reader-CAD
combination was thus probably inadequate as an alternative to a single experienced
reader. However, the readers in their study were not allowed to take advantage of
image manipulation tools such as MIPs, and so may have been at a disadvantage.
The study sample was also small, and studies were performed at standard and not
low-dose. Another study with a much larger population has illustrated the utility of
CAD as a second reader for both experienced and inexperienced radiologists [293],
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Recently, there has also been interest in using CAD as a concurrent rather than
second reader. In concurrent reading, the first round of radiologist reading is
removed; instead, the study is read by the CAD, the radiologist then reviews the
CAD marks, and confirms or deletes them accordingly, followed by an independent
reading by the radiologist. This method has undergone only limited evaluation, with
conflicting reports with regards to its effect on reading times and sensitivity [294,
354],
There is thus scope for further investigation of the optimum reader paradigm
where an assisted reader, be it CAD or a radiographer, is involved.
1.6.4 Economic aspects
The question of the most cost-effective reading strategy goes hand-in-hand with
analyses of reader performance, both in screening and regular clinical practice. Some
evidence for the cost-effectiveness of double-reading again comes from
mammographic screening. For example, in an analysis from the Netherlands,
Groenewaud et al. suggest that while a double-reading with a "referral if any reader
suggests" strategy could result in four times as high referral rates and an increase of
biopsies or other invasive procedures, the cost-effectiveness of €4,190 per life-year
gained may still be economically acceptable [105], Interestingly, a recent analysis
from the UK concluded that at current false positive rates prompting recall, CAD in
mammographic screening would not be a cost-effective alternative to double-reading
[355], The issue of cost-effective reading strategies remains largely unexplored in
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LDCT screening but needs addressing before a national lung screening programme
can be recommended.
1.7 Aims of thesis
This thesis aims to identify an optimum and pragmatic reading strategy in lung
cancer screening using computed tomography, by investigating:
1 .The training of radiographers as readers;
2.The performance of radiographers in direct comparison with radiologists;
3. The use of radiographers as concurrent readers to assist radiologists;
4. The performance of radiographers compared to a CAD system; and
5.The impact of double- and triple- reading strategies, and of different methods
of arbitration for discordant findings, on radiologists' performance.
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CHAPTER 2: GENERAL METHODOLOGY
2.1 Introduction
This chapter describes the methods used to construct the training and evaluation
datasets used in Chapters 3 and 7, the recruitment and selection criteria for the
United Kingdom Lung Cancer Screening (UKLS) pilot trial participants that formed
the study groups for Chapters 4 to 6, the image acquisition and post-processing
techniques used, nodule reading protocols, and statistical methods. Methodology that
was specific to a chapter will be described in that chapter itself.
2.2 Ethical approval for the UKLS
Ethical approval for the UKLS trial was granted by the National Research
Ethics Service Committee, NHS R&D, the National Information Governance Board
for Health and Social Care, and the Administration of Radioactive Substances
Advisory Committee (ARSAC) (application no. 0521, reference ECC 2-02(a)/2011,
approved 15.03.2011). In addition, all participating sites had undergone site specific
assessment conducted by their local R&D department.
Informed consent had been obtained from all participants. In consenting to the
trial, participants also consented to trial CT screening, investigations, treatment,
follow-up and data collection. The investigations performed for this thesis formed
part of the investigations into CT screening undertaken within the UKLS pilot trial.
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2.3 Construction of a training dataset from the NELSON study
Two-hundred and sixty-three consecutive LDCT screening studies were
initially procured from the NELSON study following approval from the NELSON
investigators (see Appendix 1). These studies had been performed at Utrecht
Hospital, Netherlands. Two-hundred and two of these studies were reported by
NELSON radiologists to contain a total of 701 nodules (696 solid and five sub-solid
nodules).
To ensure adequate representation of part-solid and nodules greater than
500mm3, this initial dataset was enriched by a further 10 cases containing 20 ground-
glass nodules and 20 Category 4 nodules, also obtained from the NELSON study.
The selected NELSON cases were all pre-anonymised: each study had been
given a unique reference number, and no patient identifiable data was visible. Data
pertaining to image reconstruction parameters, and metadata, such as scanner type,
were retained.
Volumetric datasets containing contiguous images were obtained via
encrypted hard disk, in Digital Imaging and Communications (DICOM) format and
in accordance with the data protection protocols of both the NELSON and UKLS
studies. All studies were then transferred from hard disk to the internal hard drive of
the digital workstation used at the three participating trial sites (Royal Brompton
Hospital, London; Liverpool Heart & Chest Hospital, Liverpool; and Papworth
Hospital, Cambridge).
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2.4 Participants in the UKLS pilot study
2.4.1 Recruitment methods
Participants (male and female) aged 50 to 75 years of age were selected
randomly from National Health Service (NHS) or Strategic Health Authority (SHA)
records, and approached with an invitation letter and a questionnaire to assess their
risk for lung cancer. The responses to the questionnaire were entered into the
Liverpool Lung Project (LLP) Risk Prediction Model for each patient to calculate
their risk of developing lung cancer [157, 157], The LLP Risk Prediction Model
calculates the absolute risk of lung cancer over a defined period, based on age, sex,
smoking duration, family history of lung cancer, history of non-pulmonary malignant
tumour, history of pneumonia, and occupational exposure to asbestos; it has been
internally and externally validated [356],
2.4.2 Selection criteria
Inclusion criteria were those patients who have a 5% risk of developing lung
cancer in 5 years, based on the LLP Risk Prediction Model. Exclusion criteria were
those subjects who: were unable to give consent; had a co-morbidity that would
unequivocally contraindicate either screening or treatment if lung cancer were
detected; had a CT scan performed within one year of the invitation to be screened;
were unable to lie flat; weighed greater than 200 kg (too large for the CT scanner).
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2.5 UKLS Low-dose CT screening
2.5.1 Participating sites
LDCT scans were performed and read at two participating local sites
(Liverpool Heart & Chest Hospital, Liverpool and Papworth Hospital, Cambridge).
Scans were then transmitted to a central site (Royal Brompton Hospital, London - see
section 2.6.2) for a second reading and arbitration in the event of discrepant findings.
2.5.2 Scanning technique
Participants' weight and height were ascertained prior to scanning to allow
selection of appropriate exposure factors. Imaging was performed during suspended
maximal inspiration. No intravenous contrast material was administered. The lung
parenchyma (lung apices to bases) was scanned in its entirety in a single
craniocaudal acquisition. The field of view (FOV) selected was the smallest diameter
as measured from the widest point of the outer rib to outer rib large enough to
accommodate the entire lung parenchyma (usually no more than 35cm). Thin
detector collimation (0.5 - 0.625mm) was used with a pitch of 0.9-1.1. Exposure
factors were tailored to patient height and weight (Table 2.1). CT dose index
(CTDIvol) was kept below 4 mGy, with the effective radiation dose below 2 mSv.





Voltage (kVp) 100 120 140
Tube current-
time product (mAs)
Adjusted depending on scanner type to achieve target CTDIvol
CTDIvol (mGy) 0.8 1.6 3.2
Effective dose
taking into account <0.7 <1.0 <1.6
scout view (mSv)
Table 2.1. Exposure factors used in the UKLS trial, modified from Baldwin et al. [157],
2.5.3 Image reconstruction
Images were reconstructed at lmm thickness with 0.7 increment, using both
moderate and high spatial frequency kernels.
2.5.4 Quality control
Ten randomly selected cases from both sites were reviewed every month at
the central site with respect to adequacy of craniocaudal coverage, field of view,
degree of inspiration, motion artefacts, radiation exposure parameters, radiation dose,
and reconstruction algorithms. Feedback was provided to local sites.
2.6 Data collection
2.6.1 UKLS database
The UKLS database was managed and maintained by the UKLS project team.
It was a web-based database that was built on the Nelson Management System
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(NMS) design [155], and accessible upon registration with the UKLS project
manager. Access rights were configurable such that readers in the study were not
able to view the recordings of other readers unless they were involved in consensus
or arbitration. The database held all trial information for the participants. The
participant's surname and demographic details were visible to the reader to ensure
accurate identification.
2.6.2 Data storage and retrieval
All scans performed at the local sites were transferred to the reading
workstation at the local site (Syngo, Siemens Medical Solutions, Erlangen, Germany)
as well as to the local Picture Archiving and Communications System (PACS). At
the same time, the scans were also transferred via encrypted network transfer to the
Image Exchange Portal (Burnbank Systems, Ipswich, England) and then downloaded
onto the Syngo workstation at the central site, as well as to the central site PACS
server, ensuring backup of data at both local and central sites.
A UKLS reader opened the study in "LungCARE", the volumetric
segmentation package used for reading (LungCARE, version Somaris/5 VB 10A,
Siemens Medical Solutions). Each detected nodule was evaluated and recorded in the
UKLS database using a non-commercial database electronic soft-copy entry
proforma (Artex Nodule input for UKLS version 4.4, Logiton, Netherlands) (Figure
2.1). Options for nodule categorisation and segment location were available from
drop-down menus, while the slice position of the nodule was entered using free-text.
Once a reading for a particular nodule had been completed, the information from the
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proforma was copied and pasted into a structured DICOM report in an Extensible
Markup Language (XML) format. The XML file was then transferred to a local
network drive, so that the file could be uploaded to the patient's record on the UKLS
database via a PC with web access. The XML file contained information regarding a
nodule's size, table position location, lung and segment location, category and
volume.
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Nodules were defined as follows:
Category 1 Benign nodules: Nodules fulfilling one of the following criteria; a
benign pattern of calcification, fat, measuring less than 3 mm in diameter or volume
< 15 mm3. Intrapulmonary lymph nodes (IPLNs) if the following criteria were
fulfilled: lie within 5 mm of the pleura, < 8 mm in diameter, smooth border, ovoid or
non-spherical, and at least one interlobular septum radiating from surface of nodules.
Category 2 If solid and intraparenchymal with a maximum diameter of 3.1 -4.9 mm
or a volume of 15-49 mm3; if solid and pleural or juxtapleural with a maximum
diameter of 3.1-4.9 mm; if non-solid or part-solid with a maximum non-solid
component diameter of 3.1-4.9 mm, and, where there was a solid component, this
had a diameter of < 3 mm and/or volume of < 15 mm .
Category 3 If solid and intraparenchymal with a volume of 50-500 mm3; if solid and
pleural or juxtapleural with a diameter 5.0-9.9 mm; if non-solid with a maximum
diameter of > 5mm; if part-solid with a maximum non-solid component diameter of
> 5mm, and with a solid component volume of 15-500 mm3 or solid component
diameter of 3.0- 9.9 mm.
Category 4 If solid and intraparenchymal with a volume > 500 mm3; if solid and
pleural or juxtapleural with a diameter of > 10 mm; if part-solid and the solid
component had a diameter of> 10 mm or had a volume > 500 mm .
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2.7.2 Semi-automated volumetric nodule segmentation method
The volumetric segmentation method was performed using LungCARE
(Siemens Medical Solutions, Erlangen, Germany) and is similar to the technique
described in other studies using this software [313], First, the reader marked a
candidate nodule with a mouse click. Then the programme automatically defined a
volume of interest around the candidate nodule, which could be further analyzed by
using volume-rendered displays or a coronal reformation. The candidate nodule
could then be either approved or discarded. The evaluation of a nodule with a second
mouse click initiated an automated volume measurement programme. The
programme used a fixed-attenuation threshold of -400 HU to extract a three-
dimensional connected "structure of interest". This structure of interest consisted of
the nodule and, if present, connected structures such as vessels or parts of the chest
wall. Subsequently, a small spherical three-dimensional template that originated from
the click point was gradually expanded; its cross-correlation with the segmented
nodule was computed for each step. The peak value of the cross-correlation curve
was determined, and an empirical cut-off value close to the peak value was used to
separate the nodule from potential adjacent structures. In this manner, an optimum
three-dimensional template was generated. Finally, the nodule was segmented by
fusing the optimum three-dimensional template and the structure of interest; this was
followed by spatial reasoning to remove adjacent structures. The segmented nodule
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Figure 2.2. Example of marking and annotation of a nodule within LungCARE by a
radiologist on an anonymised LDCT study. The CT is presented in a 2 x 2 viewing
partition with a default window setting level -500 HU, width 1500 HU, and arranged in
the following manner: (A) top left panel, maximum intensity projections (MIPs) with a
default setting of 10mm thickness, showing a nodule marked with a yellow outline box
in the left lower lobe; (B) top right panel, 1mm-collimation axial images; (c) bottom left
panel, 0.7mm-collimation coronal images; and (D) bottom right panel, displaying
volumetric segmentation of a nodule once that nodule is selected with a mouse click.
2.7.3 Follow-up protocols
The follow-up protocols for the nodules were based on initial volume and
volume doubling time (VDT), as shown in Figure 2.3.
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2.8.1 Measures of observer performance
In investigations of image interpretation, the observer, rather than the
imaging equipment itself, may be considered as the diagnostic test under scrutiny
[357],
2.8.1.1 Sensitivity
Sensitivity is the proportion of subjects with a condition (for example, a
pulmonary nodule) who have a positive test [97], It is calculated by the formula:
(true positives) xlOO
(true positives) + (false negatives)
The higher the sensitivity, the lower the proportion of false negative cases. As such, a
highly sensitive test can be considered a good "rule out" test.
2.8.1.2 Specificity
Specificity is the proportion of people without a disease who have a negative
test [97], It is calculated by the formula:
(true negatives) xlOO
(false positives) + (true negatives)
The higher the specificity, the lower the proportion of false positive cases A highly
specific test can be considered a good "rule in" test.
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Sensitivity and specificity are measures of a diagnostic test which are unaffected by
disease prevalence.
2.8.1.3 Positive predictive value
The positive predictive value of a test is the probability of disease given a
positive test [358], It is calculated by the formula:
(true positives) xlOO
(true positives) + (false positives)
2.8.1.4 Negative predictive value
The negative predictive value of a test is the probability of absence of disease
given a negative test [358], It is calculated by the formula:
(true negatives) xlOO
(true negatives) + (false negatives)
Unlike sensitivity and specificity, both positive and negative predictive values are
affected by the prevalence of disease.
2.8.1.5 Average false positive detections per case
The average number of false positive detections (FPs) per case for a given
reader is calculated by dividing the total number of FPs by the total number of cases
read. The average FPs per case is a parameter that is often quoted for computer-aided
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detection (CAD) systems, when it is usually described as the "false positive rate"
[359], However, as explained in section 1.2.2.2, the false positive rate is actually
defined as the probability of obtaining a false positive result, and is given by (1-
specificity) [97]; use of the term "false positive rate" in the CAD literature is
therefore potentially confusing. As such, the terms "average number of false positive
detections per case" or "average FPs per case" will be used in this thesis with respect
to false positive detections, for the purposes of clarity.
2.8.2 Comparison between groups
The type of test used to compare the differences between groups depends on
whether the data are:
• independent or paired (i.e. related);
• categorical or continuous; and
• normally or non-normally distributed.
2.8.2.1 Categorical data
The chi-square test of homogeneity is used to compare two groups of
subjects that have been sampled from two independent populations and a binary
outcome (e.g. positive or negative) is used for classification [360], It tests the null
hypothesis that there is no difference between the observed and expected frequencies
of a result. The expected frequency is calculated according to the null hypothesis in
each cell of a 2 x 2 contingency table for the binary outcomes. If the expected
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frequencies are close to the observed frequencies, the model according to the null
hypothesis fits the data well; thus, the null hypothesis should not be rejected.
However, the chi-square test may not be accurate when sample sizes are
small [360], In such instances, Fisher's exact test is preferred. Although there is no
definite cut-off defined for when the Fisher's exact test should be used, a useful rule
is to apply this test when the total sample size is less than 30 [360] or the expected
cell count within any cell in the 2 x 2 contingency table is less than five [361],
McNemar's test is used to compare paired observations of categorical data,
for example the comparison of the observations of different readers on the same
subject. The data are not independent (as they are being performed on the same
subject) and thus the chi-square test would not be appropriate. Unlike the chi-square
test, the McNemar's test only considers those pairs of observations which are
discordant (e.g. true positive and false negative, false positive and true negative),
while ignoring the concordant pairs. For such situations, the null hypothesis is that
the proportions of positive results are the same for two observations by two different
readers, versus the alternative hypothesis that they are not the same [360],
2.8.2.2 Continuous data
The independent samples t-test is a parametric test for comparing the means
between observations from independent samples [362], The non-parametric
equivalent is the Mann Whitney U test [363], When observations are paired, the
paired student's t-test and the Wilcoxon signed rank test are the parametric and non-
parametric equivalents for comparing the mean difference, respectively [364],
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2.8.3 Measures of agreement
Observer variation of categorical data, such as in the classification of nodules,
can be measured by the kappa coefficient (multirater k), which represents the
agreement obtained between two readers beyond that expected by chance [365], The
kappa coefficient is calculated by
k = Pa - Pe / 1-Pe
where PA is the proportion of cases for which agreement exists, and Pe is the
proportion of cases in which raters would agree by chance. The weighted kappa
coefficient adjusts for the extent to which disagreement occurs when a grading
system consisting of more than two categories is used [365],
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CHAPTER 3: TRAINING RADIOGRAPHERS IN LUNG
NODULE DETECTION
3.1 Introduction
Radiologists are arguably best suited to the task of lung nodule identification
on CT because they have medical knowledge, an understanding of CT anatomy, and
reading experience. However, it could be reasoned that these attributes help mainly
with the interpretation and the assignment of some level of clinical significance to a
particular finding, rather than to the detection of that finding itself. As discussed in
section 1.6.1, the detection of a lung nodule is mainly a matter of perception. If the
task of detection could be reliably and consistently performed by a suitably trained
non-radiologist, there would in theory be a greater pool of readers available for CT
lung cancer screening. Radiologists could then focus on the important tasks of
interpretation of findings, recommendations for follow-up and arbitration, rather than
on nodule detection alone.
An alternative reader to a radiologist is a radiographer (or technologist as
they are referred to in the USA). Radiographers are an obvious first choice for this
task, as they have a basic understanding of both technical and anatomical aspects of
thoracic CT. Radiographers have already been assessed as readers in screening
mammography [339, 366] and screening CT colonography [367, 368], After a
period of training, key performance indicators can be identified for such tasks [369],
However, no precedent for radiographers reading thoracic CTs currently exists, and
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therefore the optimum type and duration of training they require to develop the skills
necessary for this task is unknown.
It is generally accepted that feedback provided by tutors is integral to medical
training [370], Feedback is a process that allows two-way interaction between a
learner and tutor, so that learning takes place in a non-evaluative and non-
judgemental environment, allowing both the learner and tutor to identify areas for
modification and reinforcement in their learning.
The aim of the current investigation was to evaluate the effect of continuous
feedback as a means of training radiographers in the task of lung nodule detection.
3.2 Materials and Methods
3.2.1 Training dataset and subsets
The methods of CT acquisition, procurement of scans from the NELSON
study, and data anonymisation and storage have been described in Chapter 2. From
the 202 CT studies initially procured for the training dataset (section 2.3), 100 studies
containing a variable number of nodules were chosen at random. The training dataset
was arbitrarily divided into 10 training subsets, each containing 10 CT scans. Each of
these scans had been read by one NELSON reader at the local scanning site, a
NELSON reader at a central site, and in cases where there had been disagreement, by
a third NELSON reader. The final consensus answer for the nodules identified by the
NELSON readings in these studies had all been recorded on a spreadsheet that
accompanied the CTs from the NELSON database. Each nodule identified by the
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NELSON reading was visually confirmed by one of two thoracic radiologists [Dr A.
Devaraj (AD) or me (AN)]. As the NELSON nodule protocol did not specifically
discriminate between intrapulmonary lymph nodes (IPLNs) and nodules, these
radiologists (AD or AN) also recorded IPLNs.
3.2.2 Selection of radiographers
Four radiographers who were able to commit at least four hours a week over
a five-month period were selected as readers. All four radiographers had experience
in thoracic CT scan acquisition and thus had a basic understanding of acquisition
parameters and thoracic CT anatomy. Readers 1 to 3 had 10 or more years'
radiography experience, while reader 4 had 4 years.
3.2.3 Introductory tutorial
The radiographers were first given a PC-based presentation (prepared by AD)
covering the basic principles of thoracic CT anatomy and low-dose CT acquisition.
They were then shown 20 CTs containing examples of different types of lung
nodules as well as focal opacities such as pleural thickening and atelectasis that can
mimic lung nodules. They were provided with the UKLS definitions of lung nodules,
as described in section 2.7.1. The images of these various opacities were obtained
from 20 CT studies from the original pool of 202 LDCT studies that had been
obtained from the NELSON study, but that had not been included in the 100 scans
forming the training dataset for the current study.
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The radiographers were also tutored in the use of the LungCARE software on
the Syngo workstation (Siemens Medical Solutions, Erlangen, Germany), and were
trained to use the software's measurement tools as well as image manipulation tools
such as magnification and maximum intensity projection (MIP), to ensure they were
sufficiently able to optimise their nodule detection technique.
3.2.4 Radiographer reading
Each radiographer was provided with the unique identifier numbers of the 10
anonymised CT studies comprising each training subset. Radiographers were only
given one subset at a time to analyse, and were all given the CTs and the subsets in
the same order.
Radiographers were asked to identify all category 2, 3 and 4 nodules, and
only to identify category 1 nodules if they met all criteria for intrapulmonary lymph
nodes (see section 2.7.1). For each nodule, radiographers were asked to record the
slice position, location (right or left lung), and category of the nodule. The
radiographers performed semi-automated volumetric analysis on any segmentable
solid nodule or solid component of a part-solid nodule on the LungCARE software.
For non-solid nodules, the radiographers categorised the nodules based on the
maximum diameter. All recordings were entered on a spreadsheet created using
Microsoft Excel (version 2007, Microsoft Corp., Redmond, CA).
The time taken for each radiographer to complete each subset of 10 scans was
recorded to the nearest 0.25 hours.
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3.2.5 Evaluation of radiographer answers and feedback to
radiographers
After each radiographer had completed a subset of 10 scans, one of the two
radiologists (AD or AN) reviewed each opacity that had been identified by the
radiographers. All opacities were classified by the radiologist into one of four levels
(Table 3.1). This process was performed in the presence of that radiographer, and so
acted as feedback for the radiographer, providing him or her with the opportunity to
ask questions on a case-by-case basis. The radiographers could only move on to the








If a nodule recorded by the
radiographer matched the slice
position, location and size (volume
or diameter) of the NELSON
reading, the nodule was recorded
as being in agreement.
If a genuine nodule that was not
part of the NELSON reading was
identified by the radiographer, it
was considered an extra positive
finding.
A verified nodule (whether
discovered on the NELSON
reading or by at least one other
radiographer) that had not been
identified by the radiographer was
considered a missed nodule.
"Overcall" An opacity not thought to represent
a nodule or a nodule that was too
small (i.e. category 1 and not
matching criteria for an IPLN) was
considered an 'overcall'. The
nature of the opacity was recorded
by the radiologist (see Table 3.5).
Table 3.1. Classification of opacities identified by radiographers.
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3.2.6 Reference standard
After four radiographers had completed the analysis of all 100 cases, all extra
findings identified by at least one radiographer (but not by the NELSON readers)
were reviewed by two radiologists in consensus. Thus in summary, the reference
standard for this study consisted of:
1. An initial evaluation by at least 2 NELSON readers;
2. A validation of that evaluation by one of two participating radiologists (AD
or AN) in this study;
3. A two-stage refinement process consisting of radiographer identification of
extra findings and consensus interpretation of those extra findings by two
radiologists.
3.2.7 Statistical analysis
The sensitivity, specificity, average number of false positive detections per
case, and the ratio of true positive to false positive detections for each radiographer
as compared to the reference standard was calculated for the 100 scans in total. The
ratio of true positive to false positive detections per unit hour for each radiographer
was also calculated. The sensitivity and specificity of each radiographer was also
calculated for each subset of 10 scans. A two-tailed Fisher's exact test was used to
compare the sensitivities and specificities from one subset to the next for a given
radiographer. All analysis was performed using Medcalc (version 12.5.0.0, MedCalc
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All 100 subjects in the CT test cohort were male, aged 53-79 years old. A
total of 417 opacities were identified in 91 out of the 100 CT studies. A range of 1 to
23 opacities were identified per scan. The range of opacities per subset of 10 studies
varied between 14 and 79. Figure 3.1 illustrates the distribution of opacities by each
set. In the remaining 9/100 studies, no opacities were identified by radiographers.
Figure 3.1. Number of opacities identified per subset of 10 CT studies.
139
The mean time taken for each subset by radiographers 1,2,3 and 4 was 3.1,
2.2, 2.4 and 2.3 hours respectively, corresponding to a mean time per subject of 18,
13, 14 and 14 minutes respectively.
3.3.2 Reference standard
A total of 282 opacities were considered identifiable nodules (IPLNs or
category 2 to 4 nodules) in 83/100 CT studies. 76 (27.0%) were designated IPLNs,
150 (53.2%) category 2, 51 (18.1%) category 3, and 5 (1.8%) category 4 nodules. In
total, 17/100 CT studies had no opacities designated as positive nodules in the
reference standard; these included the 9 CT studies with no positive findings
identified by any radiologist or radiographer, and 8 CT studies with at least one false
positive finding by a radiographer.
3.3.3 Overall performance of individual radiographers
The overall performance of each radiographer over the 100 scans is shown in
Table 3.2. The mean sensitivity and specificity were 60.5% and 68.4% respectively.




1 2 3 4
Sensitivity (%) 78.0 75.5 39.7 48.6
Specificity (%) 74.3 65.3 70.1 63.9
Average no. of FP 0.37 0.50 0.43 0.52
detections per case
Ratio of TP:FP detections 5.95 4.26 2.60 2.63
Table 3.2. Overall performance of individual radiographers over the 100 scans.
TP= true positive; FP= false positive.
When the amount of time for task performance was considered, the ratios of
true positive (TP); false positive (FP) detections per unit hour for radiographers 1, 2,
3 and 4 were 1.9, 1.9, 1.1 and 1.1 respectively.
3.3.4 Effect of feedback on radiographer performance
The sensitivities of each radiographer for each subset of 10 scans are
illustrated in Table 3.3. Statistically significant increases in sensitivity were observed
for radiographers 3 and 4 between subsets 4 and 5 only (increases of 38.3% and
40.3% respectively). Nevertheless, radiographers 3 and 4 showed a slight trend




Subset Sens (%) P Sens(%) P Sens (%) P Sens(%) P
1 86.4 NA 81.8 NA 22.7 NA 54.5 NA
2 73.7 0.44 68.4 0.47 42.1 0.31 31.6 0.21
3 84.8 0.31 73.9 0.76 34.8 0.59 34.8 1.00
4 65.9 0.05 75.0 1.00 20.5 0.16 27.3 0.50
5 82.4 0.13 67.6 0.61 58.8 0.0008 67.6 0.0005
6 82.1 1.00 85.7 0.14 35.7 0.08 60.7 0.60
7 75.9 0.75 72.4 0.33 48.3 0.42 69.0 0.59
8 79.2 1.00 75.0 1.00 58.3 0.58 54.2 0.39
9 81.8 1.00 63.6 0.69 36.4 0.29 27.3 0.17
10 72.0 0.69 88.0 0.17 48.0 0.72 60.0 0.15
Table 3.3. Sensitivities of radiographers for each subset. P values are for the
difference in sensitivity between the particular subset and the one preceding it, using
the two-tailed Fisher's exact test. P values in bold indicate statistically significant
differences.
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Figure 3.2. Variation in sensitivity between subsets for radiographers 1 to 4.
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The specificities of each radiographer for each subset of 10 scans are
illustrated in Table 3.4. Statistically significant decreases in specificity were
observed for Radiographer 2 between subsets 3 and 4, 5 and 6, and 9 and 10 (47.7%,
33.3% and 65.0% respectively), and for Radiographer 4 between subsets 4 and 5
(73.3%). Statistically significant increases in specificity were seen for Radiographer
2 between subsets 4 and 5, and for Radiographer 3 between subsets 3 and 4 (75.0%
and 42.4% respectively).
No particular trend was observed for the changes in specificity for any
radiographer (Figure 3.3).
Radiographer
ibset Spec(%) P Spec (%) P Spec(%) P Spec(%) P
1 64.3 NA 64.3 NA 92.9 NA 50.0 NA
2 57.1 1.00 71.4 1.00 85.7 1.00 42.9 1.00
3 72.7 0.41 72.7 1.00 57.6 0.22 78.8 0.08
4 75.0 1.00 25.0 0.03 100.0 0.04 100.0 0.31
5 80.0 1.00 100.0 0.0003 66.7 0.12 26.7 0.001
6 50.0 0.13 66.7 0.03 75.0 0.69 58.3 0.13
7 75.0 0.24 62.5 1.00 56.3 0.43 50.0 0.72
8 100 0.11 58.3 1.00 58.3 1.00 75.0 0.25
9 85.7 0.37 100.0 0.11 85.7 0.33 85.7 1.00
10 80.0 1.00 35.0 0.006 70.0 0.63 70.0 0.63
Table 3.4. Specificities of radiographers for each subset. P values are for the
difference in specificity between the particular subset and the one preceding it, using
the two-tailed Fisher's exact test. Rvalues in bold indicate statistically significant
differences.












































Figure 3.3. Variation in specificity between subsets for radiographers 1 to 4.
3.3.5 Characteristics of false positive findings
The types of false positive findings identified by each radiographer varied
widely between each radiographer (Table 3.5). In general, false positive findings
were most frequently due to a combination of pleural or fissural thickening,
atelactasis, presumed scarring and overcalling vascular structures.
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Radiographer
1 2 3 4
Type of false positive finding No. (%)
Pleural/fissural thickening, pleural plaques 9 (24.3) 11 (22.0) 4 (9.3) 11 (21.2)
Atelectasis 6 (16.2) 7 (14.0) 9 (20.9) 9(17.3)
Presumed scarring 7 (18.9) 7 (14.0) 10 (23.3) 7(13.5)
Linear opacity 0 (0.0) 3 (6.0) 2 (4.7) 1 (1.9)
Calcified nodule 3(8.1) 0 (0.0) 3(7.0) 2(3.8)
Nodule < 3mm in diameter 0 (0.0) 8 (16.0) 4(9.3) 7(13.5)
Vascular structure 7 (18.9) 10 (20.0) 9 (20.9) 8(15.4)
Diaphragm/diaphgramatic fat 1 (2.7) 2 (4.0) 0 (0.0) 1 (1.9)
Mucus plug 2 (5.4) 2 (4.0) 1 (2.3) 3(5.8)
Others
(motion artefact / osteophyte-related opacity)
2 (5.4) 0 (0.0) 1 (2-3) 3(5.8)
Total 37 50 43 52
Table 3.5. Types of false positive findings. Numbers in parentheses indicate the
proportion of false positive findings in that category as a percentage of the total false
positive findings for a particular radiographer.
3.3.6 Characteristics of false negative findings
Table 3.6 illustrates the wide variation in the types of nodules missed
between the 4 radiographers. The majority of nodules missed by all radiographers




1 2 3 4
No. (%)
1 (i.e. IPLN) 18(29.0) 17(24.6) 45 (26.5) 38 (26.2)
2 41 (66.1) 39 (56.5) 94 (55.3) 84 (57.9)
3 3 (4.8) 11 (14.5) 28 (16.5) 22 (15.2)
4 0 (0.0) 2 (2.9) 3(1.8) 1 (0.7)
Total 62 69 170 145
Table 3.6. False negative findings. Numbers in parentheses indicate the proportion of
false negative findings in that category as a percentage of the total false negative
findings for a particular radiographer.
3.4 Discussion
The mean and range of sensitivities for pulmonary nodule detection by
radiographers in this study were largely comparable to the wide range (between 21%
and 70%) reported for radiologists in the literature [289, 290, 293, 334, 336, 338,
371], However, a learning effect on sensitivity and specificity over the sequential 10
subsets was not demonstrated. Training would intuitively be expected to enhance
performance. In an article examining this issue, Wood stated that "with practice...the
novice will build a mental library of patterns of normality and abnormality, along
with a library of information. Frequent feedback and affirmation will ensure that this
experience grows" [372], The lack of a conspicuous learning curve in the current
study may be due to the small number of scans in each subset, as well as varying
levels of difficulty that may have existed within each subset. However, this level of
difficulty is not something that is easy to quantify or standardise.
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The fact that the first two readers had a higher sensitivity than radiographers
3 and 4 could be due to differences in inherent ability. Over time it might have been
expected that the poorer sensitivity of readers 3 and 4 in comparison to readers 1 and
2 would have improved. Indeed, a small but inconsistent trend in this direction was
observed for radiographers 3 and 4 in the later subsets, but their sensitivity still did
not match that of the two most sensitive radiographers.
The lack of a learning curve has been shown in other detection performance
studies. Burling et al. did not manage to find a learning effect for the selection of the
correct management strategy or for lesion detection in an evaluation of five
radiographers performing CT colonography interpretation, and similarly concluded
that this may have been due to the underpowered nature of their study [373].
Kinnunen et al. found no improvement effect of training for four groups of
radiologists in the radiographic diagnosis of midfacial trauma [374],
As the current study is the first, to my knowledge, to evaluate radiographers
in a potential LDCT lung cancer screening setting, comparative evidence for
radiographer perfonnance in this field is unavailable. However, there is some
evidence to support a hypothesis of innate perceptual skill from studies involving
radiographer or "naive" readers in mammography and CT colonography settings.
Davies et al. evaluated expertise in categorising mammograms, showing that a group
of 3 "naive" readers with no radiographic experience performed as well as three
radiographers (who had exposure to mammograms but no formal training in reading
them) and that their performance exceeded that expected by chance, after only a few
hours of training [375], Studies evaluating various training methods for
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radiographers in CT colonography have demonstrated a similar training effect for
detecting polyps [367, 368, 373, 376].
In the current study, the length of radiographers' "experience" did not seem
to affect sensitivity; indeed, the radiographer with the longest duration of
"experience" (Radiographer 3) had the lowest sensitivity. This is not unexpected
since any radiographer, independent of his or her seniority, would be assumed to be
starting from the same baseline as far as pulmonary nodule detection on CT is
concerned.
Studies using radiologists with different levels of experience have shown
conflicting results in terms of the level of reader experience on nodule detection
ability. For instance, Awai et al. demonstrated that the area under the free-response
receiver-operator characteristic (ROC) curve was not significantly different when
comparing five board-certified radiologists (who did not specialise in thoracic
radiology) against five radiology residents [337], Brochu et al. found there was a
significant difference in the sensitivities of 3 radiologists with different levels of
experience for the detection of pulmonary nodules in an LDCT screening setting, but
that it was the radiologist with the least experience that had the greatest sensitivity
(70%) compared to two other thoracic radiologists with 15 and 20 years' experience
respectively (sensitivity 54% and 38% respectively) [338], Brown et al. found that
when six non-radiologists, four non-thoracic radiologists and six thoracic radiologists
read 8 LDCT cases for pulmonary nodules, the mean detection rates were 62%, 62%
and 72% for the non-radiologists, non-thoracic radiologists and thoracic radiologists,
respectively, indicating that experience did not have a substantial impact on nodule
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detection [345], Again, these findings reinforce the idea that nodule detection ability
is more closely related to an inherent perceptual ability unique to each individual.
An attempt was made to understand the types of opacities that cause
difficulty in classification leading to false positives, as well as the characteristics of
nodules that were missed by radiographers. It appears that radiographers, perhaps
predictably, had difficulty in detecting smaller nodules, and were more likely to
"overcall" opacities due to pleural thickening, pleural plaques, atelectasis, or
prominent vascular structures.
It is important to recognise that the mean times taken by the radiographers per
CT study (range 13-18 minutes) in this study were longer than that taken by the
radiologists in more or less comparable studies, for instance by Rubin et al. (range
4.7-9.8 minutes) and Roos et al. (range 4.9-12.3 minutes); the longer reading times
could have helped increase radiographer sensitivity. In a CT colonography setting, it
has been demonstrated that radiographers (but not radiologists) have an increased
accuracy with longer reading times [377], and vice-versa [373], This has also been
shown to a certain extent in the present study: Reader 1, who took the longest time,
had the highest sensitivity. However, the ratio of true positive to false positive
findings is more instructive when determining the likelihood that a nodule of tme
significance versus one of less or no significance will be detected, and in this regard,
readers 1 and 2 had similar ratios per unit time, indicating that overall Reader 2 made
the most efficient use of time. An increase in reading time may have cost-
effectiveness implications if the use of radiographers is contemplated in a lung
cancer screening programme, as the volume of CTs read by a radiographer could be
substantially less than that of an experienced radiologist. However, the fact that the
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additional time spent appears to increase the number of true positive detections (i.e.
sensitivity) rather than the number of false positive detections is still reassuring in the
specific context of a screening programme.
This study has a few limitations. First, like all nodule detection studies
without histopathological proof, the determination of a nodule as a true positive
necessarily depends on a less than "golden" reference standard. In this case, a
reference standard was used that was a composite of the radiographers' readings, as
well as a total of four radiologists' readings. In terms of bias considerations, two of
the four radiologists determining the reference standard were also training the
radiographers and providing feedback; inevitably the radiologists' own
interpretations of findings would have influenced that of the radiographers and of the
reference standard. However, as has been concluded by Annato et al., variation in
opinion as to what constitutes a "true nodule" in a reference standard is extensive
[378, 379], and as such this variation would be present in any reference standard that
was derived from radiologists' interpretations.
As discussed earlier, the subsets may have been too small to demonstrate a
learning effect. However, as the CT studies in the training set were chosen at
random, the number of nodules within each subset was not predetermined, inevitably
leading to some subsets with smaller number of nodules. Such variation in the
number of nodules would of course also be encountered in clinical practice.
Although the length of time taken for the radiographers to read each subset
was recorded, this was not done for the radiologists who originally read these studies,
as those evaluations were performed as part of the original screening trial and time
150
data was not collected in the NELSON trial. It is therefore not possible to make a
direct observation regarding the time-effectiveness of the radiographers as compared
to radiologists.
3.5 Summary
• Radiographers' performance in lung nodule detection, after a short period of
training and using continuous feedback, was variable but for some individuals
was similar to that reported for radiologists.
• A learning effect could not be demonstrated, indicating that an innate
perceptual ability is likely to be a significant determinant of performance.
• The performance of radiographers as readers in a lung cancer screening
programme thus needs to be formally evaluated against that of radiologists;
this will be the subject of the next investigation.
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CHAPTER 4: PROSPECTIVE COMPARISON OF
TRAINED RADIOGRAPHERS WITH EXPERIENCED
THORACIC RADIOLOGISTS FOR CT LUNG NODULE
DETECTION
4.1 Introduction
A CT lung screening programme requires a reading radiologist to dedicate a
significant amount of time to the task of lung nodule detection. Should a national
lung screening programme be launched, the number of radiologists reading lung
screening CTs would, in terms of current working practices, need to increase,
especially if the reading protocol involved more than one reader with consensus and
arbitration.
As discussed in Chapter 3, one possible method of circumventing the increase
in radiologist-hours required for screening is to use radiographers as part of the CT
reading process. Having provided radiographers with a basic level of training, it is
imperative that their performance is assessed against the established methodology of
various screening trials, in which radiologists perform all reading. The aim of this
investigation was therefore to evaluate the performance of radiographers in lung
nodule detection on CT, compared with radiologists in the setting of the UK Lung
Cancer Screening (UKLS) pilot trial.
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4.2 Materials and Methods
4.2.1 Study design and case selection
This study was performed prospectively. Two-hundred and ninety
consecutive CT studies performed for the UK.LS pilot trial were read for this study
between November 2011 and April 2012. All CT studies were performed at one of
two participating sites, according to trial protocols as specified in section 2.5.
4.2.2 Classification of nodules
Nodules were classified according to the UKLS definitions described in
section 2.7.1. The electronic database entry proforma (Artex VOF, Logiton,
Netherlands) used for recording nodules as described in section 2.6.2 also allowed
for intrapulmonary lymph nodes (IPLNs) to have an additional unique designation so
that these could be identified separately.
4.2.3 CT evaluation by radiologists
Each CT examination was read by a single radiologist at each of the two
participating sites (Radiologist A at Local Site 1 and Radiologist B at Local Site 2,
both with more than 10 years of specialist thoracic imaging experience). The CTs
were then transmitted to the central reading site on the same day via the Image
Exchange Portal (Burnbank Systems, Ipswich, England) described in section 2.6.2
for a second independent reading (by Radiologist C, 10 years' experience), and read
as described in section 2.7.2.
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The access rights to the UKLS database of the two reading radiologists at the
participating sites were configured such that they were not able to view the
recordings of other readers, but the central radiologist (Radiologist C) could access
these readings as he had to identify any discrepant findings that required arbitration.
The central radiologist only viewed the readings of the local site radiologists once he
had completed his own reading.
4.2.4 Selection of reading radiographers
Four radiographers who were able to commit at least four hours a week over
the study period were selected as readers. Radiographer 1 read CTs at Local Site 1,
and Radiographer 2 read CTs at Local Site 2. Two radiographers (Radiographers 3
and 4) read CTs at the central site. As such, each CT study was read by two
radiologists and at least one radiographer, with a maximum of two radiographers
(one local site radiographer and one central site radiographer).
All four radiographers had experience in thoracic CT scan acquisition.
Radiographers 3 and 4 had participated in the investigation described in Chapter 3
and had thus already undergone training, while Radiographers 1 and 2 were trained
using a method similar to that described in Chapter 3. However, as no useful learning
effect had been noted in Chapter 3 using feedback after every 10 training cases read,
the radiographers instead read 80 training cases (the same training cases used in
Chapter 3) - 20 cases where reading was directly supervised by the local site reading
radiologist, followed by 60 cases of self-directed training by radiographers with
indirect supervision from the local site reading radiologist.
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Prior to commencing reading, all four radiographers and all three radiologists
also achieved at least 80% sensitivity (as compared to nodules identified by
NELSON radiologists) on a test set of 25 different cases that were gleaned from the
NELSON training dataset described in section 2.3. This training target was set at a
higher level than that achieved by most radiologists in the literature (between 21%-
70%, as described in section 3.4) because the CT studies were being read
prospectively for clinical, and not solely experimental, purposes. As such, the ability
of a reader to detect a high proportion of potentially clinically relevant nodules had
to be ensured.
4.2.5 Reference standard
After the second reading, the radiologist at the central site (Radiologist C)
reviewed, weekly, all nodule candidates identified by radiologists for each subject on
the database to identify any discrepancies. Arbitration on discrepancies was provided
at the central site by a thoracic radiologist with more than 20 years of experience,
and the final consensus view was recorded on the database. All agreed category 2 to
4 nodules and intrapulmonary lymph nodes were included in the reference standard.
In addition, the maximum diameter of each nodule comprising the reference standard
as recorded on the UKLS database was recorded.
4.2.6 Classification of discrepancies
For each CT, a list of each reader's reading was generated and compared
against the reference standard. A nodule was considered to have been missed by a
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reader if it was included in the reference standard but not recorded by that reader. In
addition note was made of nodules classified as IPLNs by the reference standard but
recorded as category 2 to 4 by the reader, and vice versa.
4.2.7 Statistical analysis
The sensitivity (the percentage of reference standard nodules identified) and
the average false positive detections (FPs) per case (expressed as mean and standard
deviation) were calculated:
• for each reader, for all cases read by him or her;
• for each radiographer and radiologist within a particular radiographer-
radiologist combination (10 combinations in total), taking into account only
cases read by that combination, to enable direct comparison between that
radiographer and radiologist (comparisons of sensitivity and average FPs
were performed using McNemar's test and paired student's t-test,
respectively);
• for each reader in the first 10 weeks (PI), and compared to that in the second
10 weeks (P2) of the study (comparisons of sensitivity and average FPs per
case were perfonned using the Chi-square test and independent samples
student's t-test, respectively).
A post-hoc analysis of differences between radiographer and radiologist
sensitivity when considering only reference standard nodules at two higher diameter
thresholds (> 5mm and > 6mm) was subsequently conducted , to investigate the
effect of increasing the threshold for nodule positivity on radiographer performance.
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The agreement between each radiographer and the reference standard for the
classification of IPLNs and category 2 to 4 nodules was assessed using the weighted
kappa statistic (multirater k), as detailed in Chapter 2. Kappa values were defined as
follows: a k less than or equal to 0.2, poor agreement; 0.21-0.40 fair agreement;
0.41 -0.6 moderate agreement; 0.61 -0.80, good agreement; and 0.81-1.00, very good
agreement [380], All analysis was performed using Medcalc (version 12.5.0.0,
MedCalc Software, Mariakerke, Belgium). A P value of less than 0.05 was assumed
to be statistically significant.
4.3 Results
4.3.1 Reference standard
Eighty-one (27.9%) of the 290 CT studies did not contain any nodules. The
reference standard thus consisted of 599 nodules in the remaining 209 (72.1%) CT
studies. The majority of CTs had 1 (35.4%), 2 (23.0%) or 3(21.5%) nodules per CT
(Figure 4.1). The median number of nodules per scan was 2, with a range of 1 to 18



















0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
No. of reference nodules per case
Figure 4.1. Distribution of the number of nodules per CT scan.
The breakdown of nodules in the reference standard according to UKLS size
category and type is illustrated in Table 4.1. The majority were solid nodules
(62.1%), with just under a third (32.6%) classified as IPLNs. 98.2% of nodules were




Part-solid Non-solid IPLN1 Total
1 NA NA NA 195 (32.6) 195 (32.6)
2 247 (41.2) 2 (0.3) 7(1.2) n/a 256 (42.7)
3 115 (19.2) 4 (0.7) 18 (3.0) n/a 137 (22.9)
4 10(1.7) 1 (0.2) 0(0) n/a 11 (1.8)
Total 372 (62.1) 7(1.2) 25 (4.2) 195(32.6) 599 (100.0)
Table 4.1. Distribution of nodules according to UKLS size category and nodule type.
Figures in parentheses are percentages of the total number of nodules. Minor
inconsistencies in summation of the percentages is due to rounding of percentages to
1 significant figure. IPLN= intrapulmonary lymph node. NA= not applicable.
1IPLNs are category 1 by definition in the UKLS.
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4.3.2 Overall performance of radiographers and radiologists
Radiographers 1, 2, 3 and 4 had sensitivities of 67.6%, 77.8%, 79.4% and
61.6% respectively (mean sensitivity 71.6 ± 8.5%). Radiologists A, B and C had
sensitivities of 88.9%, 87.0% and 74.0% respectively (mean sensitivity 83.3 ± 8.1%).
The average FPs per case for radiographers 1, 2, 3 and 4 were 1.2 ± 2.1, 2.9
± 2.8, 0.6 ± 1.0 and 1.1 ± 1.3 respectively, while that of radiologists A, B and C were
0.5 ± 0.8, 0.7 ± 1.0 and 0.2 ± 0.5 respectively.
4.3.3 Comparison of radiographer and radiologist performance
The sensitivities of each radiographer compared to those of the corresponding
radiologists within a particular radiographer-radiologist combination are illustrated in
Table 4.2. Radiographers 1 and 2 could only be compared with their corresponding
local site radiologists (i.e. radiologists A and B respectively) and the central site
radiologist (radiologist C). Radiographer sensitivity was significantly lower than
radiologist sensitivity in 7 of 10 radiographer-radiologist combinations (range of

















1-A 130 67.6 88.0 20.4 0.0008
1-C 130 67.6 74.5 6.9 0.30
2-B 139 77.8 87.4 9.6 <0.0001
2-C 139 77.8 74.5 -3.3 0.20
3-A 68 81.0 92.2 11.2 0.01
3-B 87 78.5 88.2 9.7 0.0087
3-C 155 79.4 76.2 -3.2 0.32
4-A 64 53.8 86.6 32.8 <0.0001
4-B 49 68.7 85.5 16.8 0.0051
4-C 113 61.6 72.0 10.4 0.0119
Table 4.2. Comparison of radiographer and radiologist sensitivity for the 10
radiographer-radiologist combinations. A negative value for the difference in
sensitivity indicates a lower radiologist sensitivity compared to a radiographer. P
values are those derived from the McNemar's test. P values in bold are statistically
significant.
Radiographers had significantly higher average FPs per case than radiologists
in 8/10 combinations (range of difference, 0.4-2.6, P < 0.05), and there was no
significant difference in the remaining two combinations (Table 4.3).
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Average FPs per case
Radiographer-
radiologist combination
Radiographer Radiologist Difference P value
1-A 1.1 ±1.3 0.5 ±0.8 -0.6 <0.0001
1-C 1.1 ±1.3 0.1 ±0.5 -1.0 <0.0001
2-B 2.8 ±2.8 0.7 ± 1.1 -2.1 <0.0001
2-C 2.8 ±2.8 0.2 ±0.5 -2.6 <0.0001
3-A 0.9 ± 1.4 0.5 ±0.8 -0.4 0.0176
3-B 1.4 ±2.5 0.6 ± 1.0 -0.8 0.0015
3-C 1.2 ± 2.1 0.1± 0.5 -1.1 <0.0001
4-A 0.4 ±0.8 0.5 ±0.8 0.1 0.2009
4-B 0.8 ± 1.2 0.8 ± 1.3 0 0.71
4-C 0.6 ± 1.0 0.2 ±0.5 -0.4 0.0001
Table 4.3. Comparison of radiographer and radiologist average FPs per case for the 10
radiographer-radiologist combinations. A negative value for the difference indicates a
lower radiologist average FPs per case compared to a radiographer. P values are
those derived from the paired student's t-test. P values in bold are statistically
significant.
4.3.4 Reader performance in the first 10 weeks versus second 10 weeks
The two radiographers with the lowest overall sensitivity (Radiographers l
and 4) showed a significant improvement in sensitivity between the first and second
10-week period (sensitivity 50.0% in PI versus 74.1% in P2 for Radiographer 1,
41.8% in P1 versus 67.2% in P2 for Radiographer 4, P < 0.005), but their sensitivity
in P2 still did not reach the level of Radiographers 2 and 3, who showed no
significant difference in their sensitivity between the two periods. Radiologists'
sensitivity did not significantly differ between the two periods. No radiographer or
radiologist demonstrated a significant difference in average FPs per case between the
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two periods. As such, the improved sensitivity of Radiographers 1 and 4 in the
second 10 weeks did not come at the expense of increased average FPs per case.
4.3.5 Characterisation of intrapulmonary lymph nodes and nodules
Radiographers showed moderate to good agreement with the reference
standard for the classification of IPLNs and category 2 to 4 nodules (Table 4.4).





Table 4.4. Agreement between radiographer and the reference standard for IPLN and
nodule classification.
4.3.6 Comparisons of sensitivity using alternate diameter thresholds
There were 236 reference standard nodules that were 5mm or greater in
diameter. When considering only these nodules, the number of radiographer-
radiologist combinations with significantly lower radiographer sensitivity decreased
to 4/10 combinations (range of difference, 17.2%-37.3%, P < 0.05) (Table 4.5). No















1-A 87 63.2 80.5 17.2 0.0041
1-C 87 63.2 82.8 19.5 0.0053
2-B 128 82.0 89.1 7.0 0.1508
2-C 128 82.0 83.6 1.6 0.8501
3-A 45 80.0 88.9 8.9 0.3438
3-B 82 79.3 89.0 9.8 0.1153
3-C 127 79.5 85.0 5.5 0.2482
4-A 51 41.2 78.4 37.3 0.0005
4-B 42 78.6 88.1 9.5 0.4240
4-C 93 58.1 79.6 21.5 0.0011
Table 4.5. Comparison of radiographer and radiologist sensitivity for the 10
radiographer-radiologist combinations for nodules > 5mm diameter. P values are
those derived from the McNemar's test. P values in bold are statistically significant.
There were 165 reference standard nodules that were 6mm or greater in
diameter. As with nodules that were 5mm or greater in diameter, the number of
radiographer-radiologist combinations with significantly lower radiographer
sensitivity also decreased to 4/10 combinations (range of difference, 18.3%-40.6%, P
















1-A 60 65.0 83.3 18.3 0.0127
1-C 60 65.0 85.0 20.0 0.0169
2-B 91 79.1 90.1 11.0 0.05
2-C 91 79.1 82.4 3.3 0.66
3-A 30 83.3 90.0 6.7 0.63
3-B 60 75.0 88.3 13.3 0.08
3-C 90 77.8 85.6 7.8 0.14
4-A 37 40.5 81.1 40.6 0.0015
4-B 29 75.9 89.7 13.8 0.34
4-C 66 56.1 80.3 24.2 0.0009
Table 4.6. Comparison of radiographer and radiologist sensitivity for the 10
radiographer-radiologist combinations for nodules > 6mm diameter. P values are
those derived from the McNemar's test. P values in bold are statistically significant.
4.4 Discussion
The mean and range of sensitivities of radiographers and radiologists in this








Marten et al. 2004 4 radiologists 40 21-57
Brochu et al. 2007 3 radiologists 54 38-70
Rubin et al. 2005 3 radiologists 50 41-60
Roos et al. 2010 3 radiologists 53 44-59
Wormanns et al. 2005 3 radiologists 64 NR
Beigelman-Aubry et al. 2007 2 radiologists 52 46-58
Fraioli et al. 2007 3 radiologists 57 46-68
Current study 2012 3 radiologists 83 74-89
4 radiographers 72 62-79
Table 4.7. Sensitivities of radiologists in a selection of nodule detection studies. NR=
not reported.
Caution should always be exercised when comparing sensitivities between
nodule detection studies, as differences in the derivation and stringency of the
reference standard [285], and in the types of patients undergoing CT examinations
(e.g. patients with multiple metastases versus lung screening studies) may profoundly
affect sensitivity. Nevertheless, it is reassuring that not only did the mean sensitivity
of radiologists in the current study exceed those of previous studies, but
radiographers had sensitivity comparable to radiologists in reported previous studies.
The importance of a high rate of nodule detection- i.e. high sensitivity - is
underscored by the fact that most failures in lung cancer diagnosis are due to errors
of detection rather than interpretation [381, 382]. Considering this in isolation, the
desideratum of any CT screening programme is to have readers with the highest
possible sensitivity, and in this context radiographers cannot be considered ideal first
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readers for lung screening, since their overall performance in the majority of cases
was statistically significantly lower than that of the radiologists reading the same
CTs.
However, initial experience from the UKLS pilot trial has indicated that the
vast majority of nodules smaller than 5mm in diameter (i.e. category 2 nodules)
demonstrate no growth on volumetry within a 12-month period. As such, it may be
prudent to raise the threshold for considering a nodule positive, to avoid unnecessary
follow-up. A recent retrospective analysis from the I-ELCAP trial has reinforced this
notion, suggesting that using diameter thresholds of 6mm, 7mm and 8mm could
decrease further work-up by 36%, 56% and 68% respectively, while resulting in a
maximum delay in lung cancer diagnosis of 9 months in 0%, 5% and 5.9% of cases
respectively [383], It could thus be argued that the sensitivity of radiographers in a
screening programme need not be as high as that of radiologists across the whole
spectrum of nodules, but should be optimised for larger nodules. This notion
prompted the post-hoc analysis of radiographer sensitivity confined to reference
standard nodules that were 5mm and greater (the current definition of a positive
result in I-ELCAP), and 6mm and greater in diameter. Radiographer sensitivity
became more closely aligned with that of radiologists using these higher diameter
thresholds in the majority of combinations, but there were still four combinations
where radiographers were less sensitive at both diameter thresholds. Nevertheless,
such comparability between radiographer and radiologist sensitivity, when viewed in
conjunction with their satisfactory ability to accurately categorise nodules according
to precise definitions, suggests that a radiographer could function adequately as an
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aid to nodule detection rather than a first reader, in the same way that computer-aided
detection (CAD) does.
The average false positive detections per case of the radiographers in this
study were significantly higher than those of radiologists. However, it is reassuring
that radiographers in general did not exceed 3 average FPs per case, and are thus
comparable to CAD systems, where average FPs per case between 0.3 and 15 per
case have been reported [384], When viewed in this context, the higher average FPs
per case of radiographers compared to radiologists in this study does not disqualify
them from being used as aids to reading.
In contrast to the lack of a learning effect observed in Chapter 3, an
improvement in sensitivity of the two least sensitive radiographers between the first
and second 10-week periods in the present study was noted, and occurred despite the
lack of a formalised programme of feedback. It is thus likely that exposure to more
nodules over a longer period may help to improve the sensitivity of less sensitive
readers. Importantly, the improved sensitivity did not come with the penalty of
increased average false positive detections per case.
This study has a few limitations. First, the reference standard presumed that
any nodule detected by a radiographer but not by a radiologist was not a true
positive. This was a necessary condition within the UKLS trial because
radiographers are not currently validated as readers in lung screening, and so it could
therefore be argued that it would have been unethical for any radiographer findings
to direct clinical care. However, this does potentially mean that there were less true
positives and more false positives within the radiographer readings, thereby
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potentially exaggerating their false positive detection rate. Even so, this reference
standard still serves as a valid relative standard against which to measure
radiographer performance. Also, radiographers were not provided with continuous
feedback in this study, which might have been useful to assess the effect of feedback
over a larger set of nodules than that used in Chapter 3. Such an assessment was not
the primary objective of this study, but it is worth noting that radiographers were
comparing their own readings with those in the consensus, once consensus had been
achieved, and so were enacting a form of self-directed learning. However, this effect
cannot be quantified.
4.5 Summary
• Radiographers' in this study displayed, on average, a lower sensitivity for
nodule detection and higher false positive detections per case compared to
radiologists reading the same CTs.
• Radiographers are thus probably not sensitive enough to be used as first
readers.
• However, the fact that the performance of some radiographers compared
favourably with radiologists, especially when larger nodules were considered,
suggests that radiographers could fulfil the role of an assistant reader.
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CHAPTER 5: THE EFFECT OF RADIOGRAPHERS AS
CONCURRENT READERS ON THE PERFORMANCE
AND READING TIME OF EXPERIENCED
RADIOLOGISTS IN LUNG CANCER SCREENING
5.1 Introduction
The use of radiographers as human aids to radiologists for the task of lung
nodule detection remains untested. In contrast, computer-aided detection (CAD)
software as a second reader for this task has been extensively evaluated and shown to
improve sensitivity, as discussed in detail in section 1.6.3.
Despite this extensive evaluation, CAD has not been universally adopted in
lung nodule detection, and has also not been prospectively evaluated in any of the
randomised control trials in CT lung cancer screening. The reticence to use CAD
may be due to the practicalities of integrating it with CT reporting workflow, but
these difficulties are not insurmountable. A greater encumbrance may be the need for
two rounds of reading by a radiologist when using CAD as a second reader - the
radiologist has to first independently read the study, present it to the CAD system,
and then re-evaluate the study with the specific aim of assessing the CAD marks, in
order to arrive at a final set of agreed findings. This has led to interest in using CAD
as a concurrent reader. In concurrent reading, the first round of radiologist reading is
removed; instead, the study is processed by the CAD and presented to the radiologist,
who accepts or rejects the CAD marks, and finally performs an independent search
for any missed nodules. Although this method has undergone only limited
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evaluation, it has been shown to decrease reading times without compromising
sensitivity [294, 354],
The aim of the present investigation was thus to prospectively compare the
performance of radiologists reading CTs independently (i.e. unaided) with their
performance when using radiographers as concurrent readers, with respect to
sensitivity, false positive detection, and reading times, in an actual lung screening
setting.
5.2 Materials and Methods
5.2.1 Study design and case selection
This study was performed prospectively. Between June and October 2012,
the baseline CT studies of 369 consecutive participants in the LDCT arm of the
UKLS trial were read for this study. All CT studies were performed at one of two
participating sites, according to trial protocols as specified in section 2.5.
5.2.2 CT evaluation by radiologists
Each CT study was read by a single radiologist at one of the two participating
sites, namely Radiologist A at Local Site 1 and Radiologist B at Local Site 2, both
with more than 10 years of specialist thoracic imaging experience. The studies were
then transmitted to a central reading site as described in section 2.6.2 for a second
independent reading by Radiologist C, 10 years' experience, and read as described in
section 2.7.2. Radiologists A, B and C were the same radiologists as in Chapter 4. In
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addition, a second central reading radiologist with 7 years' experience, Radiologist
D, also participated in this study.
Nodule classification and recording was exactly the same as described in
sections 2.6.2 and 4.2.2.
5.2.3 Selection of reading radiographers
The same radiographers as in Chapter 4 participated in this study:
Radiographer 1 read CTs at Local Site 1, Radiographer 2 read CTs at Local Site 2,
and Radiographers 3 and 4 read CTs at the central site.
5.2.4 Concurrent reading workflow
In concurrent reading, the following steps were perfonned:
1. Each CT was first read by a radiographer on the LungCARE workstation,
who uploaded his or her report to the UKLS database under a personal login,
as explained in section 2.6.2.
2. The radiographer's stored nodule recordings (in the fonn of a DICOM
structured report, or DICOM SR) were then made available to the reading
radiologist. For each recording, the radiologist had one of three options. He
could accept a particular finding if he agreed with it, and leave the
radiographer recording unmodified. He could reject a finding if he disagreed
with it (i.e. he thought the finding did not represent a nodule), in which case
he would delete the recording. Finally, he could amend the recording if he
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agreed that the finding represented a nodule, but disagreed with its
categorisation (for example, he thought it was a subsolid nodule where a
radiographer had classified it as solid), in which case he would re-report the
nodule using the electronic soft-copy entry proforma (Artex VOF, Logiton,
Netherlands) (see section 2.6.2) and copy and paste his own report into the
nodule report.
3. After reviewing the radiographer's recordings, the radiologist performed
another search to identify any additional nodules missed by the radiographer.
4. The radiologist then saved his recordings as a new DICOM SR, and uploaded
this report to the UKLS database.
In this way, the radiologist still only performed a single reading of the CT. Figure
5.1 summarises the concurrent reading process as compared to first reading and
second reading.
2nd round:







Radiologist also reads independently
2nd round:















Radiologist reviews radiographer marks I Radiologist






Figure 5.1. The process of reading in first (5.1A), second (5.1B) and concurrent (5.1C)
reading with radiographers.
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5.2.5 Selection of CT studies for independent single reading versus
concurrent reading
It was decided that the most practical strategy of comparing the concurrent
reading and independent single (i.e. unaided) reading performance for each
radiologist would be for him to read a number of CTs using one method, and then to
switch to the other method after two months. In this way, the radiologist would be
reading in actual screening conditions, potential variability in CT studies (such as the
number and type of nodules per CT) would be adjusted for, and central and local site
radiologists could all be assessed. As such, for the first two months (June-August),
the local radiologists (Radiologists A and B) were instructed to read independently,
while the central radiologists (Radiologists C and D) read concurrently, and the
reading methods were switched between the sites over the second two months
(August-October).
5.2.6 Reading times
Radiologists and radiographers were instructed to record the method and the
times, to the nearest minute, on the CTs they read. The decision to record to the
nearest minute, rather than second, was made so that a meaningful change in reading
time (i.e. measurable in minutes, not seconds) that would translate into a potential
real saving in an actual screening setting could be detected. Recording to the nearest
minute was also less disruptive to reading workflow.
Reading time recordings were saved together with the radiologists' reports on
the UKLS database. Recognising that recording reading times for every CT when
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reading large numbers of screening studies during the UKLS could be difficult, the
aim was to ensure at least two-thirds of CTs read had a recorded reading time.
5.2.7 Reference standard
After both local and central readings had been performed, the radiologists at
the central site (Radiologist C or D) reviewed all identified nodule candidates for
each subject on the database to identify any discrepancies. Arbitration on
discrepancies was provided at the central site by a thoracic radiologist with more
than 20 years of experience, and the final consensus answer was recorded on the
database. All agreed category 2 to 4 nodules and intrapulmonary lymph nodes were
considered positive in the reference standard. The reference standard was thus
composed of any nodules which had been identified and agreed on by both
radiologists, as well as any nodule that had been identified by at least one radiologist,
and subsequently ratified by the expert arbiter, including those radiographer-
identified nodules that had been agreed or amended by a radiologist during
concurrent reading.
5.2.8 Statistical analysis
The numbers of concurrently and independently read CTs were calculated for
each radiologist. Comparisons of the number of reference standard nodules between
concurrent and independent reading datasets for each radiologist were performed
using the two-tailed Mann-Whitney Test (a non-parametric distribution of nodules
was assumed).
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Sensitivity, the absolute number of false positive detections (FPs) and
average FPs per case (expressed as mean and standard deviation) were separately
determined for the cohorts of CTs read independently and concurrently per
radiologist. The sensitivity of each radiologist was calculated by dividing the number
of true positive nodules detected by the total number of nodules in the reference
standard for the cases read by that radiologist. Average FPs per case was calculated
by dividing the total number of FPs by the total number of cases read by that
radiologist. Differences in proportions were compared using the Chi-squared test or
the Fisher's exact test in the case of smaller sample sizes (see section 2.8.2.2) [360,
361] as appropriate.
Differences in reading times between concurrent and independent reading for
each reader were compared using the independent samples t-test. A post-hoc analysis
to determine the correlation between numbers of nodules and reading time was
subsequently performed using Spearman's rank correlation, and differences in
correlation coefficients analysed for statistical significance.
All analysis was performed using Medcalc (version 12.5.0.0, MedCalc





A total of 369 LDCT studies were read during the study period. 123 (33.3%)
of the 369 CT studies did not contain any nodules. The reference standard thus
consisted of 694 nodules in the remaining 246 (67.7%) CT studies. Figure 5.2
illustrates the distribution of the number of nodules per CT study. The majority of
CTs had 1 (23.6%), 2 (16.3%), 3 (8.9%) or 4 (6.8%) nodules. The median number of
nodules per CT was 1, with a range of 1 to 17 nodules. The majority of reference
standard nodules were solid nodules (51.3%) and intrapulmonary lymph nodes
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Part-solid Non-solid IPLN1 Total
1 NA NA NA 292 (42.1) 292 (42.1)
2 219 (31.6) 2 (0.3) 11 (1.6) NA 232 (33.4)
3 119 (17.1) 8 (1.2) 21 (3.0) NA 148 (21.3)
4 18 (2.6) 1 (0.1) 0 (0.0) NA 19 (2.7)
U2 0 (0.0) 0 (0.0) 3 (0.4) NA 3 (0.4)
Total 356(51.3) 11 (1.6) 35 (5.0) 292 (42.1) 694 (100.0)
Table 5.1. Distribution of nodules according to UKLS size category and nodule type.
Figures in parentheses are percentages of the total number of nodules.
1lntrapulmonary lymph nodes (IPLNs) are category 1 by definition in the UKLS.
2U=uncategorised. Three nodules were categorised as non-solid nodules (Category C)
but could not have their sizes calculated due to a database error.
NA= not applicable.
5.3.2 Number of cases and number of nodules by reading method
The number of cases read by each radiologist varied from 83 to 119 using
independent reading and from 69 to 122 using concurrent reading (Table 5.2).
However, there was no significant difference between the numbers of reference
standard nodules per case in the independent versus concurrent reading cohorts for
any of the four radiologists (Figure 5.3).
Radiologist
A B C D
Independent 83 119 94 84
Reading
Method
Concurrent 88 79 122 69
Rvalue 0.83 0.18 0.41 0.74
Table 5.2. Numbers of cases read by each radiologist using each reading method. P
values are for differences between the number of reference standard nodules per case

































0 2 4 6 8 10 12 14 16




0 2 4 6 8 10 12 14 16
No. of Reference standard nodules
0 2 4 6 8 10 12 14 16












0 2 4 6 8 10 12 14 16
No. of Reference standard nodules
Figure 5.3D.
Figure 5.3. No. of reference standard nodules per case for each reading method for
Radiologists A-D.
CR= concurrent reading, IR= independent reading.
5.3.3 Sensitivity of radiologists
The overall sensitivity of each radiologist for the different reading methods is
detailed in Table 5.3. The mean sensitivity for radiologists reading independently
was 77.5 ± 11.2%, increasing to 90.8 ± 5.6 % with the use of concurrent reading. For
all but one radiologist (Radiologist D), statistically significant higher sensitivity was
achieved with concurrent reading compared to independent reading.
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Radiologist
A B C D
Independent 78.9 79.8 62.2 89.2
Methoc? Concurrent 90 4 98.2 84.5 90.1
Difference 11.5 18.4 22.3 0.9
P value 0701 <0.0001 <0.0001 197
Table 5.3. Sensitivity of radiologists for each reading method. Except for P values,
figures shown are percentages. Rvalues are those derived from the Chi-square test. P
values in bold indicate statistically significant results.
5.3.4 False positive detections (FPs)
There was a wide variation in the average FPs per case. While the overall
mean of average FPs per case increased from 0.33 ± 0.20 with independent reading
to 0.60 ± 0.53 with concurrent reading, average FPs per case ranged between 0.06
and 1.38, increasing with concurrent reading for Radiologists A, B and C (and




D .. Independent 0.31 ± 0.75 0.47± 1.10 0.06 ± 0.25 0.48 ± 0.96Reading ^
Method
concurrent 0.37+0.65 1.38 ± 1.46 0.21 ± 0.61 0.42 ± 0.76
Difference 0.06 0.91 0.15 -0.06
Rvalue 156 <0.001 O03 (169
Table 5.4. Average FPs per case for each reading method. A negative difference
indicates a lower average FP per case with concurrent compared to independent
reading. Rvalues are those derived from the independent samples t-test. Rvalues in
bold indicate statistically significant results.
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5.3.5 Reading times
Radiologists A, B, C and D recorded their reading times for 100%, 77%,
75%, and 90% of their concurrently read cases, respectively, and for 83%, 71%, 85%
and 89% of their independently read cases, respectively. The mean reading times per
case for concurrent reading ranged from 6.2 minutes to 8.6 minutes, compared to 7.0
to 12.4 minutes for independent reading (Table 5.5).
Concurrent reading was faster than independent reading for all radiologists,
but this increase in reading speed was not statistically significant for Radiologist C.







Independent 12.4 (11.1,13.5) 8.8 (7.8, 9.8) 7.0 (6.5, 7.5) 8.3 (7.4, 9.3)
Concurrent 8.6 (7.9, 9.3) 6.2 (5.5, 7.0) 6.9 (6.4, 7.4) 7.0 (6.2, 7.8)
Difference -3.8 -2.6 -0.1 -1.3
P value <0.0001 0.0001 0.65 0.03
Table 5.5. Mean reading times of radiologists for each reading method. Numbers
shown are time in minutes, except for P values. Numbers in parentheses are 95%
confidence intervals for the mean. A negative difference indicates a shorter time with
concurrent compared to independent reading. P values are those derived from the
independent samples t-test. P values in bold indicate statistically significant results.
182
5.3.6 Relationship between number of nodules per CT and reading time
The finding that concurrent reading was quicker despite there being no
significant difference between the number of reference standard nodules per CT led
to a post-hoc analysis to investigate the relationship between the number of nodules
per CT and reading time. As could be expected, there was a significant correlation
between the number of reference nodules per subject and the time taken for each CT,
and for Radiologists A, C and D, this correlation was stronger for independently read
CTs (Table 5.6). However, the strengthening of this correlation was only statistically
significant for Radiologist D.
Radiologist

















Table 5.6. Rank correlation between number of nodules per patient and time taken.
Figures shown are Spearman's coefficient of rank correlation (Spearman's rho), and
figures in parentheses are Rvalues for significance level. Rvalues in the final row are
for significance levels of the difference between correlation coefficients for




The current investigation is, to my knowledge, the first evaluation of
radiographers as concurrent readers for pulmonary nodule detection in CT lung
cancer screening. It has shown that the sensitivity of the majority of radiologists in
this study group improved by using radiographers as concurrent readers, with a
statistically significant reduction in mean reading time, but accompanied by a
simultaneous increase in false positive detections.
The improvement in sensitivity in this study was seen for all except the most
sensitive radiologist, but the range of sensitivities of radiologists in this study was
reassuringly comparable to that reported for radiologists (between 40% to 83%), as
discussed earlier in sections 3.4 and 4.4. As such, there is every reason to expect that
concurrent reading with radiographers could improve the sensitivity of the majority
of expert thoracic radiologists.
The mean sensitivity achieved by the radiologists reading independently in
this study (77.5 ± 11.2%) was lower than that in Chapter 4 (82.5 ± 7.7%), although a
statistical comparison of these means is difficult due to the different numbers of
cases read. However, the reference standards in the two investigations were also
different: the reference standard in the current investigation included all
radiographer-identified nodules that had been agreed by at least one radiologist and
an arbiter, or both radiologists, while radiographers' readings were not considered by
radiologists and so not included in the reference standard in Chapter 4. As such, the
denominator of the total number of positive nodules in the current standard may be
larger, so apparently lowering sensitivity during independent reading.
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Of course, the increased average false positive detections per case that
accompanied the increases in sensitivity with concurrent reading is once again a
salutary reminder of the trade-off between sensitivity and "overcalling" of nodules,
especially for the two readers with the greatest sensitivity improvements
(Radiologists B and C). Given the design of the present study, it is not possible to
ascertain whether a radiologist may have designated the same false positives as a
radiographer in the absence of a radiographer mark. However, the fact that the same
radiographers in the current study demonstrated in general higher average FPs per
case compared to radiologists in Chapter 4 implies that radiographers are probably
the main drivers of false positive detections in the concurrent reading scenario.
Intuitively, it could be expected that the increase in FP detection is particularly due to
radiographers identifying a large number of small opacities as nodules, and
subsequent reticence of the radiologists to reject such marks once presented with
them. Certainly, a previous study with CAD has shown that a radiologist's
confidence in designating a small nodule as positive was enhanced when presented
with a CAD mark, even if it did not improve overall accuracy [385],
It is important to put the increase in average FPs per case into perspective
when considering concurrent reading with radiographers as an alternate strategy to
independent reading, as compared to CAD. CAD results in average FPs per case of
3.7 to 4.15 when including nodules as small as 3mm, the size-cut off used for
inclusion in the UKLS and the present study [354, 386]. This rate is much higher
than the highest rate with concurrent reading in the present study (Radiologist B,
1.38). Nevertheless, the consequences that can be triggered by false positives (such
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as increased number of CTs requiring arbitration, follow-up, and increased anxiety to
patients) must be acknowledged.
Concurrent reading also proved statistically significantly faster than
independent reading for three of the four radiologists. However, the statistical
significance of the decrease in time may not translate into a clinically relevant time-
saving benefit for every radiologist; in this study, Radiologist A would save just
under 4 minutes per subject with concurrent reading, whereas Radiologist C was
hardly affected by it. Nevertheless, when extrapolated to the 187,500 or so CTs per
year that would need to be read in a UK national screening programme (Dr A
Devaraj, written communication, 22nd February 2013), a time saving of 4 minutes per
CT for each radiologist becomes significant. More importantly, concurrent reading
did not increase the mean reading time.
The reasons for the variation in time-saving are probably very much
radiologist-dependent. Much of the time that may be saved when using radiographers
in concurrent reading may be attributable to the time taken to fill in the nodule input
proforma for each opacity. Although the time taken to report each nodule for each
reader was not recorded (as this would not be practical), it takes approximately 0.5
minutes to complete the reporting of a single nodule, from volumetric segmentation
to filling in and electronically pasting the proforma into the nodule report, whereas
the review of a radiographer mark takes only a few seconds. However, this time-
saving could be nullified by the need to review a large number of identified opacities,
especially if modifications to the interpretation need to be made. This may explain
why the correlation between the number of nodules per CT and reading time was
poorer for concurrent reading. Whereas an increase in nodules per CT can be
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expected to cause an increase in reading time when reading independently, the
interaction of numbers of nodules and the number of marks requiring changes or
deletion may all contribute to a less linear relationship between nodule number and
reading time in concurrent reading.
In contrast to concurrent reading using radiographers, there is some evidence
for concurrent reading using CAD in lung nodule detection, with evaluations in two
studies [294, 354], Both of these studies assessed CAD as a second reader and as a
concurrent reader, using a concurrent reading sequence similar to the current
investigation, and performing concurrent and independent reading on the same CTs
after an interval of 12-16 weeks and 2 months respectively. However, both studies
also have important methodological differences.
Beyer et al. evaluated four radiologists reading 50 CTs performed for varying
clinical indications under experimental conditions [294], Independent and concurrent
reading were performed on the same CTs 12 to 16 weeks apart. An individual who
was not part of the reading process timed the radiologists. They found that while
concurrent reading reduced reading time (by a mean of only 19.8 ± 14.5 seconds), in
contrast to the current investigation, pooled sensitivity using concurrent reading with
CAD resulted in either lower (for nodules < 1.75mm) or equivalent (for nodules >
1,75mm) sensitivity compared to independent reading. They hypothesised that this
apparently paradoxical result could have occurred due to the interaction of two
effects: (1) a decreased vigilance, as a result of a shortened reading time, and (2) an
increase in sensitivity due to additional CAD-identified nodules. Their reference
standard was established by including all CAD marks accepted by all radiologists,
and review by a consensus panel of two radiologists of all opacities detected by at
187
least one radiologist (whether or not detected by the CAD system). All CAD marks
not detected by any radiologists did not form part of the reference standard. As such,
their reference standard was not dissimilar to the current study. However, as
explained earlier, the findings of the present study do not support their hypothesis:
radiologists' sensitivity increased with concurrent reading, and there were more false
positives, possibly signalling an increased, not decreased vigilance. If anything, the
increased stringency of their reference standard as result of using two arbiters in
consensus would have made the denominator of total positive nodules smaller, and
so should have resulted in overall increased sensitivity compared to the readers in the
present study, as has been previously illustrated by Armato et al. [285] and discussed
in Chapter 1.
In contrast, Foti et al. found that concurrent reading with CAD increased
sensitivity for nodule detection in 100 patients with pulmonary metastases, but not to
a level reaching statistical significance [354], and with an increased mean reading
time (by 60 seconds). However, the two radiologists performing concurrent reading
were different to the two radiologists who performed the initial independent reading.
They have thus compared two different pairs of radiologists with no statement
regarding the baseline independent sensitivity of the radiologists performing
concurrent reading, and so their conclusions should be interpreted with caution. It
was also unclear from their study whether the reading time stated included the time
taken for CAD to process the study, but given the small increase in reading time, it is
unlikely that the CAD processing time was taken into account.
The present study has some limitations. The concurrent and independent
reading cohorts consisted of different patients, unlike the previous studies mentioned
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above [294, 354], However, this was the most practical way of performing this study
prospectively, with real lung screening cases being read under actual reporting rather
than experimental conditions, and as such has practical applicability. To minimise
potential variations in the number of nodules per CT (in other words, the "level of
difficulty" of each CT) affecting the cohorts, a strategy of switching the reading
methods after 2 months was adopted. It is reassuring that the number of reference
standard nodules per subject between reading methods was not different for any of
the four radiologists. The strategy of switching between reading methods would also
have mitigated variations in each radiologist's performance during one or other
period.
Timing was performed by each individual, to the nearest minute, and not
second. A greater statistically significant reduction in time could potentially have
been seen if reading times had been recorded to the second, but it was important in
this study to detect time reductions that would translate into clinically meaningful
reductions, i.e. minutes, not seconds. There was no way to blind each radiologist to
the reading method he was using, by definition, and so there could have been a
selection bias of the radiologists in choosing which cases they recorded times for.
Again, this was the most practical way to record timing given the large volumes of
CTs to be reported.
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5.5 Summary
• This study demonstrated that radiologists' sensitivity in lung nodule detection
could be improved with the use of radiographers as concurrent readers.
• An increase in false positive detections with radiographer-assisted concurrent
reading occurred, but this increase was still below that reported for CAD
systems.
• Concurrent reading with radiographers was also faster than single reading,
but on a per case basis the time saved was relatively modest.
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CHAPTER 6: PERFORMANCE OF RADIOGRAPHERS
COMPARED TO COMPUTER-AIDED DETECTION
(CAD) IN LUNG NODULE DETECTION FOR LUNG
CANCER SCREENING
6.1 Introduction
In the preceding chapters, it has been inferred that radiographers have similar
sensitivities and lower average false positive detection rates per case than some
computer-aided detection (CAD) systems in the published literature. The aim of this
investigation was to directly compare radiographer performance with that of a CAD
system for screening studies performed in the UKLS trial.
6.2 Materials and Methods
6.2.1 Study design and case selection
Between April and June 2012, the baseline CT examinations of 108
consecutive participants in the LDCT arm of the UKLS trial were read. This time
period was chosen to ensure that these examinations had not been included in the
investigations performed for Chapters 4 and 5.
6.2.2 LDCT evaluation, arbitration and consensus
The same radiographers in Chapters 4 and 5 performed CT reading
prospectively: Radiographer 1 at Local Site 1, Radiographer 2 at Local Site 2, and
Radiographers 3 and 4 at the central site. In addition, the same UKLS radiologists
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who had read examinations in Chapters 5 and 6 had also read these examinations.
Nodules were classified according to the UKLS definitions described in section
2.7.1, and the procedure for nodule recording was exactly the same as described in
sections 2.6.2 and 4.2.2.
Radiographers and radiologists performed evaluations independently and
uploaded these to the UKLS database, and radiologists did not refer to radiographers'
recordings during the course of their reading. To create a database of all recorded
nodules, the category and location of opacities identified by each radiographer and
radiologist (available on the UKLS database) were separately recorded on a
Microsoft Excel spreadsheet (version 2007, Microsoft Corp., Redmond, CA).
6.2.3 Computer-aided detection (CAD) software
The CAD system used for this study (Visia CT Lung System version 3.1,
Mevis Medical Solutions, Bremen, Germany; formally known as the ImageChecker
CT Lung system, R2 Technology, California) is approved by the US Food and Drug
Administration (F.D.A.) for commercial use in the detection of lung nodules.
The CAD algorithm detected and analysed focal opacities by first isolating
the lung parenchyma using threshold-based segmentation methods. The software
then used techniques such as 3D region-growing and attenuation thresholding to
identify groups of voxels with attenuation numbers above a pre-specified threshold,
and created regions of interest (ROIs) in each image corresponding to these groups.
These ROIs represented potential candidate lesions for the software to analyse. Most
of the candidate lesions represented blood vessels and airway walls; thus, the
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software needed to distinguish these from true abnormalities. It did this by
calculating geometric parameters for each ROI including size, shape, density and
location. These features were used to classify each lesion by comparison with a
reference database of expected appearances of nodules and vessels. The software
then used a decision-making tree to assign a likelihood rating to a lesion, as to
whether it represented a true lesion. The CAD system would only highlight a lesion
to the reader with a mark (Figure 6.1) if the likelihood rating exceeded a pre-defined
threshold.
Figure 6.1. Nodule mark in the left lower lobe by the Visia CAD system.
The Visia CT Lung System was configured to detect solid nodules if greater
than 4mm and less than 30mm in diameter, but it could detect smaller and larger
nodules if they were dense, well-defined and completely surrounded by aerated lung
It was also calibrated to have an average false positive detection (FP) per case of 2.0
It was not designed to detect part-solid or non-solid lesions. It was able to generate
volumetric measurements of each lesion. A user could also click on (and annotate)
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other potential nodule candidates not highlighted by the CAD. If the system accepted
such a candidate, it would generate volumetric measurements of this candidate as
well. Even if it was not able to accept the candidate and generate volumetric
measurements, the system still allowed the additional nodule to be annotated and
measured using callipers. A final report was then generated which indicated the slice
number, whether it was detected by CAD or the user, and size and density
parameters.
The CAD system had two components: a server and a workstation. The server
ran on a 64-bit Windows XP Professional operating system (Microsoft systems,
Richmond, Virginia) that was based on a network server at the Royal Brompton
Hospital. The workstation ran on a normal Windows-based PC.
6.2.4 CAD evaluation and comparison with radiographers and
radiologists
The selected 108 CTs were imported from PACS in Digital Imaging and
Communications (DICOM) format for processing on the workstation. Once
processed, the CAD results were sent to the server, and CAD marks were available
for review on the workstation.
Readings from radiographers and radiologists were visually matched to the
CAD readings on the CAD workstation. Opacities that CAD had identified were
designated CAD-positive. In order to accurately compare CAD readings against
those of radiographers and radiologists, only nodules that the CAD should be
expected to identify were included for comparison. However, readers in the UKLS
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would designate any nodule greater than 3mm as positive according to UKLS
definitions, while the CAD, with its minimum diameter threshold of 4mm, would not
necessarily do so. Opacities that had been identified by at least one radiographer or
radiologist but that had been missed by CAD were thus measured. If they exceeded
the size thresholds or they were subsolid, they were excluded. Any cases of diffuse
infection thought secondary to infection (by the arbitrating radiologist) were also
excluded. Thus, only nodules that were solid and met size criteria were considered
CAD-negative, and radiographer - or radiologist-positive as appropriate. The
exclusion of nodules that the CAD could not be expected to identify, based on its
operating parameters, ensured that the final dataset of nodules considered positive
was not biased towards the radiographers and against the CAD system.
6.2.5 Reference standard
Any opacity agreed by both local and central radiologists was designated a
reference standard nodule and required no arbitration. Opacities were presented for
arbitration if they had been identified by only one radiologist, or by only a
radiographer or CAD and not by at least one radiologist. Arbitration of these
discrepancies was provided at the central site by a thoracic radiologist with more
than 20 years of experience (the same arbiter as for Chapters 4 and 5).
6.2.6 Statistical analysis
As this study evaluated the performance of radiographers against CAD, the
readings of radiologists were excluded from comparison. The number of cases read
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by each radiographer was calculated. For each radiographer and for CAD, sensitivity
was calculated by dividing the number of true positive nodules identified by the total
number of true positive nodules in the reference standard. Sensitivity for subgroups
of nodules measuring < 5mm & > 5mm respectively was also calculated. The
average FPs per case (expressed as mean and standard deviation) was calculated by
determining the total number of FP detections for each case, summing this number
and dividing it by the total number of cases read. Each radiographer was compared
against CAD only for the cases read by both. Sensitivity was compared using
McNemar's test, and average FPs per case were compared using the paired samples
t-test.
All analysis was performed using Medcalc (version 12.5.0.0, MedCalc




Of the 108 baseline CT examinations performed during this study period, 9
cases had to be excluded. Four cases were excluded due to technical difficulties that
led to the CAD server being unable to process the CTs. Three cases were excluded
because they contained no nodules suitable for CAD analysis (i.e. no solid nodules
between 4mm and 30mm in diameter). Two cases were excluded because they were
deemed to contain infection-related diffuse nodularity by the arbitrating radiologist.
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As such, the final number of cases that were eligible for CAD analysis was 99
examinations. Radiographers 1, 2, 3 and 4 read 40, 36, 47 and 43 cases respectively.
6.3.2 Reference standard
Thirty-two (32.3%) of the 99 CT studies did not contain any nodules. The
reference standard thus consisted of 180 nodules in the remaining 67 CT studies. The
majority of CTs had 1 (29.3%), 2 (14.1%), 3 (5.1%) or 4 (6.1%) nodules per study
(Figure 6.2). The median number of nodules per CT was 1, with a range of 1 to 8
nodules.
The mean diameter of reference standard nodules was 6.6 ± 3.3mm (median
5.7mm, range 2.8-25.2mm).
Of the 180 reference standard nodules, 125 (69.4%) were identified by at
least one radiologist, 24 (13.3%) by at least one radiographer but not by any
radiologist or CAD, 21(11.7%) by CAD only, and 10 (5.6%) by both CAD and at
least one radiographer but not by any radiologist.
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Distribution of reference nodules
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012345678
No. of reference standard nodules per case
Figure 6.2. Frequency distribution of the number of nodules per CT study.
6.3.3 Comparison of sensitivity
The mean sensitivity of radiographers was 70.1 ± 13.0 % (range, 53.3%-
85.0%) compared to an overall CAD sensitivity of 58.9%. Only Radiographer 2 had
a significantly higher sensitivity compared to CAD (85.0% versus 63.3%
respectively, P < 0.05) for the same cases read, while the sensitivities of the





No. of cases read 40 36 47 43
71.8 85.0 70.4 53.3Sensitivity of
radiographer (%)
Sensitivity of CAD 5g 2 63 3 5yA 63 3
( /o)
Difference 12.6 21.7 13.3 -10.0
P value 0.19 0.02 0.07 0.26~
Table 6.1. Sensitivity of radiographers compared to CAD. P values are derived from
McNemar's test. P values in bold indicate statistically significant results.
When subgrouped according to reference standard nodules with diameter <
5mm and > 5mm respectively, no statistically significant difference was found
between radiographer and CAD sensitivity (Table 6.2).
Radiographer
2 3
Size (mm) <5 >5 <5 >5 <5 >5 <5 >5
Radiographer
sensitivity 77.3 69.4 87.0 83.8 71.0 70.1 52.0 54.3
(%)
CAD





22.7 8.2 34.8 13.5 22.6 8.9 4.0 20.0
0.23 0.56 0.06 0.27 0.14 0.35 1.00 0.12
Table 6.2. Sensitivity of radiographers compared to CAD for nodules <5mm and >
5mm. P values are derived from McNemar's test.
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6.3.4 Comparison of average false positive detections per case
The average FPs per case by the CAD system across all 99 CT examinations
was 2.19. When comparing only the same cases read by both CAD and a particular
radiographer, the average FPs per case was lower than that of CAD for all four
radiographers, and was statistically significantly lower for three of the four




Average Radiographer 0.65 ± 1.25 1.58 ±2.03 1.15 ±1.41 0.16 ±0.43
FPs per
case CAD 2.10 ±2.28 2.19 ±2.82 2.36 ± 2.67 2.09 ± 2.20
Mean 1.45 0.61 1.21 1.93
difference
P value 0.0002 0.10 0.0004 <0.0001
Table 6.3. Average FPs per case for each radiographer as compared to CAD. Rvalues
are those derived from the paired samples t-test. Rvalues in bold indicate statistically
significant results.
6.4 Discussion
The radiographers in this study demonstrated sensitivities that were
comparable, and possibly superior, to that of a commercially available CAD system
reading the same CTs for the detection of pulmonary nodules in baseline lung cancer
screening CT examinations. This comparable sensitivity was maintained even when
nodules were subgrouped according to a higher diameter threshold of 5mm or greater
- that is, the same higher threshold diameter at which radiographers had already
demonstrated greater alignment with radiologists' sensitivity in Chapter 4. In
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addition, the majority of radiographers demonstrated a significantly lower average
number of FP detections per case than the CAD system.
CAD systems have been extensively investigated as second readers in
double-reading scenarios to aid radiologists and shorten reading times. Various
studies have demonstrated the ability of CAD to either improve the performance of
experienced radiologists, or to augment the performance of junior radiologists or
residents such that it becomes comparable to accredited radiologists [288, 289, 291,
293, 336, 337, 346-348, 353, 371, 387], However, an acknowledged trade-off in the
increased sensitivity of a CAD system is the penalty of increased false positive
detections (FPs).
CAD systems vary widely in their reported baseline sensitivities. A literature
review by Li et al., for example, showed that the variation in sensitivity between nine
systems was as much as 21.4% (between 69.8% and 91.2%), with average FPs of
between 0.3 and 15 per case reported [384], This variation between systems can be
expected due to differences in detection techniques, CT acquisition and
reconstruction parameters, and the databases of "ground truth" that have been used in
the establishment of thresholds for lesion identification. A further source of
variability is introduced by the use of different reference standards in different
studies, which can have a profound impact on sensitivity [285], Thus, comparison
between different studies using different CAD systems is extremely difficult, and
efforts to combine these algorithms and encourage more open assessment are
underway [295],
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However, even when the same CAD system is evaluated in different studies,
markedly variable results have been reported. This is best illustrated by three
evaluations of predecessor versions of the CAD system (previously known as
ImageChecker) used in the current study. Lee et al. investigated the ImageChecker
CT LN-1000 CT and reported a CAD sensitivity of 60%, with an average of 1.56 FPs
per subject [387], However, Das et al. compared the ImageChecker system to the
Nodule Enhanced Viewing (NEV) system (Siemens Medical Solutions, Forchheim,
Germany) and quoted a sensitivity of 73% and an average of 6 FPs per case [291],
Godoy et al. assessed the performance of ImageChecker CT V2.0 for pathologically
proven lung cancers that manifested as nodules greater than 4mm, finding a
sensitivity of 87.7% and average FPs of 0.9 per case [388], The current results
(sensitivity 58.9%, average FP detections of 2.15 per subject) thus most closely
approximate those of Lee et al., but such variation again can be attributable to
differences in reference standards. For example, Lee et al. excluded CT examinations
with multiple nodules (more than 6 nodules) from analysis while this has not been
done in the current study, unless such nodularity was in keeping with infection.
There are also conflicting reports of the impact of CAD-identified FPs on
readers' confidence in nodule designation. In a mammography study, a CAD system
operating at high average FPs per case lowered confidence in the system, because
readers had to review a large number of CAD marks, and so were reluctant to accept
these marks [389], As such, there may be an element of the CAD "crying wolf' on
too many occasions, resulting in more CAD rejections, whether true or false positive.
However, Nietert et al. recently demonstrated that when radiologists had less than
100% "confidence" in designating a particular opacity as a nodule, their
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"confidence" was significantly enhanced by the presence of a CAD mark, although
this did not help improve reader accuracy [385], Indeed, readers' FP rates per case
seem to increase with CAD as a second reader [387, 390], The pattern of increase is
also interesting: if an increasing number of CAD detections is sequentially presented
to a reader, an initial sharp increase in true positive detections is subsequently
attenuated, and FP detections increase, suggesting that there is an optimum FP
operating point beyond which the benefit of CAD is negated [290], Of course, this
operating point would again differ between systems.
Given the many wide variations that can occur with a CAD system, the
alternative of using a radiographer as a human aid to detection should thus not be
discounted. As demonstrated in this study, the sensitivity of radiographers for
detecting solid nodules that would warrant follow-up was comparable to that of
CAD. Furthermore, the number of nodules identified by only radiographers or only
CAD but not by any radiologist was almost equal, suggesting that the additive effect
of either method on the sensitivity of a radiologist would probably be equal (although
each method would result in different nodules being called and missed).
The argument for using CAD rather than radiographers as aids in pulmonary
nodule detection are the same as against using any human reader, in that fatigue may
interfere with the nodule reading task, there may be a high turnover of personnel,
more person-hours are required overall, and greater demands may be placed on
infrastructure (e.g. more reporting workstations needed). However, the radiographers
in the current study read the CT examinations prospectively in the course of the
UKLS pilot trial, and not under experimental conditions. Despite this their sensitivity
at the very least matched the CAD system, suggesting that a radiographer's vigilance
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can be maintained without adversely affecting performance. Importantly, the
maintained sensitivity of radiographers did not come at the expense of higher
average FP detections per case.
The notion that a CAD system can be recalibrated, by adjusting the average
FPs per case and sensitivity such that it is more aligned with a particular group of
readers, has been explored under experimental conditions [289, 290], However, these
parameters are not adjustable in commercial software such as the CAD system in this
study, and so such re-alignment is presently a fallacy. Also, the reference standards
for CAD nodule identification - the databases of "ground truth" that have been used
in the establishment of thresholds and feature classification - are not known to the
reader, and cannot be re-adjusted. In contrast, findings can be discussed with
radiographers, and the reasons for rejections of nodule marks explained. All
radiographers in a particular screening programme can be evaluated on the same
training and testing datasets, and re-training is possible. In this way, direct
"calibration" by a radiologist is more feasible for radiographers than it presently is
for CAD. A radiologist is arguably more likely to have confidence in an assisted
reader when that reader can be aligned with the radiologist in this manner. Of course,
such "calibration" by a radiologist with inherently low sensitivity could also have a
detrimental effect on radiographer's sensitivity, underscoring the need to ensure that
reading radiologists in a screening programme meet a minimum acceptable level of
sensitivity at the outset.
Another important advantage of using radiographers is that their time-saving
role extends not only to nodule detection, but to logistical tasks such as matching
nodules between readers on a database, as well as nodule matching on baseline and
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follow-up subjects. Although nodule matching software for comparing studies is
available and accurate [391], human confirmation of matching accuracy will still be
required. This time-saving should not be underestimated in a screening programme,
as experience from the UKLS pilot trial suggests considerable effort needs to be
expended on such tasks.
Radiographers can also alert the radiologist to findings (such as a large
nodule) that need urgent referral. CAD systems such as the one used in this study do
not currently have the functionality to generate alerts for urgent findings.
This study has some limitations. Only solid nodules were included, as the
CAD algorithm was not optimized to detect non- or part-solid nodules. The impact of
CAD (whether as a concurrent or second reader) on radiologists' sensitivity in the
setting of an actual lung screening trial cannot be directly evaluated, as there was no
precedent or ethical approval for CAD to be used in such a decision-making capacity
in the UKLS pilot trial. As with all studies on nodule detection in the absence of




• Sensitivity of radiographers for CT pulmonary nodule detection was
comparable, and possibly superior, to that of the CAD system in this study.
• The comparable sensitivity of radiographers was maintained both for nodules
smaller than 5mm, and nodules equal to or greater than 5mm.
• The majority of radiographers had significantly lower average false positive
detections per case compared to CAD.
• Radiographers may thus be able to act as aids for nodule detection that are at
least as sensitive as CAD, and with a potentially lower false positive penalty.
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CHAPTER 7: THE IMPACT OF THE NUMBER OF
READERS AND METHODS OF ARBITRATION ON
READER PERFORMANCE IN LUNG NODULE
DETECTION
7.1 Introduction
The numbers of readers used in lung cancer screening studies with low dose
CT have varied. Some have used single reading [ 151, 164, 392] whereas the majority
have used double-reading strategies [142, 146, 150, 156, 158-160, 174, 393], The
rationale behind using two readers is that lung nodule detection rates are improved
[334, 336] and hence potentially fewer lung cancer are missed. However few studies
have evaluated the impact of reader numbers on lung nodule identification, and these
have been limited in certain ways.
First, the reference standards in previous studies of nodule detection
performance have varied in their derivation. The reference standard usually
incorporates the readings of observers, as well as an expert opinion. The expert
opinion may be that of a single radiologist only [334], or a consensus opinion of two
[289, 290, 293, 294, 336, 337] or sometimes even three [345, 346] experienced
radiologists. The variation in experience of these experts may in turn influence the
reference standard [394], Additionally, the expert or experts may either perform an
initial independent search ("free-search") for nodules themselves, followed by a
review of all positive findings identified by the observers (directed search), or they
may only perform the latter.
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In addition the issue of resolving discordant readings has not been fully
addressed in previous studies. Discordant readings arise because one radiologist has
missed (a discrepancy in detection) or deliberately chosen to ignore (a discrepancy in
interpretation) a finding. Discrepancies between radiologists can be resolved in a
variety of ways, including:
1. Combining radiologists' readings (which assumes all discordant
readings are positive findings, regardless of whether the discordance
is due to differences in detection or interpretation) [334, 342, 343];
2. A process of consensus where readers discuss individual discrepancies
[159, 393] to determine if these findings should be designated
positive, thus facilitating debate when there are discordances in both
detection and interpretation. This method is commonly accepted both
as a valid method of resolving discrepancy [208, 344], However,
consensus interpretation is itself subject to inherent limitations such as
"groupthink" [344];
3. Using an independent arbiter;
4. Using a form of "internal" arbitration where a reader is independently
shown and asked to form an opinion on nodules identified by other
readers and not by themselves [285, 395]; and
5. A combination of these methods [142, 156, 174],
The previous chapters have shown that radiographers can assist radiologists
in lung nodule detection. However, regardless of whether radiologists read
independently or concurrently, the final interpretation of an opacity rests with
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radiologists, and thus more needs to be known about the impact of the numbers of
readers and of methods of resolving discrepancy.
Therefore, the purpose of the current investigation was to evaluate the impact
of double- and triple-reading on lung nodule detection accuracy, and to assess the
effect of different methods of arbitration on this detection accuracy.
7.2 Materials and methods
7.2.1 Construction of the reading dataset
The CT studies used in this study were all obtained from the NELSON study,
as described in Chapter 2. From the 202 procured scans, 100 CT studies were
randomly chosen that contained a variable mix of nodules (as identified by NELSON
readers). Fifteen of these studies could not be processed by the LungCARE
application and were excluded. Thus, 85 CT scans formed the total dataset for this
investigation, hereon referred to as the reading dataset.
7.2.2 CT reading
7.2.2.1 Reader training and image manipulation
Five expert thoracic radiologists who work in different institutions were
invited to take part in this study. The radiologists had different levels of radiology
experience: Reader A, 19 years; Reader B, 13 years; Reader C, 7 years; Reader D, 21
years; and Reader E, 9 years.
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All radiologists were given a tutorial on usage of the LungCARE software on
the Syngo workstation, including image manipulation and measurement tools. The
radiologists were also given examples of the nodules they were being asked to mark
based on the nodule definitions below. These examples were taken from NELSON
CT examinations which had been obtained during the procurement exercise but
which were not part of the reading dataset, to avoid recall bias.
Studies loaded into LungCARE were presented in a 2 x 2 viewing partition
with a default window setting level -500 HU, width 1500 HU, and arranged in the
following manner: top left panel, maximum intensity projections (MIPs) with a
default setting of 10mm thickness; top right panel, lmm-collimation axial images;
and bottom left panel, 0.7mm-collimation coronal images. The bottom right panel
was initially blank, and was used to display volumetric segmentation of a selected
nodule (Figure 7.1).
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Figure 7.1. Example of marking and annotation of a nodule within LungCARE by a
radiologist on an anonymised LDCT study.
Readers were free to alter MIP thickness and window settings. Readers were
not asked to record volumetric measurements of each nodule, nor any nodule
characteristics, so that there was no interruption to their workflow.
Nodules were marked and annotated by a reader using the "set marker" and
"annotate" options respectively, both accessible on a right mouse click. The
"annotate" feature provided a free text box where readers inserted their
categorisation of an opacity according to the definitions in Table 7.1 below. Each
reader saved their readings as a DICOM structured report (DICOM SR) with their
initials as a unique identifier.
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7.2.2.2 Nodule characterisation and reading timeframe
The radiologists performed two rounds of reading each.
First reading (R1)
During the first reading (Rl), each radiologist performed a free search of the
entire CT dataset, and classified all opacities as positive or negative (Table 7.1). A
nodule was defined according to the Fleischner Society Glossary of Terms for
Thoracic Imaging - that is, a rounded or irregular opacity, well or poorly defined,
measuring up to 3cm in diameter [230],
Category Definition
Definite non-calcified solid nodule > 3mm in maximum transverse
diameter;
OR
any non-solid or part-solid nodule;
Positive
OR
an intrapulmonary lymph node, that satisfied all 5 criteria of:
-a smooth margin
-an ovoid or triangular (but not round or spherical) shape
- < 8mm in maximum transverse diameter
- within 5mm of the pleura (or lies within an interlobar or accessory
fissure)
- at least one interlobular septum radiating from its surface
A non-nodular opacity, that did not have all the characteristics of a
nodule or intrapulmonary lymph node (e.g. a linear or curvilinear
opacity);
OR
Negative A very small opacity, that met the definition of a nodule but was <
3mm
(NB: Radiologists were asked to ignore opacities that they judged to
be an obvious benign opacity (e.g. scar-like opacities or nodules with
a benign pattern of calcification)
Table 7.1. Definition of opacities.
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The purpose of requiring radiologists to mark opacities that were considered
negative was to subsequently allow the distinction to be made between opacities that
were missed and those that had been deliberately ignored.
Following the completion of Rl, the DICOM SR of each reader was reviewed
in LungCARE to identify each recorded opacity. As LungCARE provides only z-axis
and not x- and y-axis coordinates, each opacity was visually matched to the marks on
LungCARE using a separate open-source DICOM software package (Osirix version
4.1.1, Osirix Foundation, Geneva, Switzerland) capable of recording all 3 spatial
coordinates, so that each nodule had a unique set of identifying coordinates. In this
way, two nodules within the same axial slice could be spatially distinguished and not
mistaken for each other.
The designation of each opacity as positive or negative was also recorded for
each reader on Osirix. The spatial coordinates and designations of each opacity were
tabulated for each reader using a commercially available PC database (Microsoft
Excel version 2007, Microsoft Corp., Redmond, CA, USA). Once all detected
opacities were matched and tabulated in this manner, it was possible to generate, for
each radiologist, a list of opacities that had not been recorded by him or her, but had
been identified by at least one other radiologist.
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Second reading (R2)
In the second reading (R2), each radiologist was directed to opacities that had
not been recorded by them but had been identified as a positive nodule by at least
one other radiologist, and asked to categorise them as positive or negative. Each
radiologist was not shown the number of other radiologists who had identified the
opacity. This was done to prevent a "forced" consensus, whereby a radiologist's
opinion might inadvertently be influenced by the opinion of the majority.
7.2.3 Derivation of the reference standard
It was decided at the outset that for a panel of five radiologists, agreement
between any four radiologists after R2 as to the positivity or negativity of a nodule
would constitute the reference standard. A reference standard requiring all five to be
in agreement was regarded as being too stringent, and would have resulted in a small
number of nodules within the reference standard. In turn, this could have spuriously
elevated sensitivity [285] and could also have excluded potentially important
nodules. A reference standard requiring only three radiologists to be in agreement, on
the other hand, was regarded as unsatisfactory, as it would have required only a small
majority to be in agreement.
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7.2.4 Simulation of reader combinations and methods of arbitration
With five radiologists it was possible to simulate 10 pairs of double-readers
and 20 combinations of triple readers. The complex permutations and combinations
that arose from these pair and triplet-combinations are illustrated in section 7.3.
7.2.4.1 Double-reading
In double-reading, there are a variety of methods available to deal with
discordant readings. As indicated in the introduction, a method commonly used is
"consensus" whereby readers discuss (often alongside one another) discrepancies and
decide upon a final answer. However, this method was not used because of its
inherent limitations [344], Instead four possible ways of dealing with discrepancies
in double-reading were evaluated:
1. Double-reading with no arbitration:
In this scenario, any finding deemed positive in the first round of
reading by one OR other radiologist in the pair was considered
positive for that pair, without any need for arbitration. In other words
readers' positive nodules were combined.
2. Double-reading with only internal arbitration:
In this scenario, a reader's interpretation of nodules identified by
another radiologist but not by him or her was taken into account. After
the second round of reading (R2), opacities which were considered
positive by both parties were deemed as positive. Opacities that still
had discrepant designations were considered negative.
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3. Double-reading with only external arbitration:
In this scenario, each radiologist within a pair was assumed to only
have performed a single round of reading (Rl), and would not have
had the opportunity to view the other radiologists' detections. An
opacity identified by both radiologists was accepted as positive
without any arbitration. Any opacity designated a nodule by only one
radiologist was referred for external arbitration by an independent
thoracic radiologist with 10 years of experience.
4. Double-reading with internal arbitration followed by external
arbitration:
In this scenario, readers' interpretation after both R1 and R2 was
taken into account (akin to method 2 above), but this time with
external arbitration of outstanding discrepancies by an independent
reader (the same independent thoracic radiologist as in method 3
above).
7.2.4.2 Triple reading
Triple reading was modelled by combining each pair after R2 with one of the
remaining three readers. For each pair, there were 3 possible triplet combinations,
giving rise to 30 triplet combinations in total. For a particular triplet, an opacity was
regarded as positive if it had been identified by at least two of the three radiologists.
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7.2.5 Measurement of opacity size
The maximum and minimum transverse diameters of each opacity were
recorded, and the average diameter calculated. These measurements were performed
separately by a radiology resident with three years of general radiology experience,
to ensure that this task did not distract any of the five radiologists in performing their
primary functions of detection and interpretation during the two rounds of reading.
7.2.6 Statistical analysis
The total number, median and range of all opacities and of reference standard
nodules identified in the 85 CT studies was calculated. Average nodule diameter for
both reference standard nodules and negative opacities was expressed as mean,
standard deviations, median and range.
Sensitivity and specificity were calculated as explained in Chapter 2. The
following comparisons of the sensitivities and specificities of the different methods
of reading and arbitration were made:
1. Double-reading with no arbitration versus single reading
2. Double-reading with only internal arbitration versus single reading
3. Double-reading with only external arbitration versus single reading
4. Double-reading with only external arbitration versus double-reading
with only internal arbitration
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5. Double-reading with internal arbitration followed by external
arbitration versus single reading
6. Double-reading with internal arbitration followed by external
arbitration versus double-reading with only internal arbitration only
7. Triple reading versus double-reading with internal arbitration.
All comparisons were made using McNemar's test. All analysis was
performed using Medcalc (version 12.5.0.0, MedCalc Software, Mariakerke,





All subjects were male, aged 53-79 years old (mean 62.6 years, median 63).
Three of the 85 CTs contained no opacities identified by any of the five radiologists
A total of 528 opacities were identified by all radiologists in the remaining 82 CTs,
corresponding to 6.44 nodules per subject. A range of 0 to 22 opacities (median 5)
were identified per subject. The distribution of subjects according to the number of
opacities is shown in Figure 7.2.
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No. of identified opacities per subject
Figure 7.2. The number of identified opacities per subject.
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7.3.2 Reference standard
Of the 528 opacities, 186 (35.2%) met the reference standard criteria (i.e.
agreed as a nodule by any four of five radiologists) in 64/85 patients (75.3%). The
nodules comprising the reference standard had a mean diameter of 4.6 ± 1,6mm
(median 4.4mm, range 2.1mm to 15.6mm). The negative opacities had a mean
diameter of 3.5 ± 1.3mm (median 3.4mm, range 1.5 to 13.3mm).
7.3.3 Performance of individual radiologists
The sensitivity and specificity of the individual radiologists is shown in Table
7.2. The mean and median sensitivity were 64.5% and 58.6% respectively; the mean
and median specificity were 84.6% and 89.3% respectively.
Radiologist A B C D E
Sensitivity (%) 86.6 74.7 52.2 50.5 58.6
Specificity (%) 66.7 85.2 89.3 91.6 90.4
Table 7.2. Performance of individual radiologists.
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7.3.4 Summary of comparisons
The effects of double- and triple reading and methods of arbitration are
summarised in Table 7.3.
























































30/30 0/30 0/30 0/0 30/30 0/30
Table 7.3. Summary of effects of double- and triple reading methods on sensitivity and
specificity. Figures are proportions of pairs (for double-reading) or triplets (for triple
reading).
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7.3.5 Performance of double-reading and arbitration
The effect of double-reading using the four scenarios is presented in Tables
7.4-7.15. For each reader, four different pair combinations were possible; thus, a total
of 20 pair-combinations were assessed.
7.3.5.1 Double-reading without arbitration
Sensitivity significantly improved for all readers across all pair-combinations
(Table 7.4). The median sensitivity improved from 58.6% (range 50.5%-86.6%) to
83.6% (range 66.7%-92.5%). There was a corresponding significant decrease in
specificity for all readers, with median specificity decreasing from 89.3% (range
66.7%-91.2%) to 77.1% (range 57.7%-84.9%) (Table 7.5).
7.3.5.2 Double-reading with only internal arbitration
Double-reading with internal arbitration had a variable effect on sensitivity as
compared to a single reader (Table 7.6). Sensitivity significantly increased for 8 of
the 20 pair-combinations (median 16.4%, range 9.1%-32.3%), decreased in 2 pair-
combinations (mean 20.7%, range 16. l%-25.3%), and did not change in the
remaining 10.
The improvement in specificity was more consistent: specificity increased
significantly for 16 pairs (median 7.7%, range 4.6%-29.3%), decreased in 1 pair
(4.6%), and did not change in 3 pairs (Table 7.7).
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5.4 5.9 4.8 4.3
(0.002) (0.0010) (0.039) (0.008)
17.2 9.1 5.9 8.6
(<0.0001) (<0.0001) (0.001) (<0.0001)
40.3 31.7 17.7 23.1
(<0.0001) (<0.0001) (<0.0001) (<0.0001)
40.9 30.1 19.4 16.1
(<0.0001) (<0.0001) (<0.0001) (<0.0001)
32.2 24.7 16.7 8.1
(<0.0001) (<0.0001) (<0.0001) (0.0001)
Table 7.4. Changes in sensitivity using double-reading without arbitration. For a given
pair, each figure represents the percentage change in sensitivity as compared to the
single reader, with P values (McNemar's test) in parentheses. P values in bold font
indicate statistically significant change.


































































Table 7.5. Changes in specificity using double-reading without arbitration. For a given
pair, each figure represents the percentage change in specificity as compared to the
single reader, with P values (McNemar's test) in parentheses. P values in bold font
indicate statistically significant changes.
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Table 7.6. Changes in sensitivity using double-reading with only internal arbitration.
For a given pair, each figure represents the percentage change in sensitivity as
compared to the single reader, with Rvalues (McNemar's test) in parentheses. P
values in bold font indicate statistically significant changes.





































-1.1 11.9 11.6 5.8
(0.6171) (<0.0001) (<0.0001) (0.0008)
6.7 7.8 8.4 7.5
(<0.0001) (<0.0001) (<0.0001) (<0.0001)
1.4 5.3 6.1 4.6
(0.4414) (0.0013) (<0.0001) (0.0014)
-4.6 0.6 6.4 5.8
(0.027) (0.8597) (0.0003) (<0.0001)
Table 7.7. Changes in specificity using double-reading with only internal arbitration.
For a given pair, each figure represents the percentage change in specificity as
compared to the single reader, with Rvalues (McNemar's test) in parentheses. P
values in bold font indicate statistically significant changes.
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7.3.5.3 Double-reading with only external arbitration
Double-reading using only external arbitration also had a variable effect on
sensitivity as compared to a single reader (Table 7.8). Sensitivity significantly
increased for 11 of the 20 pair-combinations (median 14.0%, range 5.9%-26.9%),
decreased in 4 pair-combinations (median 7.8%, range 4.8%-10.2%), and did not
change in the remaining 5 pair-combinations.
However, specificity increased significantly for only 4 pairs (median 14.3%,
range 12.8%-15.7%), decreased in 6 pairs (median 6.4%, range 4.9%-10.4%), and
did not change in 10 pairs (Table 7.9).
When compared to double-reading with only internal arbitration, double-
reading with only external arbitration improved sensitivity in 4 of 10 pairs (median
12.9%, range 9.1%-17.7%), decreased sensitivity in 2 of 10 pairs (median 7.0%,
range 6.5%-7.5%), and did not change sensitivity in the remaining 4 pairs (Table
7.10). However, significantly decreased specificity was seen for all 10 pairs (median
6.4%, range 4.6%-13.6%) (Table 7.11).
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Table 7.8. Changes in sensitivity using double-reading with only external arbitration.
For a given pair, each figure represents the percentage change in sensitivity as
compared to the single reader, with P values (McNemar's test) in parentheses. P
values in bold font indicate statistically significant changes.
































































Table 7.9. Changes in specificity using double-reading with only external arbitration.
For a given pair, each figure represents the percentage change in specificity as
compared to the single reader, with Rvalues (McNemar's test) in parentheses. P















AB 88.2 81.7 -6.5 0.019
AC 61.3 79.0 17.7 <0.0001
AD 82.8 76.3 -6.5 0.082
AE 86.0 78.5 -7.5 0.0108
BC 58.6 73.1 14.5 0.0003
BD 71.0 69.4 -1.6 0.7277
BE 78.0 72.6 -5.4 0.0776
CD 49.5 58.6 9.1 0.0171
CE 53.2 64.5 11.3 0.0043
DE 59.7 61.8 2.1 0.4807
Table 7.10. Comparison of the sensitivity of double-reading with only external
arbitration to double-reading with only internal arbitration. P values in bold font














AB 84.1 79.4 -4.7 <0.0001
AC 95.9 82.3 -13.6 <0.0001
AD 93.0 81.2 -11.8 <0.0001
AE 85.8 80.9 -4.9 <0.0001
BC 97.1 87.0 -10.1 <0.0001
BD 96.8 86.7 -10.1 <0.0001
BE 91.0 85.2 -5.8 <0.0001
CD 97.7 91.9 -5.8 <0.0001
CE 96.8 90.1 -6.7 <0.0001
DE 96.2 90.1 -6.1 <0.0001
Table 7.11. Comparison of the specificity of double-reading with only external
arbitration to double-reading with only internal arbitration. P values in bold font
indicate statistically significant changes.
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7.3.5.4 Double-reading with internal arbitration followed by external
arbitration
Introducing external arbitration on the pair combinations only when there
were outstanding discrepancies after internal arbitration demonstrated increased
sensitivity for 18 out of 20 pairs over a wide range (median 18.5%, range 4.3%-
40.9%), and did not change in the remaining 2 pairs. Sensitivity did not decrease for
any reader (Table 7.12).
This method increased specificity in only 4 pair-combinations (median 9.1%,
range 5.5%-12.8%), and decreased specificity in 10 pair-combinations (median
8.4%, range 4.1 %-17.1 %), with no change in the remaining 6 pairs (Table 7.13).
When compared to double-reading with only internal arbitration, double-
reading with internal followed by external arbitration significantly improved
sensitivity in 9 out of 10 pairs (median 8.6%, range 3.8%-26.3%) (Table 7.14), but at
the expense of diminished specificity in all 10 pairs (median 11.4%, range 7.0%-
16.5%) (Table 7.15).
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Table 7.12. Changes in sensitivity using double-reading with internal followed by
external arbitration. For a given pair, each figure represents the percentage change in
sensitivity as compared to the single reader, with Rvalues (McNemar's test) in
parentheses. Rvalues in bold font indicate statistically significant changes.







A B C D E
A 5.5 12.8 11.6 6.7
If
M


















(0.0002) (0.1930) (0.5322) (0.1939)
n




(<0.0001) (0.0011) (0.6476) (0.0058)
re
CQ c
-17.1 -10.4 -4.1 -4.1
(<0.0001) (<0.0001) (0.0140) (0.0140)
Table 7.13. Changes in specificity using double-reading with internal followed by
external arbitration. For a given pair, each figure represents the percentage change in
specificity as compared to the single reader, with Rvalues (McNemar's test) in
















AB 88.2 90.9 2.7 0.4984
AC 61.3 87.6 26.3 <0.0001
AD 82.8 91.4 8.6 0.0002
AE 86.0 89.8 3.8 0.0233
BC 58.6 81.7 23.1 <0.0001
BD 71.0 79.6 8.6 0.0002
BE 78.0 82.3 4.3 0.0133
CD 49.5 71.0 21.5 <0.0001
CE 53.2 76.9 23.7 <0.0001
DE 59.7 67.7 8.0 0.0003
Table 7.14 Comparison of the sensitivity of double-reading with internal followed by
external arbitration, to double-reading with only internal arbitration. R values in bold















AB 84.1 72.2 -11.9 <0.0001
AC 95.9 79.4 -16.5 <0.0001
AD 93.0 78.3 -14.7 <0.0001
AE 85.8 73.3 -12.5 <0.0001
BC 97.1 86.1 -11.0 <0.0001
BD 96.8 84.6 -12.2 <0.0001
BE 91.0 80.0 -11.0 <0.0001
CD 97.7 90.7 -7.0 <0.0001
CE 96.8 86.4 -10.4 <0.0001
DE 96.2 86.4 -9.8 <0.0001
Table 7.15 Comparison of the specificity of double-reading with internal followed by
external arbitration, to double-reading with only internal arbitration. P values in bold
font indicate statistically significant changes.
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7.3.6 Performance of triple reading
With triple reading, a universal improvement in sensitivity occurred for each
of the 10 pairs, across each of its 3 possible combinations (median 23.9%, range
6.5%-47.8%) (Table 7.16). However, as with double-reading with external
arbitration (either alone or following internal arbitration), a universal decrease in




























































































Table 7.16. Changes in sensitivity using triple reading, compared to double-reading
with only internal arbitration. Figures are percentage changes in sensitivity, with P




















































































Table 7.17. Changes in specificity using triple reading, compared to double-reading
with only internal arbitration. Figures are percentage changes in sensitivity, with P
values (McNemar's test) in parentheses. P values in bold font indicate statistically
significant changes.
7.4 Discussion
The results of this investigation show that the effect of double-reading on the
performance of individual experienced radiologists is immensely variable, depending
on the method used to deal with discordant readings.
Double-reading without arbitration was shown to universally increase
sensitivity for nodule detection. The impetus for improving nodule detection alone -
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without necessarily an interpretation component - is strong when one considers that
most failures of lung cancer diagnosis are due to failures of detection [381, 382], The
findings of the present investigation support the notion that increasing the number of
readers in detection tasks improves the sensitivity of detection, simply by combining
the evaluation of both readers. This observation is consistent with those of
Wormanns et al., in one of the few studies of double-reading in pulmonary nodule
detection. That study, performed in a group of patients with pulmonary metastases
rather than a lung cancer screening population, found that mean sensitivity for
detection using independent double-reading without any arbitration improved
sensitivity from 64% for a single reader to 79% on LDCT [334],
A similar effect of double-reading on sensitivity when using this independent
double-reading strategy has been observed in mammographic screening, with
increased cancer detection rates [342, 343], However, the penalty for an increased
sensitivity is usually an increase in false positive detections, resulting in a decreased
specificity and positive predictive value [341], This decrease in specificity has been
replicated in the current study, and has particular relevance to lung cancer screening
with CT, which is known to generate large of numbers of false positive detections
even with single readers [164],
For this reason, lung cancer screening studies and other evaluations of
double-reading in nodule detection have also incorporated some form of arbitration
or consensus, so that there is a mechanism to decide what should be designated a
positive or an "actionable" finding. Double-reading in lung cancer screening has
been in use since the Early Lung Cancer Action Project (ELCAP) [142] and has also
been used in multiple European randomised control trials, including the NELSON
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trial. In both the ELCAP and NELSON trials, two readers initially tried to achieve
consensus through discussion. The NELSON study used two readers, one at a
peripheral reading site and one at a central site, and in cases of discrepancy the
central reader would attempt to achieve consensus with the first through discussion.
If no consensus could be reached, arbitration by a third reader of 20 years'
experience was used, with the majority decision of the three readers used as the final
result [169, 174], In these studies attempting consensus, the use of discussion could
potentially result in forced or "coerced" consensus, where the opinions of more
experienced radiologists supersede those of less experienced ones [344], As noted by
Bankier et al., participation in a group consensus effort may have a modifying effect
on an individual radiologist's opinion, diminishing the value of a consensus
agreement (which they termed "groupthink"). In any case, the merit of consensus
discussion on the nature of a small opacity is questionable; such opacities have very
few defining characteristics, and so do not lend themselves to discussion.
Thus, instead of using consensus by discussion, three different methods of
resolving discrepancies using double-reading with arbitration were modelled. First,
with double-reading using only internal arbitration, radiologists were shown nodules
that they had missed during the first round of reading, providing them with the
opportunity to record nodules that they may have failed to detect during the initial
read. This method had the advantage of allowing "internal" arbitration regarding an
opacity without requiring all radiologists to be present simultaneously, and also
without any particular radiologist forming a dominant opinion that may inadvertently
coerce the agreement of other radiologists. It also prevented radiologists from
altering the categorisation of nodules which they had initially detected on free search.
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Using this method had a variable effect on sensitivity. The variability of the
results of this method of arbitration was understandably a reflection of the baseline
sensitivity of the individual readers comprising the pair. A very sensitive reader
could significantly improve the sensitivity of a pair, as demonstrated by the 7 pairs
involving readers A or B using this method. However, the effect of less sensitive
radiologists on the very sensitive radiologists is not easy to predict: in the present
investigation, reader C significantly weakened the sensitivity of readers A and B (the
two most sensitive readers) while readers D and E had no effect.
These findings thus underscore the importance of establishing the baseline
performance characteristics of any reader in a multiple reader setting. Notably, the
sensitivities of the individual readers (50.5% to 86.6%) in the current study were
similar to those in previous studies [289, 293, 325, 334], and so there is no reason to
suspect that these findings are unique to the expert readers in the present study.
Despite this variability in performance, there are two trends revealed by this
method of double-reading with internal arbitration that are complementary and
potentially advantageous to a lung cancer screening programme. First, sensitivity
was either unchanged or improved in the majority of pair-combinations. Second,
specificity was improved in the majority of combinations.
Next double-reading with external arbitration was simulated, where the
opinion of the third independent reader was sought in all cases that were discordant
after round 1. This had a markedly variable effect on sensitivity and specificity as
well, compared to a single reader. Furthermore, this method was not superior to
simply using internal arbitration alone. In the third method, double-reading with
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internal followed by external arbitration was simulated. On the whole this led to
increased sensitivity, compared to a single reader, and compared to internal
arbitration alone. However, this increased sensitivity came at the expense of either
unchanged or diminished specificity, when compared to a single reader in the
majority of combinations.
Finally, triple reading was investigated. Triple reading seemed to be
universally reliable in improving sensitivity, but again at the expense of specificity,
as compared to double-reading with internal arbitration only.
There are two implications of these results for lung screening in practice.
First, if external arbitration does not consistently improve sensitivity, while leaving
specificity diminished or unchanged, reliance on this method is questionable.
Second, the highly labour- and time-intensive natures of this strategy are additional
reasons for caution when applying these methods to lung screening practice. It is
worth noting here that "double"-reading in cases where some fonn of external
arbitration is used is in fact fallacious; such cases invariably will have to involve the
services of a third reader, and so are really also forms of triple reading. The
identification of discrepant nodules requiring arbitration and the recording of final
readings during external arbitration are administrative tasks that can lengthen the
total time taken for this process.
The potential lack of benefit of double-reading has been demonstrated by
Ying Wang et al. In a retrospective analysis of 74 proven lung cancer cases from the
prevalence screening round of the NELSON study, they concluded that double-
reading detected only 2 (2.7%) more lung cancers with a 0.2% reduction in
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specificity [174], This conclusion is probably premature given the small sample size.
It may also not be applicable to the task of lung nodule detection in general, given
that the main criteria for assessment of nodules in the NELSON study is growth as
demonstrated by semi-automated volumetry, a relatively reproducible parameter
[311, 313]; as previously discussed in section 1.6.2.3, volumetry helps with
interpretation, but not with detection itself. Nevertheless, this adds to the evidence
regarding variable effects of multiple reading strategies shown by the current study.
The findings in the present investigation also have implications for the widely
varying reference standards used in studies on lung nodule identification. A single
expert radiologist acting as a reference standard would be questionable; it is arguable
whether any one radiologist can have the "final word" in defining such a standard,
since sensitivity (as demonstrated by previous studies and reinforced by the results of
the present investigation) and agreement among radiologists with respect to nodule
characteristics are highly variable [142, 396, 397], In studies on computer-aided
diagnosis (CAD) as compared to radiologists, the reference standards were
established by two expert radiologists in consensus who reviewed the marks made by
CAD software and readers, and were free to add their own detection marks [289,
293, 336], In defining these standards, no methods of arbitration have been
described; it is conceivable that differing reference standards could be produced by
different methods of arbitration, with consequently different performance
characteristics demonstrated. It is thus important that all studies reporting nodule
detection accuracy outline in detail methods used to resolve discrepancies.
This study has a few limitations. The reference dataset has only been
established through consensus, without histological data; thus, the true significance
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of all nodules is not known. However, in screening practice histological
corroboration of the vast majority of nodules would not be available, and as such a
consensus standard is the only initial surrogate standard available to enable decision¬
making. Nevertheless, it should be noted that the sensitivity and specificity described
here are with reference to such a standard.
Also, the reference dataset was created through the involvement of the same
radiologists that were under investigation, a potential source of error which is
difficult to correct for [287], Although it has been suggested that the reference
standard should be created by another group of radiologists who are not being tested
[287] this also has its limitations because there is no reason to suppose that another
group of independent expert radiologists will perform any better than the group
under evaluation and so provide a more accurate estimate of ground "truth". Also,
the readers were from different institutions and so no "institutional" bias in terms of
attitude towards over- or undercalling nodules should be expected. Furthermore, each
radiologist was aware that they were involved in a nodule detection exercise, and
hence the potential for heightened vigilance existed. However, such vigilance also
exists in the setting of lung cancer screening. Finally, the exact values for double-
reading with external arbitration do depend to a certain extent on the sensitivity of
the external arbiter itself. The importance of this factor in turn would depend on
whether the external arbiter had higher or lower sensitivity specifically for the task of
interpretation as opposed to detection, since the process of external arbitration
requires that he or she be directed only to discordant findings and asked to provide an
interpretation, rather than performing the task of detection as well. However, the
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magnitude of this effect in this study cannot be measured because the sensitivity of
the external arbiter was not directly assessed.
It was not possible to analyse the level of disagreement between readers due
to differences in nodule measurement. It is known that interobserver agreement
improves with increasing nodule size [396], but size-based analysis was not the
primary aim of this study. Readers were instructed to classify opacities with
characteristics of a nodule that were greater than 3mm as positive, but were not asked
to record their measurements for each nodule, because (a) this would have been too
time-consuming and detract from the primary task of nodule detection and
evaluation, and (b) the interobserver variability inherent to both diameter [307] and




The performance of experienced thoracic radiologists for the task of lung
nodule detection is not invariably improved by increasing the number of
readers, and is significantly affected by the method of arbitration used.
If double-reading is to be practised, perhaps the most effective and least
labour-intensive method is double-reading with only internal arbitration, as
maintained or increased nodule detection with an unchanged or improved
specificity, without requiring the services of a third reader.
The effects of double-reading and arbitration methods must be recognised
when devising reading strategies, defining reference standards that rely on
consensus, and assessing reader performance against these standards.
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CHAPTER 8: CONCLUSION
Over the past fifteen years, lung cancer screening trials using CT have
convincingly shown that CT can detect more lung cancers than chest radiography
[142, 143, 150, 164, 398]; furthermore, that these cancers are more likely to be at an
early stage and, most recently, that a reduction in mortality can be achieved [164],
While further results from different randomised control trials are awaited to confirm
such a mortality reduction, the pessimism arising from the lack of benefit seen in
earlier screening trials using chest radiography has slowly given way to enthusiasm
for screening with CT. However, as yet there has been no detailed consideration of
the pragmatic reading strategies required when extrapolating CT lung cancer
screening from the trial setting to a national screening programme. The
investigations contained in this thesis have provided a number of insights into the
implications of different CT reading strategies for nodule detection accuracy and for
radiologists' workload should such a programme be implemented.
The evaluation of radiographers as readers in CT lung cancer screening has,
to my knowledge, not previously been reported. In Chapter 4, following a short
period of standardised training, radiographers were able to achieve sensitivities
for nodule detection that were comparable to radiologists in literature, but were
inferior to radiologists reading the same studies. Importantly, however, the range
of differences seen between radiographers and radiologists was not dissimilar to
that seen between radiologists in previous studies. The implication of these
findings is that while radiographers on the whole are not sensitive enough to be used
as first readers (a characteristic they share with CAD systems), some radiographers'
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detection abilities compare favourably with those of radiologists, potentially
allowing them to act as assistant readers. Furthermore, radiographers were clearly
able to follow strict size (predominantly volumetry-based) and morphological criteria
to designate opacities as nodules and intrapulmonary lymph nodes.
In order to determine whether radiographers could fulfil the role of assistant
readers, their effect as concurrent readers on radiologists' performance was
subsequently assessed in Chapter 5. Concurrent reading, rather than second reading,
was chosen because it is a more pragmatic method of implementing radiographer-
assisted reading in a screening programme - a radiologist could perform his or her
review of the radiographer's marks in the same sitting as a "free search" for
additional nodules. Concurrent reading has also recently been evaluated using CAD,
but with conflicting effects on sensitivity and reading time reported [294, 354]. Two
important conclusions arose from this investigation. Firstly, concurrent reading
conferred an increase in sensitivity for all but the most sensitive radiologist.
Secondly, concurrent reading was able to reduce reading time, by as much as 4
minutes. Such a time-saving, coming as it did with the benefit of increased
sensitivity, has positive implications for a national screening programme; the number
of radiologists required for such a programme could be substantially reduced by
using radiographer-assisted concurrent reading, or alternatively, a radiologist would
require less time to read an equivalent number of studies in a session. The
importance of these effects in encouraging both radiographers and radiologists to
participate in a screening programme should not be underestimated. Radiographers
would participate in the knowledge that their contribution is simultaneously
enhancing sensitivity and screening throughput. Radiologists, meanwhile, would
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arguably be more willing if they could focus their expertise on the tasks of
interpretation and decision-making rather than simply detection in screening, while at
the same time being able to read faster.
It was also inferred from the investigations in Chapters 4 and 5 that the
performance characteristics of radiographers may be similar to those of a CAD
system. To address this question directly, the performance of radiographers was
directly compared against a commercially approved CAD system in Chapter 6.
Radiographers demonstrated that they were at least as sensitive as CAD for
nodule detection. Arguments against a radiographer rather than computer assistant
often centre on the fact that a human is expensive, prone to fatigue and inconsistent,
but such arguments are at least partly one-sided; as previously discussed in Chapter
6, CAD systems, including the one evaluated in this thesis, are also prone to marked
differences in sensitivity and average false positive detections per case [359],
Ultimately, the strength of a screening programme rests on its ability to
maximise early lung cancer detection while minimising false positive detection, and
this in turn depends both on the performance of its readers and its mechanism for
arriving at a robust consensus on nodules that require follow-up. This aspect of lung
nodule detection has not been sufficiently addressed in previous studies on nodule
detection or CT lung screening; the advantages of double-reading have been taken at
face value, and methods of arbitration have differed substantially without
acknowledging their potential impact [159, 169, 289, 336, 337, 345, 346], The
modelling of different methods of arbitration in Chapter 7 exposed the stark variation
in performance characteristics that may be encountered when different methods of
resolving discrepancies and different numbers of radiologists are used for nodule
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detection and interpretation. Significantly, the comparison of models revealed that
the addition of an external arbiter does not invariably improve sensitivity for
nodule detection, and may leave specificity decreased or unchanged, making
reliance on such a mechanism of arbitration questionable. In contrast, a
mechanism of "internal arbitration" maintained or improved both sensitivity
and specificity. Such a mechanism of arbitration provides a second round of reading
in which radiologists within a pair independently decide on the significance of
nodules that they had missed, without discussion and the potential for a "forced"
agreement, and without the services of a third reader. Using such a method, only
nodules agreed by both radiologists in a pair would be included in a consensus.
However, the logistics of applying such a method of arbitration to lung screening
practice are challenging, as each radiologist would be required to read the same case
twice, at separate sittings. As such, this investigation provides insights into the
delicate balance that must be achieved by the reading strategy of a lung cancer
screening programme. In the pursuit of improved sensitivity, the variation in
different methods of double-reading has to be borne in mind, in addition to an
awareness that "double"-reading when using some form of arbitration is really a
misnomer: external arbitration requires a third reader and a total of three rounds of
reading, while internal arbitration requires two readers but a total of four rounds of
reading.
A recurring theme through all the investigations in this thesis is the accepted
trade-off between sensitivity and false positive detection, whether the reader is a
radiologist (reading alone, in combination with other radiologists, or with a
concurrently reading assistant radiographer), a radiographer, or a CAD system. An
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important finding is that although radiographers reading alone, and radiologists
performing radiographer-assisted concurrent reading, had higher average false
positive detections per case than independently reading radiologists alone, these
average false positive detections per case were still lower than those of CAD
systems in the literature, and of the CAD system evaluated in Chapter 6. A
recent investigation has demonstrated the potential for CAD's benefit as a second
reader to be negated once a certain false positive detection threshold is reached
[290], When viewed in this light, the relatively lower false positive detection with
radiographer-assisted concurrent reading is welcome, as it suggests that the false
positive detections arising from such a reading paradigm will not compromise the
benefit accrued from its increased sensitivity.
In demonstrating the variation in nodule detection performance between
readers, the investigations in Chapters 3 through to 7 have also reinforced notions of
an inherent perceptual ability unique to each individual, even if the visual search
patterns they use may differ depending on their level of training [335], However,
Chapters 3 and 4 have also captured the potential importance of exposure to a task
over a longer period of time, for readers with a lower baseline perceptual ability.
While a significant learning effect across the 10 small subsets read was not
demonstrated overall for the radiographers in Chapter 3, the two less sensitive
radiographers in Chapter 4 were able to improve their sensitivity while keeping
their average false positive detections per case static, when undertaking a 10-
week period of reading more CTs. It is important to note that while these
radiographers in the UKLS pilot study were not given direct feedback, they were
comparing their own readings with those in the consensus, once it had been achieved,
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and so were enacting a form of self-directed learning that would be crucial to the
success of assisted reading in a screening programme. Also, the fact that less
sensitive radiographers could improve distinguishes them from a CAD system,
where, even if an upgrade is performed, the dataset and algorithms for derivation of
an improved performance remain impervious to the standard radiologist.
The investigations in Chapter 4 and 6 also provide some insight into what to
expect with radiographer reading should higher size thresholds be used for nodule
positivity in future screening programmes, as recently suggested [383], If such an
approach is adopted, not only would radiographer sensitivity be maintained when
compared to radiologists or to CAD, but radiographer and radiologist sensitivity
would probably become more aligned.
The limitations of each investigation have been highlighted in individual
chapters, the most obvious, but insurmountable, limitation being the lack of
histopathological corroboration of nodules to serve as the standard of reference.
However, as histopathological information would not be available for the vast
majority of nodules in screening practice, a consensus standard is the only surrogate
standard available to enable decision-making, and serves to illustrate the
comparisons between the various reading strategies that have been explored.
In summary, the investigations in this thesis have described the performance
of different CT reading strategies for nodule detection in lung cancer screening,
including the previously unreported role of radiographers as readers. In the future,
some of these observations could be used to inform the choice of optimal reading
strategy for a national screening programme in the UK.
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Appendix 1: Permission to obtain NELSON nodules




to Mali, W., Pim, Anand, me
Dear Dr Mali,
So very many thanks for your reply. That is all very clear. Acknowledgement of
"Nelson nodules" was taken as read (in fact, the provenance of the cases would have
to be stated in the Methods section, at the very least).
As you have suggested, we will route any further questions we have about
permission/acknowledgement/authorship thro' the excellent Pim.
Thanks again,
DavidMH
From: Mali, W. [W.Mali@umcutrecht.nl]
Sent: 20 October 2011 10:57
To: Hansell David
Cc: Pim de Jong
Subject: RE: NELSON nodules/board
Dear dr Hansell, thank you for your mail.
I am glad the cases were helpful for you.
I think it is fine when these cases are used for the thesis too.
I don t think we have to be co authors but perhaps you can acknowledge
The Nelson study for supplying you with the cases.
Whenever you have more questions about the Nelson study
Or want to contact us please feel free to approach Pim de Jong
He is my trusted collaborator at the UMCUtrecht and can help you.
Best regards Willem Mali
Van: Hansell David [mailto:davidhansell@rbht.nhs.uk]





Please forgive this out of the blue approach. We have not met but Mathias Prokop
suggested I contact you.
I am involved with the UK lung cancer screening pilot study (Prof John Field is the
Priniciple Investigator) and as you may be aware Dr Pirn de Jong has been hugely
helpful in providing our Dr Arjun Nair with some CTs from Utrecht which have been
put to good effect in training our radiographers.
Dr Nair is with us for the next year or two and, with myself and a co-supervisor Dr
Anand Devaraj, we are putting together a plan for his thesis - which will revolve
around the successful, or otherwise, training of non-radiologists for reading
screening CTs (approximately 7 chapters, i.e. 7 different investigations). Because
recruiting of UKLS cases only starts in the next 3 weeks time it will be a few months
before we have sufficient UK studies to make use of, so it would be useful but not
absolutely crucial, if we could use some of the Nelson cases for studies in the first
two of his chapters.
We understood clearly from the outset, from Pirn de Jong and Mathias Prokop, that
we would need the sanction of the Nelson Board to use Nelson CTs in any study
which is why 1 am writing to you. I understand that you are on the Nelson Board and
since the CTs are Utrecht cases I thought it would be appropriate to route any such
request through you. Would that be okay? Of course, if one or other of the
investigations using "Nelson nodules" is fit for publication we would be pleased to
have relevant coauthors as suggested by you/the Board. I think the plan for Dr
Arjun's thesis will be completed in the next couple of weeks so at that point we
would have the outline of each investigation for your/Nelson Board's approval.





De informatie opgenomen in dit bericht kan vertrouwelijk zijn en is uitsluitend
bestemd voor de geadresseerde. Indien u dit bericht onterecht ontvangt, wordt u
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verzocht de inhoud niet te gebruiken en de afzender direct te infonneren door het
bericht te retourneren. Het Universitair Medisch Centrum Utrecht is een
publiekrechtelijke rechtspersoon in de zin van de W.H.W. (Wet Hoger Onderwijs en
Wetenschappelijk Onderzoek) en staat geregistreerd bij de Kamer van Koophandel
voor Midden-Nederland onder nr. 30244197.
Denk s.v.p aan het milieu voor u deze e-mail afdrukt.
This message may contain confidential information and is intended exclusively for
the addressee. If you receive this message unintentionally, please do not use the
contents but notify the sender immediately by return e-mail. University Medical
Center Utrecht is a legal person by public law and is registered at the Chamber of
Commerce for Midden-Nederland under no. 30244197.
Please consider the environment before printing this e-mail.
DISCLAIMER:
The information contained in this email may be subject to public disclosure under the
NHS Code of Openness or the Freedom of Information Act 2000. Unless the
information is legally exempt from disclosure, the confidentiality of this email, and
your reply cannot be guaranteed.
The information and material in this email is intended for the use of the intended
addressee or the person responsible for delivering it to the intended addressee. It may
contain privileged or confidential information and/or copyright material.
If you receive this email by mistake please advise the sender immediately by using
the reply facility in your email software or notify Royal Brompton & Harefield NHS
Trust Help Desk on +44(0) 20 7351 8696
Communication is not sent through a secure server; Royal Brompton & Harefield
NHS Trust cannot accept responsibility for the accuracy of outgoing electronic mail.
Any views or opinions expressed are solely those of the author and do not represent
the view of Royal Brompton & Harefield NHS Trust unless specifically stated.
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Appendix 2: Cost quote for Visia CT Lung System
version 3.1 (Mevis Medical Solutions, Bremen,
Germany)
Sales Quotation
















Part No Qiy. Amount
VCT-3100-SA
vims'" CT Lung System srttn Nodule CAD
(Version 3.1) with AutoPoinf* Temporal
Comparison and Pulmonary Artery Patency
Exam (PE"~) Feature®
Descriptor The vwa~ CT Lung System (v3.1)
promisee excsusve FDA-de3red ung nodule
corrpccer-aWed-detectJOT' (CAD; and automatic
measurement tools tor chest nurtJ-siee CT
(MSCTy includes Vista'" server (v3.1) and
wortstaoon {v'3-C.i sofware AutoPomf"
temporai conpansor fe3tire, Pulmonary Artery
Patency Exam .iPE*1* i feature, remote
instariacor, ana appications tramng ana 1-year
warranty
Wortstatten cuent Licenses 3 included
(NOTE, idsfa™ CTLung System O a scftware-
ontysauOon Customer must prwtae server
ana wortcsaoofl AanfMre compliant wXft system
requirements. I
Onelte Installation and applications training
vials'" CT Lung System service Agreement
DeserpBon The vtsia CT Lung System (v3.1)-
System Support Agreement includes telephone
technics support, remote Diagnostics and
system maintenance, 3rd software updates ana
upgrades to easang 'unctlonaltty











Terms Net 3C days FOE Factory
Frei^tt prepaid ana added
Quote va*d for 30 aays
Wananty Mevis Medical Solutions, inc warrants these products
to be fee fom aefecte in materia* and workmanship ftx a penoa
of one (1) year from date or deHvery
s pedal Conditions Cases ax wu ce adaea f me Euyer s not
ax exempt Pease mauae your tax exemption manner or oca
ax rate on yoir purchase order as applicable.
Quote Prepared By
Signature
To place an order for me produces ana or services included n
mis quocalon. please sign and dale tt*6 document in the spaoe
prov-ded or suflrht a purchase order vta mall or fax to
MeVis Medea Solutions, inc
N27 W2X075 Pajj CI Ste 10C
Pewaufcee, Wl USA 53072
Phone 262-691-953C Far 262-691-9531
Quote Accepted By
Signature
Date
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